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ABSTRACT 
Nature is known to exploit both proteins and RNA as enzymes. No natural enzymes, 
however, have been discovered that are made of DNA. One can think of both RNA and proteins 
as large biopolymers with the potential to form complex secondary and tertiary structures capable 
of doing catalysis. Given the structural similarities between RNA and DNA, it is reasonable to 
think that DNA can also form these structures. If oligonucleotides can act as comparable catalysts 
to proteins, a number of practical reasons to favor their development exist. The number of possible 
sequences is much smaller for DNA and RNA than for proteins; a sequence n units long has 4n 
possible sequences of nucleotides and 20n possible sequences of amino acids. In addition, 
oligonucleotide synthesis lacks many of the practical challenges associated with protein expression 
and purification. DNA offers further advantages over RNA: DNA is cheaper, more stable, and 
easier to synthesize.  If DNA can act as an efficient catalyst, the area of deoxyribozyme research 
is relatively unexplored, making the chances of discovering new deoxyribozymes likely. If 
deoxyribozymes can be identified that perform useful chemical reactions for which a catalyst has 
not yet been discovered, the impacts could be extensive. 
Protease enzymes, which catalyze cleavage of proteins, are essential enzymes for 
biotechnology. Engineering of natural proteases to change their site of cleavage is an exciting 
prospect, but this process usually leads to relaxed substrate selectivity, rather than a true change in 
enzyme specificity. Because DNA catalysts are identified from pools of random DNA sequences, 
no inherent peptide sequence biases must be overcome during the selection process, and thus the 
prospect of truly selective artificial proteases is reasonable. Chapter 2 describes our efforts to 
identify DNA catalysts which cleave peptide bonds. Previous efforts seeking DNA-catalyzed 
peptide cleavage resulted in DNA catalysts led to the identification of deoxyribozymes that cleave 
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a DNA phosphodiester bond. In order to avoid identifying deoxyribozymes for phosphodiester 
cleavage in future efforts for peptide bond cleavage, an additional capture reaction was employed, 
and new in vitro selection experiments identified DNA enzymes for ester cleavage and aromatic 
amide cleavage. Unfortunately no enzymes for peptide cleavage were identified.  
Several additional efforts to identify DNA catalysts for peptide bond cleavage are 
described in chapter 3. Selection experiments were performed with stronger nucleophiles including 
amine, hydrazide, and thiol included in the in vitro selection step, with the hope that 
deoxyribozymes might be identified which can use one of these nucleophiles to enable the cleavage 
reaction. Selection experiments for DNA-catalyzed cleavage of N-acetylglycine, N-
fluoroacetylglycine, and N-difluoroacetylglycine were performed, with the hope that new 
deoxyribozymes for cleavage of these activated substrates could facilitate our understanding of 
DNA-catalyzed amide cleavage. Finally, selection experiments for DNA catalysts that catalyze 
peptide self-cleavage using nucleophilic amine acids were performed, with the hope that 
deoxyribozymes which catalyze cleavage use an internal, tethered peptide nucleophile are more 
easily identified than those that catalyze hydrolysis. Unfortunately, each of these three selection 
strategies were unsuccessful. Additional selection experiments seeking amide cleavage using 
extremely long random regions were performed, based on the premise that much longer random 
regions are able to form the required complexes that shorter random region lengths cannot. 
Interestingly, deoxyribozymes identified from these selections do not catalyze amide cleavage, but 
instead they catalyze DNA cleavage by an oxidative mechanism similar to the natural product 
bleomycin. 
Previous efforts by our lab sought deoxyribozymes which catalyze the reaction between 
lysine and triphosphorylated RNA. Despite the strong nucleophilicity of primary amine functional 
iv 
 
groups, no DNA catalysts have been identified that can utilize it as a substrate. In one example, 
deoxyribozymes were identified which catalyze the reaction between phosphoramidate linkage 
and triphosphorylated RNA, even when a much stronger lysine nucleophile was available. In 
efforts described in chapter 4, a more reactive phosphorimidazolide substrate was employed to 
react with both DNA-C3-NH2 and DNA-HEG-CKA substrates. Deoxyribozymes that catalyze 
reaction between the amino group and phosphorimidazolide substrate were identified. In addition, 
a single deoxyribozyme was identified which utilizes the C4-NH2 of a cytosine nucleobase as a 
nucleophile, a finding which highlights the ongoing difficulty of identifying DNA catalysts for 
reactions involving amine-containing substrates.  
Chapter 5 describes in vitro selection efforts seeking lysine acylation, a common post-
translational modification important in gene expression, control of protein function, and primary 
metabolism. The in vitro selection strategy employed relied on glutaric acid thioester acyl donors, 
which contain a carboxylic acid that could be used in a capture reaction to separate active 
sequences from inactive sequences. The substrates used during in vitro selections were DNA-C3-
NH2 and DNA-HEG-AAAKAA. Additionally, N40 and N80 random region lengths and both 
oligonucleotide-anchored and free small molecule thioesters were employed. Thirteen rounds of 
in vitro selection were performed, but no DNA enzymes were identified. Future efforts seeking 
DNA-catalyzed acylation will use chemically-modified nucleotides to expand the functionality of 
DNA and facilitate catalysis.  
Efforts to identify deoxyribozymes which catalyze glycosylation are described in chapter 
6. Protein glycosylation is a post-translational modification critically important in molecular and 
cellular recognition. Natural glycosylating protein enzymes, glycosyltransferases, use nucleoside 
diphosphate sugars (NDP sugars) as glycosyl donors in their catalyzed reactions. Attempts to 
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identify glycosylating deoxyribozymes were hindered by the instability of NDP-sugars in the 
presence of certain divalent metal ions. Alternative glycosyl donors, O-aryl glycosides, were used 
to identify deoxyribozymes for 3′-OH glycosylation of DNA. Attempts to identify DNA catalysts 
for protein glycosylation resulted in the DNA enzymes that catalyze self-glycosylation near the 5′-
terminus of the catalytic region. A new selection strategy that prevents the selection of self-
glycosylating deoxyribozymes was designed. That strategy will be implemented in future selection 
experiments.   
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Chapter 1: Introduction to Chemical and Enzymatic Catalysis 
1.1 Overview of Catalysis 
1.1.1 Introduction to Catalysis 
It is difficult to overstate the importance that catalysis of chemical reactions has all aspects 
of our world, including manufacturing, technology, and human health.1 The development of 
catalysts that enable unique chemical reactions to occur with accelerated rate and control has and 
will continue to revolutionize industries far outside of chemistry. The pursuit of new catalysts, and 
the continued development of methods to identify new catalysts, is both intellectually and 
scientifically challenging and of broad importance to society. 
In this chapter, chemical catalysis and enzymatic macromolecular catalysis will be 
compared. The majority of the chapter will focus on macromolecular catalysis, including natural 
protein enzymes and ribozymes, as well as engineered protein enzymes, ribozymes, and 
deoxyribozymes. 
1.1.2 Chemical Catalysis 
In its most basic form, a reaction can be catalyzed by acid or base. These are reactions 
whose rates depend a great deal on the concentration of acid or base present. Notable examples of 
acid-catalyzed reactions include the Fisher esterification, in which a carboxylic acid and alcohol 
react to form an ester.2 Notable examples of base-catalyzed reactions include several hydrolysis 
reactions, such as ester hydrolysis, in which OH– is the active species in the reaction.3 In each of 
these cases, the actual conditions of the reaction act as the catalyst. 
Additionally, small molecule catalysts have been developed for more challenging chemical 
reactions. These developments have had a profound impact on the field of organic chemistry, 
enabling the synthesis of extremely complex small molecules. Small molecule catalysts are distinct 
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from the acid- and base-catalyzed examples above because the catalyst is a discrete molecule, or 
molecular complex, that can be added to the reaction. This is an important distinction. Small 
molecule catalysts have built in specificity for catalyzing certain chemical reactions. For instance, 
the Buchwald-Hartwig cross-coupling reaction4,5 is transition metal-catalyzed formation of a new 
carbon-nitrogen bond between an aryl halide and amine. This can be accomplished in the presence 
of many other different functional groups. The catalyst, in this instance, accelerates a reaction only 
between two very specific reactants, and provides the chemist with a large amount of control over 
the outcome of the reaction.  
1.1.3 Enzymatic Catalysis 
Enzymatic catalysis refers to catalysis carried out by large, macromolecular structures 
called enzymes. Perhaps the most important difference is in the selectivity of enzymes for acting 
upon certain substrates. Enzymes are macromolecules capable of adopting secondary and tertiary 
structures which can bind substrates, destabilize substrate ground states, and stabilize reaction 
transition states. The best enzy6mes have rate enhancements of greater than ~1015,7 and can have 
catalytic efficiency that is limited by diffusion of substrates into the enzyme and products out of 
the enzyme.8,9 
Because enzymes adopt very complex three-dimensional structures, the selectivity of their 
reactions is extremely high. This is the reason that enzymes are the primarily catalysts in 
biochemical reactions. They are able to impart the required selectivity to allow biology to 
function.10 In addition, this selectivity makes them ideal for many chemical and biotechnological 
applications.11  
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1.2 Natural Enzymes 
1.2.1 Protein Enzymes 
Protein enzymes have long been considered to be primary functional molecules in a cell. 
Proteins were thought to be the only enzymes in biology, responsible for cellular power, regulation, 
and replication. As mentioned above, enzymes are ideal catalysts for these tasks because they offer 
the specificity necessary to carry out chemical reactions in a biological system.  
Proteins are polymers of amino acids linked via peptide bonds. 20 naturally occurring 
amino acids are used to make up protein structures (Fig. 1.1), although unnatural amino acids and 
post-translational modifications can affect protein function beyond the natural amino acids. The 
chemical structures of these amino acids have a tremendous amount of chemical diversity, which 
is surely required for protein enzymes to catalyze such diversity of chemical reactions.   
Proteins adopt hierarchical structures which include secondary, tertiary, and quaternary 
structures. It is these complex structures that allow for a protein enzyme to catalyze a chemical 
reaction using different principles of catalysis, such as transition state stabilization, ground state 
destabilization, and the breakup of chemical reactions into many smaller steps.12 Protein secondary 
structures form when specific sequences of amino acids fold into unique structures such as -
helices and -sheets. Such secondary structures can assemble together to form tertiary structures. 
Finally, multi-subunit enzymes into quaternary structures. In general, the required amino acid 
identities to form secondary structures is quite strict, and most random protein sequences would 
not adopt the required three-dimensional structures to do catalysis. This principle will become very 
important in the discussion of protein-based selection experiments.  
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Figure 1.1. Twenty naturally occurring amino acids. The diversity of side chain functional groups 
is illustrated. 
1.2.2 Ribozymes 
RNA was once thought to simply be a passive carrier of genetic information, transferring 
information from DNA, where the information was permanently stored, to proteins, which carried 
out the many functions within a cell. The discovery that RNA was indeed catalytic was initially 
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surprising, not only because it shifted this paradigm of relating to the transfer of genetic 
information, but also because RNA should, in theory, have fewer functional capabilities than 
proteins because of the lack of diverse RNA functional groups (Fig. 1.2). Proteins have a diverse 
range of functional groups which facilitate with their many functions, including catalysis. 
Considering this lack of functionality, the finding that RNA is indeed capable of catalysis was 
indeed surprising.  
 
Figure 1.2. Chemical structure of RNA backbone and four nucleobases.  
The first natural ribozyme discovered, the group I intron from Tetrahymena 
thermophila,13,14 is 421 nucleotides long and contains a roughly 200 nucleotide catalytic core. This 
catalytic core is widely conserved amongst other group I introns, while other peripheral sequences 
are varied in different organisms.15 The group I intron catalyzes the first step in intron splicing, in 
which the 3′-oxygen of an exogenous guanosine acts as a nucleophile (Fig. 1.3a).  
RNase P was identified shortly after the discovery of the Group I intron by Sidney Altman 
at Yale University.16 Rather than utilizing the 3′-OH of a nucleotide, however, RNase P catalyzes 
direct attack of water to cleave the RNA phosphodiester backbone (Fig. 1.3b).  
In addition to the group I intron and RNase P, many smaller ribozymes have also been 
discovered in nature. The hammerhead ribozyme has been identified in a large number of different 
organisms and catalyzes RNA cleavage by transesterification to form 5′-phosphate and 2′,3′-cyclic 
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phosphate products (Fig. 1.3c),17,18 and in some instances it has also been observed that it can 
catalyze the reverse RNA ligation reaction.19 The hairpin ribozyme has function similar to the 
hammerhead ribozyme in that it can catalyze both RNA transesterification and RNA ligation 
reactions.20 The twister ribozyme also catalyzes RNA cleavage by transesterification and has been 
discovered in a number of different organisms, like the hammerhead ribozyme.21,22 The hepatitis 
delta virus (HDV) ribozyme, which is necessary for replication of the hepatitis delta virus, 
catalyzes RNA transesterification by acid-base catalysis in which a key cytosine nucleobase acts 
as a general acid to protonate the 5′-OH leaving group.23 Importantly, the prevalence of small 
catalytic RNAs provides additional support that catalytic RNA is indeed important biological 
regulation.  
 
Figure 1.3. Catalytic activities of natural ribozymes. (a) The group I intron uses the 3′-OH of an 
exogenous guanine to attack the RNA phoshodiester bond. This forms the 3′-OH and 5′-G 
products. (b) RNase P catalyzes direct hydrolysis of RNA phosphodiester bond. (c) RNA cleavage 
by transesterification, as catalyzed by several naturally occurring small ribozymes. Some of these 
(hammerhead, hairpin) also catalyze the reverse ligation reaction shown. 
7 
 
Other ribozymes exist as large ribonucleoprotein complexes (RNPs) in which the both the 
RNA and protein are required for catalytic activity, but where the RNA is actually responsible for 
catalysis. Perhaps the most notable ribozyme example is that of the ribosome. Although the 
ribosome in its active form is an ribonucleotide protein complex (RNP),24 it has been shown that 
the RNA portion is responsible for catalysis.25 Hiller and coworkers used kinetic isotope effects to 
unequivocally show that the ribosomal activity is due to RNA. See Figure 1.4 for a brief summary 
of their findings. Importantly, this disproves the speculations that the ribosome functioned simply 
by holding substrates in close proximity to one another. 
 
Figure 1.4. Possible mechanisms for ribosome function. The red, yellow, and green pathways refer 
to proposed mechanisms for ribosome catalysis. The red pathway shows concerted formation of a 
tetrahedral intermediate, followed by stepwise breakdown of the tetrahedral intermediate to form 
the products. The yellow pathway shows stepwise formation of the tetrahedral intermediate and 
concerted breakdown to form products. The green pathway shows concerted attack of the 
nucleophilic nitrogen and leaving of the 3′-OH to form products. The black pathway shows the 
uncatalyzed reaction, in which two distinct transition states are observed. Reprinted with 
permission from Ref. 25. 
Although the discovery of catalytic RNA trailed the discovery of catalytic proteins, 
catalytic RNA is involved in many different biological processes, including gene expression and 
protein synthesis. The important roles of catalytic RNA in biology highlight the effectiveness of 
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RNA as a catalyst. Their importance further suggests that engineered nucleic acids could be 
promising in vitro catalysts for chemical and biotechnological applications.  
1.3 Engineered Enzymes 
Enzymes can also be unnatural, what will be referred to here as “engineered” enzymes. An 
engineered enzyme can mean either a natural enzyme that has been somehow changed for a 
specific purpose, or a completely artificial enzyme developed without a natural enzyme starting 
point. Methods to engineer enzymes are extremely diverse, and each has various advantages and 
disadvantages. Common methods for enzyme engineering are discussed, and notable successes 
associated with these methods are highlighted. 
1.3.1 Protein Enzymes 
Engineered protein enzymes can come from either de novo protein design, in which an 
active site is designed and placed inside of a protein, or from various evolutionary methods to 
identify catalysts. This section will describe both of these general strategies.  
1.3.1.1 Protein Design 
De novo protein design begins by determining a mechanism for the reaction to be 
catalyzed, which the functional groups that would facilitate catalysis and their location within an 
active site.26-28 The overview of a protein design pipeline is shown in Figure 1.5. This active site is 
frequently called a “theozyme” because it represents the best theoretically designed enzyme.29 This 
active site is then modeled into a larger protein scaffold,30 expressed, and assayed for activity. It is 
extremely challenging to predict which scaffolds will work with certain theozymes, and more 
broadly which enzymes will have the best catalytic activity. Because of this, designed proteins are 
usually improved by performing several rounds of directed evolution.31 
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Figure 1.5. Overview of de novo protein design process. The reaction mechanism (a) is used to 
prepare a theozyme (b), or an ideal active site based on chemical principles to accelerate the 
reaction. The theozyme is computationally optimized (c) and placed into existing protein scaffolds 
(d). Scaffolds that match well with the optimized active sites are expressed and assayed for 
catalytic activity. Reprinted with permission from Ref. 28. 
Several designed enzymes have been reported, including those that catalyze the Kemp 
elimination reaction,32 the retro-aldol reaction,33 the Diels-Alder reaction,34 and ester hydrolysis.35 
Despite these successes, enzyme design is extremely challenging. Another report31 showed that 
after subjecting a designed retro-aldolase to rounds of directed evolution in order to improve its 
activity, the active site underwent rather dramatic changes. The lysine intended to participate in 
catalysis via formation of a Schiff base intermediate no longer served that role, and instead a new 
active site lysine that originated during mutagenesis was involved in the Schiff base. This 
highlights the challenges of de novo protein design and shows that a complete understanding of 
the relationship between enzyme structure and function is simply not known. With this in mind, 
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designed proteins can serve as useful starting points for subsequent directed evolution in which a 
natural protein starting point is unavailable.36 
1.3.1.2 Protein Directed Evolution 
Protein engineering relies on directed evolution for the development of proteins with their 
desired properties.11,37,38 Unlike in protein design, directed evolution requires an active enzyme 
starting point. This active enzyme is genetically mutated to create a library of mutants, and then 
mutants are either individually screened for activity or subjected to a selection in which active 
mutants are separated from inactive mutants (Fig. 1.6). Mutants that confer an advantage can be 
subjected to subsequent rounds of mutation and evolution, to further enhance their desired 
property.  
 
Figure 1.6. Overview of directed evolution process. Mutations are introduced into the parent 
protein gene to create a library of mutated genes. The protein variants are expressed and either 
screened or selected for the desired property. Protein variants not showing improvement for the 
desired property are discarded, while protein variants that do show improvement are carried 
through additional rounds of evolution until variants with the desired property are achieved. Figure 
reprinted from Ref. 38. 
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Genetic mutations can be incorporated by a number of different methods. One method for 
introducing mutations include the use of chemical mutagens such as ethane methanesulfonate 
(EMS)39 or nitrous acid40 which damage the DNA and lead to errors during replication, however 
they are not ideal for directed evolution because of biases in the mutations formed.39,40 Error-prone 
PCR41 is another mutagenesis method that increases the number of mutations a polymerase 
incorporates by using a higher concentration of Mg2+, including Mn2+, or using different 
concentrations of the four dNTPs in the PCR reaction. And although error-prone PCR also has 
mutational biases, methods have been introduced to account for this differential mutation.42 
Additionally, the enzymatic incorporation of deoxyinosine has been introduced as a form of error-
prone PCR.43 This method relies on the promiscuous base pairing interaction of deoxyinosine to 
enable mutagenesis. 
Methods to introduce focused genetic mutations are also known. Structural data can be 
used to choose mutations that are likely to affect the desired property of the protein. For example, 
these important mutations might be part of the active site if seeking to improve the catalytic activity 
of an enzyme. The chief advantage of introducing focused is that a smaller number of mutation 
sites are identified, which means a higher fraction of possible variants can be included in the 
library. Focused mutagenesis is usually accomplished using synthetic DNA that introduces genetic 
mutations at the sites to be modified, while maintaining the fidelity of the gene at all other 
locations.44 The disadvantage of protein engineering with focused is that human understanding of 
protein structure and function is limited, and residues distant to the active site of an enzyme can 
have significant effects on its activity.45 These important residues are virtually impossible to 
identify based on structural data, and are not considered when only focused mutations are 
introduced. 
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DNA shuffling is a method for introducing genetic mutations rely on the process of 
homologous recombination. Although specific details between different DNA shuffling methods 
vary, the general strategy relies on enzymatic cleavage of a gene and randomized DNA 
reassembly.46,47 DNA shuffling is only successful at introducing mutations if performed with a 
diverse array of gene, such as a library of protein homologues. Such a method takes advantage of 
the functionality that nature has provided protein families. Finally, Assembly PCR48 and synthetic 
shuffling49 are methods that rely on overlapping synthetic oligonucleotides that are assembled 
together by PCR. These methods, and others that rely on synthetic DNA, have become increasingly 
common as DNA synthesis of large numbers of diverse sequences becomes trivial.36 
A large number of methods have been used to screen for active enzyme mutants. 
Chromatography, mass spectrometry, and colorimetric assays are all commonly used to screen 
protein variants. The limitation of these methods is the limited throughput of screening sample 
variants. These methods are limited screening ~103-104 variants in a reasonable time. Fluorescence 
activated cell sorting (FACS) has also been used, together with yeast display or in vitro 
compartmentalization, to identify improved protein variants. FACS can be used to screen much 
larger libraries, up to 108 members, in 24 h, giving it much greater utility than some methods 
above. In addition, various selection methods have been developed that do not examine require 
screening every sample, but rather link protein improvement to physical separation or organism 
survival.36 This allows for rapid analysis of large libraries.  
The impact of directed evolution for protein engineering is significant. Protein enzymes 
that enable various biotechnological processes have been developed, including enzymes with 
enhanced thermostability,50 amylases that catalyze the breakdown of starches,11 and enzymes that 
catalyze deprotection of an important antibiotic compound,51   . More recent notable achievements 
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of directed evolution include the engineering of P450 enzymes to catalyze various organic 
chemistry reactions,52-55 engineering of organophosphate hydrolases to destroy nerve dangerous 
chemicals,56 and development of cellulases with increased activity.57 
One powerful variant on classic directed evolution is a method called phage assisted 
continuous evolution (PACE).58 PACE uses M13 bacteriophage to transfer genes from host cell to 
host cell. Protein activity is tied to the production of phage protein III (pIII), which is required for 
host cell binding and activity. If the selection gene does not produce a functional protein, pIII is 
not produced, and the phage are ~108 less infectious than those that do express pIII. Because 
successive rounds of evolution are dependent on the phage lifecycle, dozens of rounds of evolution 
can occur in a single day, and several hundred rounds of selection can be performed in only a few 
weeks. PACE therefore allows one to study protein evolution paths, a process that cannot be 
understood if only a small number (<15-20) of rounds of evolution can be performed. In one 
interesting application, PACE was used to study evolution of the hepatitis C virus (HCV) protease 
in the presence of two protease inhibitors, danoprevir and asunaprevir.59 In only 1-3 days of PACE, 
HCV protease mutations began to arise that matched those mutations observed in patients. One 
could imagine using PACE to look for likely mutations that might arise in a key protein upon 
treatment with a certain drug. Additionally, the effect of drug cocktails could be evaluated for 
effectiveness is suppressing drug resistance. This highlights the power of the PACE to investigate 
problems not related to protein engineering.  
1.3.1.3 mRNA display 
A method called mRNA display that is distinct from directed evolution that allows for one 
to select active protein catalysts has been reported.60,61 This method, called mRNA display, is in 
many ways similar to the in vitro selection strategies for nucleic acids that will be discussed. 
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mRNA display (illustrated in Fig. 1.7) begins with double-stranded DNA which is transcribed into 
RNA. The key step in mRNA display is modification of RNA with puromycin leads to a covalent 
linkage between the translated protein and coding mRNA. If the translated protein catalyzes the 
reaction of interest (between A and B in the illustration), reverse transcription can be performed 
and cDNA can be isolated by binding to a solid support. cDNA is amplified by PCR and 
subsequent rounds of selection and amplification can be performed.  
 
Figure 1.7. Overview of mRNA display. DNA is transcribed, modified with puromycin, and 
translated to generate the mRNA-linked product. This is subjected to selection conditions in which 
the protein can catalyze the reaction of interest, and reverse transcription and pull-down of the 
immobilized product separates active proteins which are amplified by PCR. Figure reprinted with 
permission from Ref. 61. 
1.3.2 Ribozymes 
Interest in identifying engineered ribozymes for various chemical reactions quickly became 
of interest to a number of different research groups. Development of artificial ribozymes was 
facilitated by a process called in vitro selection, which was first used in the context of RNA to 
identify RNA aptamers capable of binding to specific molecular targets.62,63 In vitro selection, 
which is often called systematic evolution of ligands by exponential enrichment (SELEX) for 
identifying aptamers, is a process in which a large number of RNA sequences are assayed for 
function at the same time, and those sequences with the desired function are physically separated, 
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PCR-amplified, and subjected to additional rounds of selection. One of the primary advantages of 
in vitro selection is that extremely large libraries of sequences, up to 1014, can be used in selection 
experiments.  
Artificial ribozymes have been identified for a large number of different chemical reactions 
involving RNA, including cleavage by transesterification,64 ligation,65,66 phosphorylation,67,68 and 
polymerization.69,70 Ribozymes have been also been identified for use with substrates that are not 
RNA, including the Diels-Alder reaction,71,72 the Aldol reaction,73 and acyl transfer reactions.74-76 
The diversity of chemical reactions catalyzed by engineered ribozymes is extremely diverse and 
shows the catalytic potential of RNA is quite good.  
Although a large number of engineered ribozymes have been identified for chemical 
reactions, there is still a dearth of information regarding how these ribozymes function compared 
to natural ribozymes. Structural data is available for a lead-dependent ribozyme77,78 that catalyzes 
RNA cleavage and for a ribozyme that catalyzes the Diels-Alder reaction.79 Next-generation 
sequencing has been used to study80 the in vitro selection process with hope to better understand 
how active sequences are enriched, but that information does not necessarily lead to more 
information about active catalysts. In general, there is still very limited understanding regarding 
how engineered ribozymes function or are identified through selection.  
1.3.3 Deoxyribozymes 
DNA and RNA are structurally very similar, only differing in that DNA lacks the 2′-OH of 
RNA and replaces the uridine ribonucleoside with thymidine deoxyribonucleoside (Fig. 1.8). 
Because of these similarities, it is reasonable to assume that DNA could also have catalytic 
abilities, despite the absence of natural catalytically active DNA. This lack of natural catalytic 
DNA is reasonable because DNA primarily exists in a double-stranded form, which lacks the 
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ability to adopt complex three-dimensional structures that catalyze chemical reactions.81 In its 
single-stranded form, however, DNA can adopt these complex structures, and thus the prospect of 
catalytic DNA in vitro is reasonable. Indeed, the first DNA catalyst was reported in 1994.82 This 
deoxyribozyme cleave a single ribonucleotide linkage in a DNA substrate. Since then, 
deoxyribozymes for a large number of other reactions have been identified.83 
 
Figure 1.8. Chemical structure of DNA backbone and four nucleobases.  
No three-dimensional structures of DNA catalysts have been reported.83 The only method 
to identify new DNA catalysts is through the use of in vitro selection. An overview of in vitro 
selection for DNA is shown in Figure 1.9. This method is similar to that described for RNA, except 
that no reverse transcription step is necessary for DNA. 
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Figure 1.9. Overview of in vitro selection strategy to identify deoxyribozymes for RNA ligation. 
A population of random DNA sequences (shown in green; N40 denotes 40 nucleotides in the 
random region) flanked by constant primer binding arms (shown in brown) are ligated to the 
substrate of interest. This ligation product is then incubated with its ligation substrate in the 
presence of divalent metal ions, allowing for any catalytically active sequences to perform 
catalysis. Active sequences are separated by PAGE, amplified by PCR, and the enriched pool is 
subjected to another round of in vitro selection.  
 
Initial DNA catalysts primarily used nucleic acid substrates, which is reasonable because 
Watson-Crick base pairing can be used to engineer facile interactions between the catalytic 
sequences and substrates. More recent efforts, primarily by the Silverman lab, have focused on 
identifying DNA catalysts that can use peptide substrates. Much success has been found using 
peptide substrates which are anchored to oligonucleotides complementary to the enzyme binding 
arm,84-86 and several deoxyribozymes have been identified that can also utilize substrates free in 
solution.87-90  
Several deoxyribozymes have been identified that catalyze reaction of the tyrosine side 
chain with triphosphates and phosphorimidazolides, to form nucleopeptides.87,89,91,92 Similarly, 
deoxyribozymes that catalyze tyrosine and serine phosphorylation have been found.85,93 DNA 
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catalysts capable of dephosphorylating tyrosine and serine side chains have also been found,88 as 
have deoxyribozymes that catalyze elimination of phosphoserine to form dehydroalanine.90 
Despite the large number of deoxyribozymes for reactions involving peptide substrates, the 
majority of these reactions involve an oxygen nucleophile and a phosphate electrophile. The dearth 
of deoxyribozymes which use other nucleophiles or electrophiles suggests some inherent difficulty 
of DNA utilizing these other substrates.  
1.4 Advantages of DNA as a catalyst 
The use of DNA as a catalyst has several advantages over both proteins and RNA. In 
comparing DNA or RNA catalysts to proteins, it is much more straightforward to select or evolve 
new catalytic function with nucleic acids. Importantly, both DNA and RNA can be amplified. 
DNA can be amplified directly by polymerase enzymes, whereas RNA first needs to be reverse 
transcribed to DNA which is then amplified by polymerase enzymes. In contrast, proteins cannot 
be reverse translated. As discussed, mRNA display has been used for in vitro selection of protein 
enzymes,60,61 but in practice its use is much more difficult than nucleic acid selections. Additionally, 
issues such as low coverage of sequence space and misfolding can complicate in vitro selections 
for proteins. 
In addition, sequence space coverage of nucleic acids is much greater than for proteins. 
Nucleic acids have four natural monomers than can be used, and proteins have twenty natural 
monomers. If an enzyme is 40 monomers long, the number of possible nucleic acid sequences is 
440, or ~1024, and the number of possible protein sequences is 2040, or ~1052. If a selection 
experiments can include ~1014 unique sequences, the sequence space coverage for a nucleic acid 
selection is much greater than for a protein selection, although sequence coverage in each case is 
quite low. For nucleic acids, this is less of a problem, because a much higher fraction of sequences 
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will form secondary structures by Watson-Crick base pairing. In practice, the identity of all 40 
nucleotides in a catalytic sequence is not strictly required. In contrast, amino acid sequences have 
very strict requirements for forming secondary structures such as a-helices and b-sheets. Therefore, 
the likelihood of random amino acid sequences adhering to these strict requirements is even lower, 
and most amino acid sequences are unlikely to properly fold. Considering the simpler selection 
process, the smaller sequence space, and the high probability of folding properly, nucleic acids 
have considerable advantages over proteins when performing in vitro selections for new catalytic 
function. 
In considering nucleic acid catalysts, DNA has further practical advantages over RNA. 
These include its chemical stability, cost, and ease of synthesis. DNA is an ideal biopolymer from 
which to identify useful macromolecular catalysts. 
1.5 Thesis Research Focus 
The work described herein is focused on the identification and development of 
deoxyribozymes for covalent protein modification. The work has focused on two primary areas: 
DNA catalysts for peptide cleavage and DNA catalysts for lysine modification. Chapter 2 focuses 
on the identification of deoxyribozymes for ester, aromatic amide, and peptide cleavage, and 
Chapter 3 discusses additional efforts that have been carried out seeking DNA-catalyzed amide 
cleavage. Chapter 4 reports the identification of DNA catalysts for lysine modification using 
phosphate electrophiles, and Chapter 5 reports subsequent efforts for identification of lysine 
acylation. Chapter 6 shifts the focus of the thesis to DNA-catalyzed glycosylation, and recent 
efforts to identify deoxyribozymes with glycosyltransferase activity are discussed. 
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Chapter 2: DNA Catalysts for Hydrolysis of Esters and Aromatic Amides1 
 
2.1 Introduction 
2.1.1 Applications of Natural Proteases in Biology and Biotechnology 
Protease enzymes are extremely important biological enzymes. Protease activity can have 
very different effects on biological outcomes, including initiation of an enzymatic cascade, 
conversion of a proenzyme into the active enzyme form, and control of protein concentrations by 
degradation of excess proteins, among many other functions.1 Several different mechanistic classes 
of proteases exist, including serine proteases, cysteine proteases, aspartate proteases, and 
metalloproteases, among others. Serine and cysteine proteases cleave peptide bonds by attack of 
either a serine or cysteine amino acid in the active site which cleaves the peptide bond and forms 
an acyl enzyme intermedate.2 This acyl enzyme intermediate is subsequently cleaved to regenerate 
the active enzyme. In contrast, aspartate proteases catalyze direct attack of water on the peptide 
bond.3 Using a network of aspartate residues, water is deprotonated and hydroxide attacks the 
peptide bond, resulting in direct cleavage. Metalloproteases also cleave by direct hydrolysis. A 
transition metal, usually zinc, is bound in the active site. This metal ion serves to activate active 
site water for nucleophilic attack on the peptide bond (e.g., zinc-bound water has pKa of ~7, 
approximately 9 orders of magnitude more acidic than bulk water).4 
Proteases are also widely used in biotechnology.5 The use of trypsin digest for protein mass 
spectrometry has been fundamental in protein biochemistry.6  Proteases with very specific 
                                                          
1 This research has been published: 
 
Brandsen, B. M.; Hesser, A. R.; Castner, M. C.; Chandra, M.; Silverman, S. K. DNA-Catalyzed Hydrolysis 
of Esters and Aromatic Amides. J. Am. Chem. Soc. 2013, 135, 16014-16017. 
 
University of Illinois undergraduate Marissa Castner performed reselections for ester cleavage and 
University of Illinois undergraduate Anthony Hesser performed selections using different random region 
lengths. 
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cleavage sites, such as thrombin or the TEV protease, have been used to cleave protein fusions or 
remove affinity tags. Additionally, certain serine proteases have been used as therapeutics, such as 
to initiate blood clotting in hemorrhaging patients.7 All of this supports the idea that proteases with 
very specific cleavage sites would be extremely valuable biotechnological tools.  
2.1.2 Applications of Engineered Proteases 
Engineered proteases have also been used for applications in biology and biotechnology. 
In general, the use of proteases for research in vitro is so widespread that proteases with unique 
cleavage specificity would certainly be of value. We have identified two specific applications for 
which deoxyribozyme proteases would be of value. One specific area of proteomic mass 
spectrometry, called middle-down proteomics, employs proteases that cut a large protein into a 
small number of pieces for mass spectrometry analysis.8 The number of natural proteases with the 
necessary cleavage sites for this method are limited, and other investigators have gone to great 
lengths to make the natural proteases work in vitro.9  
Additionally, the use of engineered proteases in biosynthesis is of broad interest. The 
biosynthesis of ribosomally synthesized and post-translationally modified peptide natural products 
requires a leader peptide for recognition by post-translational tailoring enzymes. After tailoring, 
the leader peptide is removed by endogenous proteases. Unfortunately, these endogenous proteases 
are often membrane-bound, and reconstituting them in vitro is challenging or impossible.10 
Engineering proteases for custom protein cleavage sites has two major difficulties.11 First, 
the engineering of proteases with unique specificity usually results in proteases with relaxed 
specificity compared to the protease used to begin the engineering experiment. Second, proteases 
identified from directed evolution experiments may not have the same activity or specificity with 
a full-length folded protein. The development of deoxyribozyme proteases has the potential to 
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solve both of these problems. Because DNA catalysts are identified from random populations of 
sequences rather than active enzyme starting points, there is no selectivity bias in any DNA 
sequences, and thus it is reasonable to expect deoxyribozymes identified to cleave a specific 
sequence would be selective for those sequences. Additionally, in vitro selections to identify new 
DNA catalysts could be performed using the full-length folded protein, so that any catalysts 
identified would be performing catalysis on the substrate of interest (although in practice such a 
selection would be quite challenging). Therefore, the development of DNA catalysts for peptide 
cleavage would overcome the major limitations of engineering selective protease enzymes.  
Others have sought nucleic acid-catalyzed cleavage of esters and amides, but these 
examples are limited in scope and practical utility. The group I intron has modest activity for 
cleavage of an aminoacyl ester.12 The group I intron was also evolved to cleave an amide linkage.13 
It uses a guanosine nucleophile to attack the amide analogue of the natural phosphodiester linkage. 
It is not clear, however, how this could be extended to cleave peptide bonds. Hydrolysis of a 
cholesteryl carbonate derivative was accomplished using an RNA aptamer which had been 
identified to bind to a phosphodiester transition state analogue.14 
2.1.3 Efforts for DNA-Catalyzed Peptide Bond Cleavage Lead to DNA Hydrolysis 
Previous efforts in the Silverman Lab seeking peptide bond cleavage were performed using 
a DNA-Ala-Ser-Ala-DNA substrate (in which the tripeptide is embedded between two DNA 
binding arms (Fig. 2.1).15,16 An N40 pool (i.e., 40 random nucleotides) was ligated to the tripeptide-
containing substrate and, during the selection step, incubated with divalent metal ion cofactors. 
During this selection step, DNA sequences are allowed the opportunity to cleave the peptide bond. 
DNA sequences from the N40 pool that cleave the peptide bond lose the left DNA binding arm, 
which causes sufficient gel shift for PAGE separation. These in vitro selection experiments were 
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performed, and sequences that cut a phosphodiester bond nearby to the peptide substrate were 
identified. This result was unexpected considering the uncatalyzed half-life of DNA 
phosphodiester bond hydrolysis is ~30 million years,17 while the uncatalyzed half-life of peptide 
or amide hydrolysis is ~200 years.18 The identification of deoxyribozymes which preferentially 
catalyze a much slower chemical reaction rather than a much faster reaction was surprising. 
 
Figure 2.1. Schematic showing identification of DNA-hydrolyzing deoxyribozymes. (a) 
Tripeptide substrate was used for in vitro selection for peptide hydrolysis. Catalytically active 
sequences were separated by a downward PAGE shift. (b) Cleavage site of DNA-hydrolyzing 
deoxyribozymes. Figure adapted with permission from Ref. 16. 
2.1.4 Design of In Vitro Selections for Peptide Cleavage and Peptide-Like Cleavage 
Two peptide or peptide-like substrates were chosen that have increased reactivity compared 
to a peptide or amide bond (Fig. 2.2). Esters are more reactive than amides because the hydroxyl 
leaving group is much less basic than the amine leaving group in an amide. Aromatic amides are 
also less reactive than amide substrates because aniline is less basic than an amine leaving group. 
Additionally, a tripeptide, Ala-Phe-Ala, was chosen because it contains an aromatic amino acid. 
Development of several synthetic ribozymes for tRNA acylation called flexizymes were shown to 
rely on the inclusion of an aromatic group for recognition and catalysis.19 Similarly, the Ala-Phe-
Ala contains an aromatic group that might facilitate recognition, binding, and cleavage of the 
tripeptide by the DNA catalyst.  
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Figure 2.2. Full chemical structures of the ester, amide, and tripepeptide substrates showing 
connections to DNA. The first thymidine (T) nucleoside on each side is drawn. The DNA sequence 
for the 5′-anchor segment is 5′-AAAGTCTCATGAACTT-3′, where the 3′-terminal T is illustrated. 
The DNA sequence for the 3′-anchor segment is 5′-TATGTTCTAGCGCTTCG-3′, where the 5′-
terminal T is illustrated. Substrate 4 is structurally analogous to 1, except it contains an amide 
linkage in place of the ester linkage. 
 
2.2 Results and Discussion 
2.2.1 Alternative Strategy to Achieve DNA-Catalyzed Peptide Bond Cleavage 
To identify deoxyribozymes capable of peptide cleavage, a strategy to capture the product 
of peptide bond hydrolysis was developed. In general, a capture strategy should rely on a specific 
chemical reaction between the product of the catalyzed reaction and another chemical moiety, 
usually an oligonucleotide, which will have sufficient mass to shift the active sequences away from 
the inactive sequences by PAGE. It is important that the capture reaction is specific for only the 
catalyzed reaction product and not the products of any other reactions, because the selection 
experiment may not result in selecting for the specific reaction desired.  
To select for catalysts that cleave peptide or peptide-like bonds, we chose to capture the 
carboxylic acid product. It would instead be possible to capture the leaving group, a primary amine 
in amide or peptide cleavage, but this strategy would change if selecting for cleavage of esters or 
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aromatic amides. By capturing the carboxylic acid, the capture step remains the same for each 
substrate 1-3. This strategy thus required the substrate to be ligated to the DNA pool such that the 
carboxylic acid remains attached to the active DNA sequence.  
The capture reaction was designed so that a 5′-amino-modified capture oligonucleotide was 
held in close proximity to the carboxylic acid product using a complementary DNA sequence as a 
splint (Fig. 2.3, Fig. 2.4)20 The water-soluble coupling agent DMT-MM21,22 was employed for this 
capture reaction and showed yields up to 80% in an overnight capture reaction. Additionally, no 
capture of a 3′-phosphomonoester oligonucleotide, which would be the product of DNA 
hydrolysis, was observed. This capture strategy was thus a viable method to specifically select 
DNA catalysts for ester or amide cleavage and avoid selecting deoxyribozymes for DNA 
phosphodiester bond cleavage.  
Each selection was performed using one of two incubation conditions defined as either 
(conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 
mM NaCl at 37 °C, or as (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl 
at 37 °C. Each of Zn2+, Mn2+, and Mg2+ have been effective deoxyribozyme cofactors in many 
prior selection experiments, but Zn2+ and Mn2+ cannot be used above pH 7.5 due to precipitation 
and oxidation, respectively. 
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Figure 2.3. Capture strategy to select for ester-cleaving or amide-cleaving deoxyribozymes. The 
ester or amide substrate is ligated to the random pool of DNA sequences. The ligated product is 
incubated at specific pH with divalent metal ions, allowing the population of DNA sequences the 
opportunity to cleave the scissile. Sequences that catalyze this cleavage are captured by a splinted 
condensation using an amino-modified oligonucleotide and DMT-MM and separated by PAGE. 
Figure reprinted with permission from Ref. 20. 
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Figure 2.4. Capture step during in vitro selection (a) Capture of the carboxylic acid hydrolysis 
product by a 5′-amino oligonucleotide with DMT-MM as activator. (b) Experimental validation of 
the capture reaction, along with a negative control experiment to show that the 3′-phosphate 
product of phosphodiester hydrolysis at the 5′-side of the 3′-terminal thymidine is not detectably 
captured. Figure reprinted with permission from Ref. 20. 
 
2.2.2 Synthesis of Ester, Aromatic Amide, and Tripeptide Ala-Phe-Ala Substrates 
Preparation of the ester, aromatic amide, and tripeptide Ala-Phe-Ala substrates was 
performed using a combination of solid-phase synthesis and solution-phase synthesis. Esters are 
cleaved under the basic conditions required for cleavage and deprotection of oligonucleotides 
prepared by solid-phase synthesis. An alternative strategy was developed in which the ester 
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substrate was prepared as two separate DNA oligos, and these oligos were coupled in a final 
solution-phase reaction to form the ester bond. The right side of the substrate terminating in a 5′-
OH was prepared by automated solid-phase synthesis as a standard oligonucleotide without 
modification. The 3′-CO2H oligo was prepared by coupling a 3′-CO2H modified thymidine 
nucleotide23,24 to the 5′-OH of a thymidine nucleotide anchored to a controlled pore glass (CPG) 
solid support. After coupling, the rest of the DNA substrate was synthesized from this modified 
thymidine by automated solid-phase synthesis. The 3′-CO2H oligo was cleaved from the solid 
support and deprotected using 400 mM NaOH in 4:1 methanol:water. The 5′-OH substrate and 3′-
CO2H were used to prepare full-length ester substrate by solution-phase coupling using 
EDC/HOBt and a complementary DNA splint to hold the two pieces in close proximity. The full-
length ester-containing substrate was purified by PAGE. Aromatic amide 2 and Ala-Phe-Ala 3 are 
stable in standard oligonucleotide deprotection conditions, and each was prepared by automated 
synthesis of the entire substrate with manual amide bond formation in the middle of the substrate. 
Detailed synthetic procedures for all oligonucleotide conjugates are reported in section 2.4.2. 
2.2.3 Deoxyribozymes for Ester Cleavage 
Ester-cleaving deoxyribozymes were identified from selections performed in both 
conditions A and conditions B. Selections performed in conditions A (named the ZA selections, 
which comes from an arbitrary alpha numeric system used to label selections in our laboratory) 
showed background activity of ~4% due to uncatalyzed ester cleavage during the selection step. 
Despite this background, selection activity increased above the background level beginning in 
round 8, and the selection was cloned from round 10 with pool activity of 49% (Fig. 2.5 A). Eleven 
unique DNA sequences were identified from these selection (Fig. 2.6), and each deoxyribozyme 
sequence is essentially unrelated from the others. MALDI mass spectrometry of the product of a 
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representative deoxyribozyme confirmed that cleavage was occurring at the ester linkage (Fig. 2.5 
B). 
 
 
Figure 2.5. (a) Selection progression for ZA selection experiment (ester hydrolysis, conditions A). 
Gray bars show standard capture reaction yield each round, and red bars show selection capture 
yield each round. Selection was cloned from round 10. (b) MALDI mass spectrometry to establish 
identities of cleavage products from a representative 10ZA deoxyribozyme. L denotes the left-
hand cleavage product; R denotes the right-hand cleavage product. An asterisk denotes the peak 
for uncleaved substrate with z = 2. All m/z values are [M+H]+. 
 
Figure 2.6. Sequence alignment of the 11 deoxyribozyme sequences identified from the ZA 
selections. Alignment shows only the initially random region. A dot denotes conservation, i.e., the 
same nucleotide as in the uppermost sequence. Next to the sequence length in nucleotides on the 
far right is shown (in parentheses) the number of times that sequence was found during cloning. 
All eleven 10ZA deoxyribozymes were prepared by solid-phase synthesis. The single-
turnover kobs ranged from 0.11 h
−1 for 10ZA20 up to 0.54 h−1 for 10ZA8 (Fig. 2.7). Overnight 
yields of about 90% were observed for several deoxyribozymes. The uncatalyzed background rate 
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of hydrolysis was also determined and used to calculate deoxyribozyme rate enhancement. The 
observed kbkgd of 0.0024 h
−1 (Fig. 2.7) gives rate enhancement of 225 for 10ZA8.   
 
Figure 2.7. 10ZA deoxyribozymes identified from the selection under conditions A. kobs values 
are as follows: 10ZA8: 0.54; 10ZA18: 0.34; 10ZA22: 0.15; 10ZA5: 0.51; 10ZA7: 0.33; 10ZA13: 
0.18; 10ZA1: 0.13; 10ZA23: 0.57; 10ZA15: 0.40; 10ZA19: 0.48; 10ZA20: 0.11 h−1; kbkgd 0.0024 
h−1. Figure adapted with permission from Ref. 20. 
The metal dependence and pH dependence of each 10ZA deoxyribozyme was investigated 
(Fig. 2.8 and Fig. 2.9). All deoxyribozymes required Zn2+ for catalytic activity, and only two 
catalysts, 10ZA8 and 10ZA20, could function with Zn2+ alone. All other deoxyribozymes required 
Zn2+ and Mn2+ for activity, and two functioned optimally when Zn2+, Mn2+, and Mg2+ were present. 
Each deoxyribozyme was assayed at pH 7.2, 7.5, and 7.8. Only two deoxyribozymes, 10ZA7 and 
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10ZA8, showed robust cleavage at all three pH values. Two other deoxyribozymes, 10ZA1 and 
10ZA19, were active only at pH 7.5. The remaining seven deoxyribozymes tolerated pH 7.8, but 
were inactive at pH 7.2.  
 
Figure 2.8. Dependence of the eleven 10ZA ester-hydrolyzing deoxyribozymes on metal ions. 
bkgd = background ester hydrolysis in the absence of any deoxyribozyme. Of the eleven 
deoxyribozymes, all required Zn2+. Seven (10ZA1, 7, 13, 15, 19, 22, 23) additionally required 
Mn2+, and two (10ZA5, 18) additionally required both Mn2+ and Mg2+ for optimal activity.  
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Figure 2.9. Dependence of the eleven 10ZA ester-hydrolyzing deoxyribozymes on pH. 
bkgd = background ester hydrolysis in the absence of any deoxyribozyme. 
Ester hydrolysis selections in conditions B (named the ZB selection) showed uncatalyzed 
background cleavage of ~20% after overnight incubation in conditions B. To reduce background 
activity, the selection step was reduced to 1 h, which showed ~4% background cleavage. The 
selections began showing activity above the background at round 11, they were cloned after round 
13 from pool activity of 38% (Fig. 2.10 A). Three unique DNA sequences were identified which 
are essentially unrelated from one another (Fig. 2.11).  MALDI mass spectrometry of the products 
of a representative 13ZB deoxyribozyme reaction confirmed cleavage was occurring at the ester 
linkage (Fig. 2.10 B). 
 
Figure 2.10. (a) Selection progression for ZB selection experiments (ester hydrolysis, conditions 
B). Gray bars show standard capture reaction yield each round, and blue bars show selection       
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Fig. 2.10. (cont.) capture yield each round. Selection was cloned from round 13. (b) MALDI mass 
spectrometry to establish identities of cleavage products from a representative 13ZB 
deoxyribozyme. L denotes the left-hand cleavage product; R denotes the right-hand cleavage 
product. An asterisk denotes the peak for uncleaved substrate with z = 2. All m/z values are 
[M+H]+. 
 
Figure 2.11. Sequence alignment of the three deoxyribozyme sequences identified from the ZB 
selections. Alignment shows only the initially random region. A dot denotes conservation, i.e., the 
same nucleotide as in the uppermost sequence. Next to the sequence length in nucleotides on the 
far right is shown (in parentheses) the number of times that sequence was found during cloning. 
Each deoxyribozyme sequence was prepared by solid-phase synthesis. The fastest of these 
catalysts, 13ZB38, had single-turnover kobs of 3.1 h
–1 (Fig. 2.12) and yield of ~80% in 3 h. kbkgd 
was measured as 0.013 h−1, which corresponds to a rate enhancement of 240 for 13ZB38. 
 
 
Figure 2.12. 13ZB deoxyribozymes identified from the selection under conditions B. kobs values 
(top to bottom in legend): 3.1, 1.7, 0.56 h−1; kbkgd 0.013 h
−1. Figure reprinted with permission from 
Ref. 20. 
The effect of Mg2+ concentration was evaluated, and no loss in activity of any of the 
deoxyribozymes was observed with concentration as low as 10 mM Mg2+ (Fig. 2.13). This suggests 
apparent Kd for Mg
2+ is <10 mM. Each deoxyribozyme was assayed at pH values of 7.5-10. 
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Catalytic activity for each deoxyribozyme was better as pH increased, noting that uncatalyzed 
hydrolysis also increases at higher pH (Fig. 2.14).  
All 10ZA and 13ZB deoxyribozymes were assayed for activity with structurally similar 
aliphatic amide substrate 4, but no cleavage activity was observed (data not shown). Several 10ZA 
deoxyribozymes were partially randomized (25% per nucleotide) and reselected using 4 in an 
attempt to evolve ester-cleaving deoxyribozymes to cleave amide bonds, but no activity was 
observed (data not shown). 
 
 
Figure 2.13. Dependence of the three 13ZB ester-hydrolyzing deoxyribozymes on metal ions. 
bkgd = background ester hydrolysis in the absence of any deoxyribozyme. The apparent Kd for 
Mg2+ is <10 mM for all three 13ZB deoxyribozymes. 
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Figure 2.14. Dependence of the three 13ZB ester-hydrolyzing deoxyribozymes on pH. bkgd = 
background ester hydrolysis in the absence of any deoxyribozyme. Buffer compounds are 
abbreviated H = HEPES, T = TAPS, C = CHES. 
2.2.4 Deoxyribozymes for Aromatic Amide Cleavage 
Aromatic amide-hydrolyzing deoxyribozymes were identified from selections in 
conditions A (named the ZC selection), but not from conditions B (named the ZD selection). No 
uncatalyzed background cleavage is detected with aromatic amide 2, and thus no background 
cleavage is observed during selection. Activity was first observed at round 7, and selections were 
cloned from round 8 with 38% pool activity (Fig. 2.15 A). In total, five unique deoxyribozymes 
were identified (Fig. 2.16). Each sequence shared conserved regions at both the 5′ and 3′ ends of 
the initially random region. MALDI mass spectrometry of the products of a representative 8ZC 
deoxyribozyme reaction confirmed cleavage at the aromatic amide (Fig. 2.15 B).  
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Figure 2.15. (a) Selection progression for ZC selection experiments (aromatic amide hydrolysis, 
conditions A). Gray bars show standard capture reaction yield each round, and green bars show 
selection capture yield each round. Selection was cloned from round 8. (b) MALDI mass 
spectrometry to establish identities of cleavage products from a representative 8ZC 
deoxyribozyme. L denotes the left-hand cleavage product; R denotes the right-hand cleavage 
product. An asterisk denotes the peak for uncleaved substrate with z = 2. All m/z values are 
[M+H]+. 
 
 
Figure 2.16. Sequence alignment of the five deoxyribozyme sequences identified from the ZC 
selections. Alignment shows only the initially random region. Gray boxes denote conserved 
sequence elements. A dot denotes conservation, i.e., the same nucleotide as in the uppermost 
sequence; a dash denotes a gap in the sequence. Next to the sequence length in nucleotides on the 
far right is shown (in parentheses) the number of times that sequence was found during cloning. 
Each deoxyribozyme was prepared by solid-phase synthesis. Single-turnover kobs was 
determined for each of the 8ZC deoxyribozyme (Fig. 2.17). The fastest deoxyribozyme, 8ZC30, 
had kobs of 0.19 h
–1 and up to 80% yield in 24 h. No uncatalyzed anilide hydrolysis was observed 
(<0.5%) after 96 h in conditions A, giving kbkgd as <0.00004 h
–1. This corresponds to a rate 
enhancement of >5000-fold for 8ZC30.   
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Figure 2.17. Activities of 8ZC deoxyribozymes identified from the selection under conditions A. 
kobs values (top to bottom in legend): 0.13, 0.18, 0.028, 0.19, 0.18 h
−1; kbkgd <0.00004 h
−1. Figure 
reprinted with permission from Ref. 20. 
The metal dependence of each 8ZC deoxyribozyme was evaluated (Fig. 2.18). All five 
deoxyribozymes required both Zn2+ and Mn2+ for catalytic activity, and in some cases activity was 
best when Zn2+, Mn2+, and Mg2+ were all present. Each deoxyribozyme was also evaluated at pH 
7.2 and 7.8, in addition to pH 7.5 (Fig. 2.19). Each catalyst worked optimally at pH 7.5, with four 
of the five deoxyribozymes showing very little or no yield at pH 7.2 or 7.8. 8ZC30 showed robust 
activity at pH 7.8 as well, although yield was lower than at pH 7.5.  
Finally, each deoxyribozyme was evaluated with the aliphatic amide substrates 4-6 (Fig. 
2.20). Benzylamide substrate 5 retains the aromatic ring from the aromatic amide 2 but contains a 
methylene between the aromatic and amide bond, which makes its reactivity more similar to that 
of a peptide bond than an aromatic amide. Cyclohexylamide substrate 6 is structurally similar to 
2, but the ring is not aromatic, and so its reactivity is closer to that of a peptide bond as well. 
Unfortunately, no activity was observed with any of substrates 4-6 (data not shown). This strongly 
suggests that the increased reactivity of the aromatic amide is key to our ability to identify active 
DNA enzymes for its cleavage.  
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Figure 2.18. Dependence of the five anilide-hydrolyzing 8ZC deoxyribozymes on metal ions. 
Incubation conditions derived from conditions A: 70 mM HEPES, pH 7.5, combinations of 1 mM 
ZnCl2, 20 mM MnCl2, and 40 mM MgCl2 as indicated, and 150 mM NaCl at 37 °C. Of the five 
deoxyribozymes, all required both Zn2+ and Mn2+; two (8ZC8 and 8ZC9) additionally required 
Mg2+ for optimal activity. 
 
 
Figure 2.19. Dependence of the five 8ZC anilide-hydrolyzing deoxyribozymes on pH. Incubation 
conditions derived from conditions A: 70 mM HEPES, pH 7.2, 7.5, or 7.8 as indicated, 1 mM 
ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C. 
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Figure 2.20. Full chemical structures of additional amide substrates showing connections to DNA. 
The first thymidine (T) nucleoside on each side is drawn. The DNA sequence for the 5′-anchor 
segment is 5′-AAAGTCTCATGAACTT-3′, where the 3′-terminal T is illustrated. The DNA sequence 
for the 3′-anchor segment is 5′-TATGTTCTAGCGCTTCG-3′, where the 5′-terminal T is illustrated. 
Benzylamide (5) and cyclohexylamide (6) serve as aliphatic amide structural analogs of the 
aromatic amide 2.  
 
To better understand the electronic effects of DNA-catalyzed aromatic amide cleavage, a 
set of substrates analogous to 2 were prepared substituted with either an electron-donating group 
(EDG) or electron-withdrawing group (EWG) ortho to the aromatic amide bond. Single-turnover 
kobs with each substituent was determined for each 8ZC deoxyribozyme. This data was plotted 
relative to its tablulated p (Figure 2.21). Surprisingly, no change in the kobs was observed with 
either EDG or EWG. 
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Figure 2.21. Linear free energy relationship (LFER) data for anilide-hydrolyzing 
deoxyribozymes. All kobs values were determined under conditions A (70 mM HEPES, pH 7.5, 1 
mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl at 37 °C), similar to the data in 
Figure 4. For each of 8ZC9, 8ZC30, and 8ZC4, kobs for all six substrates was determined multiple 
times (n = 3); each kobs value was calculated as mean ± standard deviation. For each of 8ZC8 and 
8ZC41, kobs was determined once. For X = Cl or CF3, a small amount of nonspecific hydrolysis 
(~2%) was observed at 30 s; the hydrolysis yield at 30 s was subtracted from the yield at all later 
timepoints. For all X other than CF3, yields at 24 h were similar to those for X = H. For X = CF3, 
yields at 24 h were 13–21%, but kobs could still be determined reliably. Error bars correspond to 
the quadratic sum of the fractional uncertainties in kX and kH.
25 Values of p were used as 
tabulated.26 
 
The observed  value of ~0 for aromatic amide hydrolysis is difficult to interpret 
mechanistically. Two possible addition-elimination mechanisms are shown in Figure 2.22. Panel 
A depicts a three-step mechanism in which addition of water is followed by a discrete nitrogen 
protonation step and finally elimination of the aniline leaving group. If either the addition or 
elimination step is rate-determining, then we expect a substituent effect of  > 0. For rate-
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determining addition, an electron-withdrawing group will increase the carbonyl electrophilicity; 
for rate-determining elimination, an electron-withdrawing group will increase the leaving group 
ability. In contrast, if the nitrogen protonation step is rate-determining, then we expect  < 0 due 
to the increase in positive charge (i.e., decrease in electron density) on the aniline upon protonation. 
Rate-determining proton transfer to nitrogen has been invoked for hydroxide-catalyzed anilide 
hydrolysis on the basis of a negative  value.27 Panel B depicts a related two-step mechanism in 
which the protonation and elimination reactions of the three-step mechanism occur at the same 
time. For the addition step we still expect  > 0, but for the elimination step with concomitant 
nitrogen protonation, we now expect a cancellation of substituent effects because protonation 
(which would lead to  < 0) and elimination (which would lead to  > 0) respond in opposite 
directions. Of the various mechanistic possibilities, the experimental observation of   0 is 
consistent only with the two-step mechanism of panel B with a rate-determining 
protonation/elimination step. Determining the identity of the general acid awaits further structural 
and mechanistic analysis of these deoxyribozymes. Nucleobases themselves can be general acids 
in ribozymes,28-30 and metal-bound water molecules are other reasonable candidates. 
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Figure 2.22. Two addition-elimination mechanisms for aromatic amide hydrolysis and expected 
substituent effects. For each step is shown the expected LFER  value if that step is rate-
determining. (a) Three-step mechanism involving addition of water, protonation of nitrogen, and 
elimination of aniline. (b) Two-step mechanism in which the protonation and elimination reactions 
occur at the same time. In this panel, note that “ 0” represents one possible specific outcome 
due to cancellation of substituent effects upon protonation ( < 0) versus elimination ( > 0). If 
the cancellation were not complete, then the  value would not be ~0. However, the experimental 
observation of   0 is consistent only with this step as rate-determining. 
 
Each 8ZC deoxyribozyme was evaluated for its capacity to cleave the structurally similar 
phenyl ester substrate (Fig. 2.23). Upon incubation in the selection conditions, the phenyl ester is 
cleaved relatively quickly, with kbkgd (i.e., background kobs) of 0.4 h
–1. Despite the high background 
activity, four of the 8ZC deoxyribozymes cleave the phenyl ester with notable enhancement over 
background cleavage. 8ZC9 and 8ZC30 exhibited the best activity, having single-turnover kobs of 
10 h–1 and 13 h–1 and rate enhancements of 25-fold and 33-fold over uncatalyzed cleavage. The 
kobs for 8ZC8 was 2 h
–1, a 5-fold rate enhancement. 8ZC41 reproducibly showed double-
exponential kinetics, showing higher kobs of 7 h
–1 (48% of total fit amplitude) and lower kobs of 0.2 
h–1 (52% of total fit amplitude). The kinetics of 8ZC4 were indistinguishable from those of 
uncatalyzed background cleavage. 
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Considering the mechanism of cleavage is extremely similar for aromatic amide cleavage 
and phenyl ester cleavage, it is more likely that the failure of 8ZC4 to cleave the phenyl ester 
results from poor binding or recognition of the substrate (e.g., 8ZC4 requires the NH interaction 
present in the aromatic amide, but absent in the phenyl ester).  
 
 
Figure 2.23. Activities of the five anilide-hydrolyzing 8ZC deoxyribozymes with a phenyl ester 
substrate. The illustrated phenyl ester was hydrolyzed by each 8ZC deoxyribozyme. All data 
values were corrected for nonspecific hydrolysis that occurred during substrate preparation. The 
illustrated data are representative of two independent experiments. The plot on the right shows the 
same data as on the plot on the left, simply expanded on the time axis. All data were fit to single-
exponential kinetics except for 8ZC41, which reproducibly required double-exponential kinetics. 
The phenyl ester substrate has a rather high background hydrolysis rate constant under the 
incubation conditions (kbkgd = 0.4 h
–1). The kobs for 8ZC4 was indistinguishable from kbkgd. The kobs 
for 8ZC8 was 2 h–1, which is 5-fold higher than kbkgd. The kobs values for 8ZC9 and 8ZC30 were 
10 h–1 and 13 h–1, which are 25-fold and 33-fold higher than kbkgd. 8ZC41 had higher kobs of 7 h
–1 
(48% of total fit amplitude) and lower kobs of 0.2 h
–1 (52% of total fit amplitude). 
 
2.2.5 Deoxyribozymes for Peptide Cleavage 
Selection experiments for cleavage of Ala-Phe-Ala tripeptide 3 using conditions A and 
conditions B led to no detectable activity (<0.5%) after 17 rounds.  
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2.2.6 Reselections to Identify Amide-Cleaving Deoxyribozymes 
One deoxyribozyme for aromatic amide cleavage, 8ZC9, was partially randomized (25% 
per nucleotide) and reselected for cleavage of aromatic amide 2 and aliphatic amide substrates 4-
6. In reselections with 2, activity was observed at round 5 and cloned from 30% pool activity at 
round 6. 13 new sequences were identified from the reselection (named the AP1 selection) (Fig. 
2.24). Interestingly, the sequences that emerged from reselection retained the conserved sequence 
elements observed in the original 8ZC deoxyribozyme family. These deoxyribozymes were found 
to have similar kobs as the 8ZC deoxyribozymes (no greater than 3-fold higher kobs). Unfortunately, 
no reselection activity for cleavage of aliphatic amide substrates 4-6 was observed, although it was 
a hopeful experiment.  
 
Figure 2.24. Sequence alignment of the 13 deoxyribozyme sequences identified from the AP1 
selection. Alignment shows only the initially random region. Gray boxes denote conserved 
sequence elements, which are the same as those in the 8ZC deoxyribozymes. A dot denotes 
conservation, i.e., the same nucleotide as in the uppermost sequence. Next to the sequence length 
in nucleotides on the far right is shown (in parentheses) the number of times that sequence was 
found during cloning. 
2.2.7 Evaluation of Random Region Length  
Performing in vitro selections using an N40 random region length is a compromise between 
the random region length being long enough to adopt complex three-dimensional structures, and 
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short enough so that sequence space coverage is reasonable. In practice, N40 random region lengths 
have allowed for the successful identification of deoxyribozymes for many different chemical 
reactions. However, it is also possible that other random region lengths could lead to better 
catalysts, and that the ideal random region length could change depending on the chemical 
reaction. Previous work showed that deoxyribozymes for DNA phosphodiester hydrolysis were 
identified from pools of N20, N30, and N40 nucleotides, but not N60 nucleotides.
31 At the same time, 
catalysts for a different reaction, nucleopeptide linkage, were identified from N30, N40, and N60, 
but not N20 nucleotides.
31 Clearly random region length is a variable that can impact catalysis.  
In vitro selection experiments were performed seeking cleavage of aromatic amide 2 and 
aliphatic amide 6 using N20, N30, N50, and N60 random region lengths. Activity was observed in the 
selections using N20 and N30 random regions. The N20 selections, named the BN1 selection, were 
cloned after 9 rounds of selection. The N30 selections, named the BQ1 selection, were cloned after 
8 rounds of selection.  
Several related sequences that share some combination of up to five mutations and shared 
a conserved region of 15 nucleotides were identified in the BN1 selection (Fig. 2.25). These 
sequences were different than the previously identified 8ZC DNA catalysts. The 9BN1 
deoxyribozymes had similar rates and yields as other aromatic amide-cleaving deoxyribozymes. 
Notably, the 9BN1 deoxyribozymes retained activity with only Zn2+, when Mg2+ and Mn2+ were 
omitted from the reaction. 
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Figure 2.25. Sequence alignment of the 11 deoxyribozyme sequences identified from the BN1 
selection. Alignment shows only the initially random region. Gray boxes denote conserved 
sequence elements. A dot denotes conservation, i.e., the same nucleotide as in the uppermost 
sequence. Next to the sequence length in nucleotides on the far right is shown (in parentheses) the 
number of times that sequence was found during cloning. 
Eight new deoxyribozymes were identified from the selection using N30 random region 
length (named the BQ1 selection). Notably, these sequences shared the same regions of 
conservation as the N40 DNA enzymes, but the variable region in the middle of the enzyme is 
simply ten nucleotides shorter (Fig. 2.26). This further supports our hypothesis that these two 
conserved regions found in N40 and N30 aromatic amide-cleaving deoxyribozymes are necessary 
for catalysis. Activity and metal dependence of the 8BQ1 deoxyribozymes was similar to that of 
the 8ZC deoxyribozymes. 
 
Figure 2.26. Sequence alignment of the eight deoxyribozyme sequences identified from the BQ1 
selection Alignment shows only the initially random region. Gray boxes denote conserved 
sequence elements, which are the same as those found in the 8ZC and 6AP1 deoxyribozymes. A 
dot denotes conservation, i.e., the same nucleotide as in the uppermost sequence; a dash denotes a 
gap in the sequence. Next to the sequence length in nucleotides on the far right is shown (in 
parentheses) the number of times that sequence was found during cloning. 
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2.3 Summary 
We identify for the first time deoxyribozymes that are able to cleave ester and aromatic 
amide bonds. These findings establish that DNA is able to catalyze hydrolysis reactions involving 
ester and amide bonds.  
Deoxyribozymes for ester hydrolysis were identified from selection experiments 
performed at (conditions A) pH 7.5 with 1 mM Zn2+, 20 mM Mn2+, and 40 mM Mg2+ at 37 C and 
(conditions B) pH 9.0 with 40 mM Mg2+. DNA catalysts identified from conditions A cleave ester 
bonds with yields up to 90% in 24 h and have single-turnover kobs up to 0.54 h
–1. All 
deoxyribozymes function optimally at pH 7.5, and several DNA enzymes retain reduced activity 
at pH 7.2 or pH 7.8. DNA catalysts show a mixture of different metal dependences, but generally 
all require Zn2+ for catalytic activity, and several require both Zn2+ and Mn2+ or Zn2+, Mn2+, and 
Mg2+ for full activity.  
Ester-cleaving deoxyribozymes from conditions B cleave have yields up to 90% in 3 h and 
have single-turnover kobs up to 3.1 h
–1. These DNA catalysts function best at more basic pH values, 
although uncatalyzed ester cleavage also increased at higher pH, and retained full catalytic activity 
with 10 mM Mg2+. 
Aromatic amide-cleaving deoxyribozymes were identified from selection in conditions A. 
These deoxyribozymes have cleavage yields up to 80% in 24 h and single-turnover kobs up to 0.19 
h–1. These deoxyribozymes show sharp pH dependences, with maximum activity at pH 7.5 and, 
with the exception of 8ZC30 that has substantial activity at pH 7.8, have trace activity at pH 7.2 
and pH 7.8. Each 8ZC deoxyribozyme requires both Zn2+ and Mn2+ for catalytic activity, and 8ZC9 
and 8ZC30 additionally required Mg2+ for maximum activity.  
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No deoxyribozymes were identified for cleavage of the aromatic amide in conditions B, 
nor were deoxyribozymes identified for cleavage of the peptide Ala-Phe-Ala substrate in 
conditions A or conditions B. These data show that DNA-catalyzed hydrolysis for more 
challenging reactions, such as aromatic amide cleavage, is only achieved in pH 7.5, probably 
because the DNA enzymes require either Zn2+ or Mn2+ for this activity. These data also show that 
the identification of DNA enzymes for aliphatic amide cleavage is challenging. In vitro evolution 
of deoxyribozymes to cleave a structurally similar, but less reactive substrate was not successful. 
Finally, the effect of electron-withdrawing and electron-donating substituents was evaluated, and 
the deoxyribozymes were observed to be relatively insensitive to substituent effects. This finding 
suggests that these DNA enzymes function with simultaneous anilide nitrogen protonation and C–
N bond cleavage. The difficulty of identifying deoxyribozymes for peptide bond cleavage suggests 
that different strategies are required for DNA-catalyzed peptide bond cleavage. Such strategies 
could include the use of a better nucleophile to enable the cleavage reaction, or the use of 
chemically modified nucleotides that provide the DNA with expanded functionality. 
2.4 Materials and Methods 
2.4.1 Preparation of Oligonucleotide Substrates 
DNA oligonucleotides and oligonucleotide conjugates were obtained from Integrated DNA 
Technologies (Coralville, IA) or prepared by solid-phase synthesis on an ABI 394 instrument using 
reagents from Glen Research. All oligonucleotides and conjugates were purified by 7 M urea 
denaturing PAGE with running buffer 1 TBE (89 mM each Tris and boric acid and 2 mM EDTA, 
pH 8.3), extracted from the polyacrylamide with TEN buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 
300 mM NaCl), and precipitated with ethanol as described previously.32,33 See final sections of the 
supporting information for all solid-phase and small-molecule synthesis procedures. 
2.4.1.1 Synthesis of ester-linked oligonucleotide conjugate 
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Synthesis of 3′-CO2H oligonucleotide. 5′-DMT-thymidine-derivatized CPG solid support 
(40 µmol/g; 200 nmol) was deprotected with TCA/CH2Cl2 (3  1 mL) and washed with CH2Cl2 (3 
 5 mL). The support was rinsed with 2% (v/v) NMM/CH2Cl2 and CH2Cl2 (3  5 mL) to improve 
the efficiency of the next coupling step and dried under a stream of nitrogen. 5′-DMT-3′-CO2H 
thymidine analogue (64 mg, 100 µmol), HATU (38 mg, 100 µmol), and HOBt (14 mg, 100 mol) 
were dissolved in 500 µL of dry DMF. NMM (26 µL, 230 µmol) was added to this solution, which 
was introduced into the DNA synthesis column via two syringes. The coupling step was performed 
for 18 h with mixing every 5 min for the first 2 h and no mixing for the remaining 16 h. The column 
was washed with DMF (3  5 mL) and CH2Cl2 (3  5 mL) and dried under a stream of nitrogen. 
The remainder of the oligonucleotide was synthesized on the ABI 394 instrument using standard 
procedures. Cleavage of the oligonucleotide from the CPG and nucleobase deprotection were 
performed using 500 µL of 400 mM NaOH in 4:1 MeOH:H2O for 24 h at room temperature. The 
sample was diluted to 2 mL with water and desalted using a PD10 column (GE Healthcare). The 
fractions containing desalted oligonucleotide were concentrated and purified by 20% PAGE. 
Figure 2.27. Solid-phase synthesis of 3′-CO2H oligonucleotide.  
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Solution-phase coupling of 3′-CO2H oligonucleotide and 5′-OH oligonucleotide. An 80 µL 
sample containing 1.0 nmol of 3′-CO2H oligonuclotide, 1.5 nmol of 5′-OH oligonucleotide, and 
1.25 nmol of DNA splint was annealed in 125 mM MES, pH 6.0, and 125 mM NaCl by heating at 
95 °C for 3 min and cooling on ice for 5 min. The sequence of the DNA splint was 
5′-CGAAGCGCTAGAACATAAAGTACATGAGACTTTAACAACAACAACAAC-3′, where the 
underlined region was included to shift the splint away from the desired product on PAGE. The 
reaction was initiated by bringing the sample to 100 µL volume containing 100 mM MES, pH 6.0, 
100 mM NaCl, 40 mM EDC, 30 mM HOBt, and 10% (v/v) DMF, which was required to dissolve 
the HOBt. The sample was incubated at room temperature for 24 h, precipitated with ethanol, and 
purified by 20% PAGE. 
 
Figure 2.28. Synthesis of ester-linked substrate by splinted coupling of 3′-CO2H oligonucleotide 
and 5′-OH oligonucleotide. 
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2.4.1.2 Synthesis of aromatic amide-linked oligonucleotide conjugate 
 
Synthesis and deprotection of 5′-amino-5′-deoxythymidine oligonucleotide (steps A and B). 
Oliogonucleotide synthesis was performed on the ABI 394 instrument using standard procedures, 
providing a CPG-supported oligonucleotide terminating in a N-MMT-5′-amino-5′-
deoxythymidine residue. The MMT protecting group was removed with 3% TCA/ CH2Cl2 (3  1 
mL), and the support was rinsed with CH2Cl2 (3  5 mL). The support was rinsed with 2% (v/v) 
NMM/CH2Cl2 and CH2Cl2 (3  5 mL) to improve the efficiency of the next coupling step and dried 
under a stream of nitrogen. 
Figure 2.29. Solid-phase synthesis of aromatic amide-linked oligonucleotide.  
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Coupling of N-MMT-4-aminobenzoic acid (step C1). N-MMT-4-aminobenzoic acid (56 
mg, 100 µmol), HATU (38 mg, 100 µmol), and HOBt (14 mg, 100 µmol) were dissolved in 500 
µL of dry DMF. NMM (26 µL, 230 mol) was added to this solution, which was introduced into 
the DNA synthesis column via two syringes. The coupling step was performed for 2 h with mixing 
every 5 min. The support was washed with DMF (3  5 mL) and CH2Cl2 (3  5 mL) and dried 
under a stream of nitrogen. 
Capping of unreacted 5′-amino groups (step C2). Capping of unreacted amino groups was 
performed using 500 µL of Glen Research Cap Mix A (10% Ac2O/10% pyridine in THF) and 500 
µL of Glen Research Cap Mix B (10% 1-methylimidazole in THF). Cap Mix A and Cap Mix B 
were combined and introduced into the DNA synthesis column via two syringes. The capping step 
was performed for 30 min with mixing every 5 min. The support was washed with CH2Cl2 (3 x 5 
mL) and dried under a stream of nitrogen. 
Deprotection of N-MMT group (step D1). Deprotection with 3% TCA/CH2Cl2 was 
performed as described above for deprotection of 5′-amino groups (step B). 
Coupling of 5′-DMT-3′-CO2H thymidine nucleoside analogue to aniline moiety (step D2). 5′-
DMT-3′-CO2H thymidine nucleoside analogue was coupled to the terminal aniline moiety using 
the coupling step described above (step C1), using the 5′-DMT-3′-CO2H thymidine nucleoside 
analogue in place of N-MMT-4-aminobenzoic acid and extending the coupling reaction from 2 h 
to 18 h. 
Capping of unreacted amino groups (step D3). Capping with acetic anhydride was 
performed as described above for capping of unreacted 5′-amino groups (step C2). 
Completion of synthesis (steps E and F). The remainder of the conjugate was synthesized on the 
ABI 394 instrument using standard procedures. The conjugate was cleaved from the solid support 
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using 500 µL of 30% NH4OH by incubating at 55 °C for 16 h. The NH4OH was evaporated, and 
the final conjugate was purified by 20% PAGE. 
2.4.1.3 Synthesis of amide-linked oligonucleotide conjugate  
Conjugate 3 was synthesized as described for anilide-linked conjugate 2 with modifications. The 
Ala-Phe-Ala tripeptide was incorporated via three cycles of steps B and C, using N-MMT-Ala, N-
MMT-Phe, and N-MMT-Ala in place of N-MMT-4-aminobenzoic acid in the first, second, and 
third step C1, respectively. The coupling time in step D2 was 2 h instead of 16 h. Conjugates 4 
and 5 were synthesized as described for anilide-linked conjugate 2, except using the appropriate 
N-MMT-protected amino carboxylic acid compound in step C1. The coupling time in step D2 was 
2 h instead of 16 h. Conjugate 6 was synthesized as described for anilide-linked conjugate 2, except 
omitting steps B and C. The coupling time in step D2 was 2 h instead of 16 h. 
2.4.2 In vitro selection procedure 
The selection procedure, cloning, and initial analysis of individual clones were performed 
essentially as described previously,32,34 but with a different ligation step35,36 and with a new capture 
step based on DMT-MM–promoted amide bond formation. An overview of the key selection and 
capture steps of each round is shown in Figure 1. A depiction of the capture step with nucleotide 
details and validation data is shown in Figure S1. The random deoxyribozyme pool was 5-
CGAAGCGCTAGAACAT-Nx-AGTACATGAGACTTAGCTGATCCTGATGG-3 (x = 20, 30, or 40). For 
a reselection experiment the pool was partially (25%) randomized, prepared using 
phosphoramidite mixtures as described previously.37,38 PCR primers were 
5-CGAAGCGCTAGAACAT-3 (forward primer) and 5-
(AAC)4XCCATCAGGATCAGCTAAGTCTCATGTACT-3, where X is the HEG spacer to stop Taq 
polymerase (reverse primer). In each round, the ligation step to attach the deoxyribozyme pool at 
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its 3-end with the 5-end of the carbonyl-based substrate conjugate was performed using a DNA 
splint and T4 DNA ligase. The splint sequence was 5-AAGTACATGAGACTTTTCC-
ATCAGGATCAGCTAAGTCTCATGTACT-3, where the underlined T is included to account for the 
untemplated A nucleotide that is added at the 3-end of each PCR product by Taq polymerase. This 
T nucleotide was omitted from the splint used for ligation of the initially random Nx pool, which 
was prepared by solid-phase synthesis without the untemplated A. Nucleotide sequences of the 
DNA anchor oligonucleotide, the deoxyribozyme binding arms, the 5-amino modified capture 
oligonucleotide, and the capture splint are shown in Fig. S1. 
2.4.2.1 Steps of in vitro selection procedure 
Procedure for ligation step in round 1. A 25 µL sample containing 1.2 nmol of DNA pool, 
900 pmol of DNA splint, and 600 pmol of carbonyl-based substrate was annealed in 5 mM Tris, 
pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 
min. To this solution was added 3 µL of 10 T4 DNA ligase buffer (Fermentas) and 2 µL of 5 
U/µL T4 DNA ligase (Fermentas). The sample was incubated at 37 °C for 12 h and purified by 
8% PAGE. 
Procedure for ligation step in subsequent rounds. A 17 µL sample containing the PCR-
amplified DNA pool (~5–10 pmol), 30 pmol of DNA splint, and 50 pmol of carbonyl-based 
substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 
°C for 3 min and cooling on ice for 5 min. To this solution was added 2 µL of 10 T4 DNA ligase 
buffer (Fermentas) and 1 µL of 1 U/µL T4 DNA ligase (Fermentas). The sample was incubated at 
37 °C for 12 h and purified by 8% PAGE. 
Procedure for selection step in round 1. Each selection experiment was initiated with 200 
pmol of the ligated pool. A 20 µL sample containing 200 pmol of ligated pool was annealed in 
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(conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA or (conditions B) 5 mM 
CHES, pH 9.0, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice 
for 5 min. The selection reaction was initiated by bringing the sample to 40 µL total volume 
containing (conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, 
and 150 mM NaCl or (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl. 
The Mn2+ was added from a 10 stock solution containing 200 mM MnCl2. The Zn2+ was added 
from a 10 stock solution containing 10 mM ZnCl2, 20 mM HNO3, and 200 mM HEPES at pH 
7.5; this stock solution was freshly prepared from a 100 stock of 100 mM ZnCl2 in 200 mM 
HNO3. The metal ion stocks were added last to the final sample. The sample was incubated at 37 
°C for 14 h and precipitated with ethanol. 
Procedure for selection step in subsequent rounds. A 10 µL sample containing the ligated 
pool was annealed in (conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA or 
(conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 
min and cooling on ice for 5 min. The selection reaction was initiated by bringing the sample to 
20 µL total volume containing (conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 
40 mM MgCl2, and 150 mM NaCl or (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 
150 mM NaCl. The sample was incubated at 37 °C for 14 h and precipitated with ethanol. 
Procedure for capture step in round 1. A 90 L sample containing the selection product, 
300 pmol of DNA splint, and 400 pmol of 5-amino capture oligonucleotide was annealed in 100 
mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on ice for 5 min. 
The capture reaction was initiated by bringing the sample to 100 µL total volume containing 100 
mM MOPS, pH 7.0, 1 M NaCl, and 100 mM DMT-MM. The sample was incubated at 37 °C for 
12 h. 
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Procedure for capture step in subsequent rounds. A 22.5 L sample containing the 
selection product, 30 pmol of DNA splint, and 50 pmol of 5-amino capture oligonucleotide was 
annealed in 100 mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on 
ice for 5 min. The capture reaction was initiated by bringing the sample to 25 µL total volume 
containing 100 mM MOPS, pH 7.0, 1 M NaCl, and 100 mM DMT-MM. The sample was incubated 
at 37 °C for 12 h. A parallel capture standard reaction was performed in each round using the 
entirely random pool. The yield of each such reaction is plotted as “control” in Figure S3; the 
position of this capture product was used as a marker for excising the appropriate gel bands. 
Procedure for PCR in subsequent rounds. In each selection round, two PCR reactions were 
performed, 10-cycle PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared 
containing the PAGE-purified selection product, 200 pmol of forward primer, 50 pmol of reverse 
primer, 20 nmol of each dNTP, and 10 µL of 10 Taq polymerase buffer (1 = 20 mM Tris-HCl, 
pH 8.8, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100). This sample was 
cycled 10 times according to the following PCR program: 94 °C for 2 min, 10 (94 °C for 30 s, 
47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Taq polymerase was removed by 
phenol/chloroform extraction. Second, a 50 µL sample was prepared containing 1 µL of the 10-
cycle PCR product, 100 pmol of forward primer, 25 pmol of reverse primer, 10 nmol of each 
dNTP, 20 µCi of -32P-dCTP (800 Ci/mmol), and 5 µL of 10 Taq polymerase buffer. This sample 
was cycled 30 times according to the following PCR program: 94 °C for 2 min, 30 (94 °C for 30 
s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Samples were separated by 8% PAGE. 
2.4.2.2 Identification of individual deoxyribozyme sequences 
Cloning and screening of individual deoxyribozymes. The PCR primers used for cloning 
were 5-CGAAGCGCTAGAACAT-3 (forward primer; same as in selection) and 
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5-TAATTAATTAATTACCCATCAGGATCAGCT-3 (reverse primer). The 10-cycle PCR product 
from the appropriate selection round was diluted 103-fold. A 50 µL sample was prepared 
containing 1 µL of the diluted 10-cycle PCR product from the appropriate selection round, 100 
pmol of forward cloning primer, 25 pmol of reverse cloning primer, 10 nmol of each dNTP, and 5 
µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to the following 
PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 
min. The sample was separated by 1% agarose gel and extracted using a GeneJET Gel Extraction 
Kit (Fermentas). The extracted product was quantified by absorbance (A260) and diluted to 4–8 
ng/µL. A 1 µL portion of the diluted PCR product was inserted into the pCR2.1-TOPO vector 
using a TOPO TA cloning kit (Life Technologies). Individual E. coli colonies harboring plasmids 
with inserts were identified by blue-white screening and grown in LB/amp media. Miniprep DNA 
was prepared using a GeneJET Plasmid Miniprep Kit (Fermentas) and screened for properly sized 
inserts by EcoRI digestion and agarose gel analysis. Before sequencing, assays of individual 
deoxyribozyme clones were performed with PAGE-purified DNA strands prepared by PCR from 
the miniprep DNA, using the single-turnover assay procedure described below. 
2.4.3 Evaluation of Deoxyribozymes 
2.4.3.1 Single-turnover deoxyribozyme assay 
The ester or anilide substrate was 5-32P-radiolabeled using -32P-ATP and polynucleotide 
kinase (Fermentas). A 10 µL sample containing 0.2 pmol of 5-32P-radiolabeled ester or anilide 
substrate and 20 pmol of deoxyribozyme was annealed in (conditions A) 5 mM HEPES, pH 7.5, 
15 mM NaCl, and 0.1 mM EDTA or (conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 
mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The DNA-catalyzed 
hydrolysis reaction was initiated by bringing the sample to 20 µL total volume containing 
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(conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM 
NaCl or (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl. The sample was 
incubated at 37 °C. At appropriate time points, 2 µL aliquots were quenched with 5 µL stop 
solution (80% formamide, 1 TBE [89 mM each Tris and boric acid and 2 mM EDTA, pH 8.3], 
50 mM EDTA, 0.025% bromophenol blue, 0.025% xylene cyanol). Samples were separated by 
20% PAGE and quantified with a PhosphorImager. Values of kobs were obtained by fitting the 
yield versus time data directly to first-order kinetics; i.e., yield = Y•(1 – e–kt), where k = kobs and Y 
is the final yield. Each kobs value is reported with error calculated as the standard deviation from 
the indicated number of independent determinations. When kobs was sufficiently low such that an 
exponential fit was not meaningful, the initial points were fit to a straight line, and kobs was taken 
as the slope of the line. 
2.4.3.2 Mass spectrometry to identify cleavage product identities 
The cleavage products of a representative deoxyribozyme from each indicated selection 
experiment were analyzed by MALDI mass spectrometry. The cleavage product was prepared 
from a 50 µL sample containing 100 pmol of ester or anilide substrate and 200 pmol of the 
indicated deoxyribozyme. The sample was annealed in (conditions A) 5 mM HEPES, pH 7.5, 15 
mM NaCl, and 0.1 mM EDTA or (conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 M 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The DNA-catalyzed hydrolysis 
reaction was initiated by bringing the sample to 100 µL total volume containing (conditions A) 70 
mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl or 
(conditions B) 70 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl. The sample was 
incubated at 37 °C for 24 h, precipitated with ethanol, desalted on Sephadex G-25 gel filtration 
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resin and Millipore C18 ZipTip, and analyzed by MALDI mass spectrometry (matrix 3-
hydroxypicolinic acid) on a Bruker UltrafleXtreme MALDI TOF/TOF mass spectrometer. 
2.4.4 Small-molecule organic synthesis 
Reagents were commercial grade and used without purification unless otherwise indicated. Dry 
solvents were obtained from Aldrich Sure/Seal or Acros Acroseal bottles or by drying over freshly 
activated 4Å molecular sieves overnight. All reactions were performed under argon unless 
otherwise noted. Thin-layer chromatography (TLC) was performed on silica gel plates pre-coated 
with fluorescent indicator with visualization by UV light (254 nm). Flash column chromatography 
was performed with silica gel (230-400 mesh). For all compounds that contain the 4,4′-
dimethoxytrityl (DMT) group or 4-monomethoxytrityl (MMT) group, silica gel columns were 
packed with the initial solvent additionally containing 2% (v/v) triethylamine. 1H and 13C spectra 
were recorded on a Varian Unity 500 or Varian Unity 500 VXR instrument. The chemical shifts 
in parts per million (δ) are reported downfield from TMS (0 ppm) and referenced to the residual 
proton signal of the deuterated solvent, as follows: CDCl3 (7.26 ppm), CD3OD (3.31 ppm) for 
1H 
NMR spectra; CDCl3 (77.2 ppm), CD3OD (49.2 ppm) for 
13C NMR spectra. Multiplicities of 1H 
NMR spin couplings are reported as s (singlet), d (doublet), t (triplet), q (quartet), dd (doublet of 
doublets), or m (multiplet and overlapping spin systems). Values for apparent coupling constants 
(J, Hz) are reported. Mass spectrometry data were obtained at the UIUC School of Chemical 
Sciences mass spectrometry laboratory using a Waters Quattro II instrument (LR-ESI). 
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5′-DMT-3′-CO2H thymidine nucleoside analogue (C) 
Synthesis of 5′-DMT-3′-CO2H thymidine nucleoside analogue (C). The 5′-TBDPS-3′-
CO2H thymidine nucleoside analogue A was prepared in six steps from thymidine as reported.
23 
Compound A was deprotected with TBAF to form the 3′-CO2H thymidine nucleoside analogue B 
according to the procedure reported for the TBDMS analogue,24 followed by 5′-OH protection 
using DMTCl to form the 5′-DMT-3′-CO2H thymidine nucleoside analogue C as reported.24 All 
compounds on this route were previously reported;23,24 1H NMR spectra of each compound were 
consistent with the reported spectra. 
General procedure for MMT protection of amino acids, including aniline derivatives. The 
specific procedure described here was used for MMT protection of 4-aminobenzoic acid; for the 
other synthesis procedures, all reagent amounts were scaled linearly. Portions of TMSCl (1.4 mL, 
11.0 mmol, 3.7 equiv) and Et3N (1.6 mL, 11.4 mmol, 3.8 equiv) were added to a suspension of 4-
aminobenzoic acid (413 mg, 3.0 mmol, 1.0 equiv) in CH2Cl2 (25 mL) at room temperature. The 
mixture was heated at reflux (bath temperature 70 °C) for 2 h. After cooling to room temperature, 
MMTCl (920 mg, 3.0 mmol, 1.0 equiv) was added, and the solution was heated at reflux for 2 h 
(aliphatic amines) or 16 h (aromatic amines). After cooling to room temperature, the solution was 
cooled further in an ice bath, and Et3N (4 mL) and MeOH (4 mL) were added to quench any 
unreacted MMTCl. After 30 min, the solution was diluted with CH2Cl2 (150 mL) and washed with 
Figure 2.30. Synthetic route for preparation of 5′-DMT-3′-CO2H thymidine nucleoside analogue. 
71 
 
5% (w/v) aqueous citric acid (30 mL) and saturated NaCl (30 mL). The organic layer was dried 
over anhydrous MgSO4 and concentrated under reduced pressure. The oily residue was purified 
by silica gel column chromatography, eluting with 0–4% CH3OH in CH2Cl2 containing 2% (v/v) 
Et3N. 
 
N-MMT-4-aminobenzoic acid triethylammonium salt 
Following the general MMT protection procedure, from 413 mg (3.0 mmol) of 4-aminobenzoic 
acid (Aldrich), 1.19 g (77%) of product was isolated as a white solid. 
TLC: Rf = 0.19 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 7.64 (d, J = 8.6 Hz, 2H), 7.33 (d, J = 7.5 Hz, 4H), 7.27-7.19 (m, 
8H), 6.79 (d, J = 8.8 Hz, 2H), 6.31 (d, J = 8.6 Hz, 2H), 3.78 (s, 3H), 2.84 (q, J = 7.2 Hz, 6H), 1.18 
(t, J = 7.2 Hz, 9H) ppm. 
13C NMR: (125 MHz, CDCl3) δ 172.3, 158.4, 149.1, 145.6, 137.2, 130.5, 130.4, 129.2, 128.1, 
127.0, 123.8, 115.1, 113.3, 71.1, 55.3, 45.0, 9.4 ppm. 
MS: m/z calcd. for C27H22NO3 [M–H]–: 408.2; found: 408.1. 
 
N-MMT-Ala-OH•Et3N 
From 265 mg (3.0 mmol) of L-alanine (Acros), 1.10 g (79%) of product was isolated as a white 
solid. 
TLC: Rf = 0.35 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 7.51 (d, J = 8.1 Hz, 4H), 7.39 (d, J = 8.1 Hz, 2H), 7.18 (t, J = 7.1 
Hz, 4H), 
7.08 (t, J = 7.0 Hz, 2H), 6.72 (t, J = 8.7 Hz, 2H), 3.71 (s, 3H), 3.15 (q, J = 6.9 Hz, 1H), 2.76 (q, J 
= 7.2 Hz, 6H), 1.12 (d, J = 6.9 Hz, 3H), 1.07 (t, J = 7.3 Hz, 9H) ppm. 
72 
 
13C NMR: (125 MHz, CDCl3) δ 180.6, 157.8, 147.4, 139.2, 130.5, 129.1, 127.7, 126.1, 113.0, 71.1, 
55.3, 53.3, 44.7, 22.4, 8.8 ppm ppm. 
MS: m/z calcd. for C23H23NO3 [M+Et3NH]
+: 463.3; found: 463.3. 
 
 
N-MMT-Phe-OH•Et3N 
From 498 mg (3.0 mmol) of L-phenylalanine (Aldrich), 1.37 g (85%) of product was isolated as a 
white solid. 
TLC: Rf = 0.51 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 7.48-7.44 (m, 4H), 7.35 (d, J = 8.9 Hz, 2H), 7.27 (d, J = 7.9 Hz, 
2H), 7.23 (t, J = 7.4 Hz, 2H), 7.18-7.14 (m, 5H), 7.10-7.07 (m, 2H), 6.71 (d, J = 8.9 Hz, 2H), 3.73 
(s, 3H), 3.47 (t, J = 6.0 Hz, 1H), 2.80 (dd, J = 13.2, 6.0 Hz, 1H), 2.72 (q, J = 7.3 Hz, 6H), 1.04 (t, 
J = 7.3 Hz, 9H) ppm. 
13C NMR: (125 MHz, CDCl3) δ 178.7, 157.8, 147.3, 147.1, 139.4, 139.0, 130.5, 130.3, 129.1, 
129.0, 127.9, 127.7, 126.1, 126.0, 112.9, 70.9, 59.1, 55.2, 44.7, 42.0, 8.7 ppm. 
MS: m/z calcd. for C29H26NO3 [M–H]–: 436.1; found: 436.2. 
 
N-MMT-4-(aminomethyl)benzoate triethylammonium salt 
From 150 mg (1.0 mmol) of 4-(aminomethyl)benzoic acid (Aldrich), 371 mg (71%) of product 
was isolated as a white solid. 
TLC: Rf = 0.24 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 8.04 (d, J = 8.1 Hz, 2H), 7.55 (d, J = 7.2 Hz, 4H), 7.46 (d, J = 8.9 
Hz, 2H), 7.42 (d, J = 8.2 Hz, 2H), 7.29 (t, J = 7.4 Hz, 4H), 7.19 (t, J = 7.3 Hz, 2H), 6.83 (d, J = 
8.9 Hz, 2H), 3.79 (s, 3H), 3.36 (s, 2H), 3.10 (q, J = 7.3 Hz, 6H), 1.30 (t, J = 7.3 Hz, 9H) ppm. 
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13C NMR: (125 MHz, CDCl3) δ 172.2, 158.1, 146.4, 144.1, 138.3, 134.3, 130.0, 129.9, 128.7, 
128.0, 127.4, 126.4, 113.4, 70.7, 55.4, 48.0, 45.0, 8.9 ppm. 
MS: m/z calcd. for C28H24NO3 [M–H]–: 422.2; found: 422.1. 
 
N-MMT-trans-4-aminocyclohexanecarboxylate triethylammonium salt 
From 145 mg (1.0 mmol) of trans-4-aminocyclohexanecarboxylic acid (TCI America), 337 mg 
(65%) of product was isolated as a white solid. 
TLC: Rf = 0.27 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 7.54 (d, J = 7.4 Hz, 4H), 7.44 (d, J = 8.8 Hz, 2H), 7.23 (t, J = 7.7 
Hz, 4H), 7.14 (t, J = 7.3 Hz, 2H), 6.78 (d, 8.8 Hz, 2H), 3.77 (s, 3H), 2.91 (q, J = 7.3 Hz, 6H), 2.25-
2.19 (m, 1H), 2.06-2.00 (m, 1H), 1.76-1.72 (m, 2H), 1.30-1.27 (m, 2H), 1.16 (t, J = 7.3 Hz, 9H), 
1.17-1.10 (m, 2H), 1.00-0.92 (m, 2H) ppm. 
13C NMR: (125 MHz, CDCl3) δ 181.4, 158.0, 147.8, 139.6, 130.1, 128.8, 127.8, 126.2, 113.1, 71.0, 
55.3, 52.3, 44.9, 44.3, 35.2, 29.4, 8.8 ppm. 
MS: m/z calcd. for C27H28NO3 [M–H]–: 414.2; found: 414.1. 
 
N-MMT-4-amino-3-(trifluoromethyl)benzoic acid triethylammonium salt 
From 203 mg (1.0 mmol) of 4-amino-3-(trifluoromethyl)benzoic acid (Matrix Scientific), 272 mg 
(47%) of product was isolated as a white solid. 
TLC: Rf = 0.28 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 8.16 (d, J = 2.0 Hz, 1H), 7.57 (dd, J = 8.9, 2.0 Hz, 1H), 7.32-7.19 
(m, 12H), 6.79 (d, J = 8.9 Hz, 2H), 6.17 (d, J = 8.8 Hz, 1H), 3.77 (s, 3H), 3.01 (q, J = 7.3 Hz, 6H), 
1.25 (t, J = 7.3 Hz, 9H) ppm. 
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13C NMR: (125 MHz, CDCl3) δ 171.8, 158.4, 145.8, 145.0, 136.7, 132.9, 130.2, 128.9, 128.2, 
127.1, 126.5, 124.3, 124.2, 116.5, 113.5, 71.3, 55.3, 45.0, 8.8 ppm (one expected peak not observed 
in aromatic region). 
MS: m/z calcd. for C28H23F3NO3 [M+H]
+: 478.2; found: 478.2. 
 
N-MMT-4-amino-3-chlorobenzoic acid triethylammonium salt 
From 170 mg (1.0 mmol) of 4-amino-chlorobenzoic acid (Aldrich), 245 mg (55%) of product was 
isolated as a white solid. 
TLC: Rf = 0.22 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 7.94 (d, J = 2.0 Hz, 1H), 7.36 (dd, J = 8.6, 2.0 Hz, 1H), 7.31-7.19 
(m, 12H), 6.78 (d, J = 8.9 Hz, 2H), 6.08 (d, J = 8.7 Hz, 1H), 6.05 (bs, 1H), 3.76 (s, 3H), 3.06 (q, J 
= 7.3 Hz, 6H), 1.30 (t, J = 7.3 Hz, 9H) ppm. 
13C NMR: (125 MHz, CDCl3) δ 171.1, 158.5, 145.1, 144.8, 136.8, 130.4, 130.3, 129.0, 128.4, 
128.2, 127.1, 123.7, 119.4, 115.3, 113.5, 71.2, 55.3, 45.3, 8.8 ppm. 
MS: m/z calcd. for C27H22NaClNO3 [M+Na]
+: 466.1; found: 466.1. 
 
N-MMT-4-amino-3-methylbenzoic acid triethylammonium salt 
From 300 mg (2.0 mmol) of 4-amino-3-methylbenzoic acid (Aldrich), 766 mg (73%) of product 
was isolated as a white solid. 
TLC: Rf = 0.25 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 7.74 (d, J = 1.1 Hz, 1H), 7.37 (dd, J = 8.6, 2.1 Hz, 1H), 7.31-7.18 
(m, 12H), 6.78 (d, J = 8.9 Hz, 2H), 6.01 (d, J = 8.6 Hz, 1H), 3.76 (s, 3H), 3.02 (q, J = 7.3 Hz, 6H), 
2.24 (s, 3H), 1.32 (t, J = 7.3 Hz, 9H) ppm. 
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13C NMR: (125 MHz, CDCl3) δ 172.2, 158.4, 147.2, 145.7, 137.4, 131.4, 130.3, 129.0, 128.1, 
126.9, 122.6, 121.4, 114.4, 113.4, 71.0, 55.3, 45.5, 18.1, 9.1 ppm (one expected peak not observed 
in aromatic region). 
MS: m/z calcd. for C28H25NaNO3 [M+Na]
+: 446.2; found: 446.3. 
 
N-MMT-4-amino-3-methoxybenzoic acid triethylammonium salt 
From 330 mg (2.0 mmol) of 4-amino-3-methoxybenzoic acid (Acros), 530 mg (49%) of product 
was isolated as a white solid. 
TLC: Rf = 0.25 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 7.44 (d, J = 1.8 Hz, 1H), 7.32-7.18 (m, 13H), 6.78 (d, J = 8.9 Hz, 
2H), 5.97 (d, J = 8.4 Hz, 1H), 3.91 (s, 3H), 3.77 (s, 3H), 3.00 (q, J = 7.3 Hz, 6H), 1.27 (t, J = 7.3 
Hz, 9H) ppm. 
13C NMR: (125 MHz, CDCl3) δ 172.1, 158.4, 146.3, 145.7, 139.4, 137.4, 130.5, 129.2, 128.1, 
126.9, 122.9, 121.8, 113.9, 113.3, 110.1, 70.7, 55.8, 55.3, 45.3, 9.0 ppm. 
MS: m/z calcd. for C28H25NaNO4 [M+Na]
+: 462.2; found: 462.2. 
 
Figure 2.31. Synthetic route for preparation of 4-Amino-3-(dimethylamino)benzoic acid. 
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4-Acetamido-3-aminobenzoic acid 
To a solution of 4-acetamido-3-nitrobenzoic acid (498 mg, 2.2 mmol, Acros) in ethanol (30 mL) 
was added cyclohexene (1.4 mL, 13.8 mmol) and 10% Pd/C (157 mg). The mixture was heated at 
reflux for 4 h (bath temperature 120 °C). The hot reaction mixture was filtered through a bed of 
Celite in a 60 mL coarse fritted funnel, and the Celite cake was washed with boiling EtOH (3  30 
mL). The flow-through was concentrated under reduced pressure to give a mixture of starting 
material and product that was used for the next step without further purification. 
 
4-Acetamido-3-(dimethylamino)benzoic acid 
The 4-acetamido-3-aminobenzoic acid from the previous reaction step was dissolved in CH3CN 
(20 mL). A solution of 37% aqueous formaldehyde (formalin, 3.0 mL) was added, and the clear 
colorless solution was stirred at room temperature for 1 h. Glacial acetic acid (0.5 mL, 8.7 mmol) 
added, and the sample was stirred for 24 h. The sample was diluted with water (50 mL) and 
extracted with ethyl acetate (5  30 mL). The organic layer was washed with saturated NaCl, dried 
over Mg2SO4, and concentrated under reduced pressure. The product was purified by silica gel 
column chromatography, eluting with 1–4% CH3OH in CH2Cl2. Appropriate product fractions 
were combined and evaporated to provide 266 mg (55% over two steps) of the product as a white 
solid. 
TLC: Rf = 0.37 (4% CH3OH in CH2Cl2). 
1H NMR: (500 MHz, CD3OD) δ 7.56 (d, J = 1.9 Hz, 1H), 7.56 (dd, J = 1.9, 8.3 Hz, 1H), 6.70 (d, 
J = 8.3 Hz, 1H), 2.65 (s, 6H) ppm, 2.23 (s, 3H) ppm. 
13C NMR: (125 MHz, CD3OD) δ 170.0, 169.8, 145.6, 138.3, 127.9, 127.1, 122.4, 121.9, 44.8, 24.4 
ppm. 
MS: m/z calcd. for C11H15N2O3 [M+H]
+: 223.1; found: 223.1. 
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4-Amino-3-(dimethylamino)benzoic acid 
4-acetamido-3-(dimethylamino)benzoic acid (200 mg, 0.9 mmol) was heated at reflux (bath 
temperature 120 °C) in a solution of 1:1 CH3OH:H2O containing 5 M KOH (10 mL) for 12 h. The 
clear colorless solution was diluted with water (50 mL) and neutralized with conc. HCl. The 
neutralized solution was extracted with ethyl acetate (3  30 mL), washed with saturated NaCl (30 
mL), and dried over MgSO4. The solution was evaporated to provide 132 mg (81%) of the product 
as a brown solid. 
TLC: Rf = 0.29 (4% CH3OH in CH2Cl2). 
1H NMR: (500 MHz, CDCl3) δ 7.66 (d, J = 1.9 Hz, 1H), 7.56 (dd, J = 8.3, 1.9 Hz, 1H), 6.70 (d, J 
= 8.3 Hz, 1H), 2.65 (s, 6H) ppm. 
13C NMR: (125 MHz, CDCl3) δ 170.9, 149.1, 140.7, 128.5, 122.4, 119.8, 114.7, 44.1 ppm. 
MS: m/z calcd. for C9H13N2O2 [M+H]
+: 181.1; found: 181.1. 
 
N-MMT-4-amino-3-(dimethylamino)benzoic acid triethylammonium salt 
Following the general MMT protection procedure, from 132 mg (0.73 mmol) of 4-amino-3-
(dimethylamino)benzoic acid, 168 mg (41%) of product was isolated as an off-white solid. 
TLC: Rf = 0.25 [4% CH3OH in CH2Cl2 with 2% (v/v) Et3N]. 
1H NMR: (500 MHz, CDCl3) δ 7.74 (d, J = 2.0 Hz, 1H), 7.31-7.19 (m, 13H), 6.79 (d, J = 8.9 Hz, 
2H), 5.99 (d, J = 8.6 Hz, 1H), 3.77 (s, 3H), 3.02 (q, J = 7.3 Hz, 6H), 2.71 (s, 6H), 1.31 (t, J = 7.3 
Hz, 9H) ppm. 
13C NMR: (125 MHz, CDCl3) δ 172.7, 158.2, 146.0, 143.8, 140.2, 137.7, 130.4, 129.1, 128.0, 
126.8, 125.9, 123.3, 120.6, 114.0, 113.3, 70.0, 55.3, 45.3, 44.5, 9.7 ppm. 
MS: m/z calcd. for C29H28NaN2O3 [M+Na]
+: 475.2; found: 475.4. 
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Chapter 3: Additional Efforts towards Amide Cleavage1 
3.1 Introduction 
 Initial efforts to identify DNA catalysts for amide bond cleavage were unsuccessful, as 
described in Chapter 2. Several additional efforts seeking peptide bond cleavage were performed 
using fundamentally different strategies than those used previously. Although many of these 
approaches did not seek hydrolytic cleavage of peptide bonds, and thus any catalysts identified 
might have less practical utility, instances in which they may be applied still exist. 
3.2 Results and Discussion 
3.2.1 Use of Amine Nucleophiles to Cleave Esters, Aromatic Amides, and Peptides 
 Linear free energy analysis of the 8ZC aromatic amide-cleavage deoxyribozymes 
described in Chapter 2 showed that the 8ZC deoxyribozymes are relatively insensitive to 
substituent effects that directly affect the reactivity of the scissile bond. This observation, together 
with the inactivity of the deoxyribozymes with aliphatic amide substrate, suggest that perhaps a 
mechanistic change would be required to cleave aliphatic amides. Perhaps the deoxyribozyme 
sequence is simply unable to catalyze attack of water into the less electrophilic aliphatic amide 
carbonyl, and thus the enzyme is inactive. If this hypothesis is correct, one strategy is to perform 
new selections for deoxyribozymes capable of using a stronger nucleophile to perform the 
cleavage.  
 One stronger nucleophile is an aliphatic amine. Natural enzymes utilize amines to cleave 
peptide bonds.1 Selections were designed so that DNA enzymes could use a 5′-NH2-modified 
oligonucleotide complementary to the right binding arm. A carbonyl substrate would be tethered 
to the 3′-end of an oligo complementary to the left binding arm. If the deoxyribozyme catalyzes 
                                                          
1 Manuscripts describing portions of this work are in preparation. 
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attack of the amine into the carbonyl substrate, a new, stable amide bond is formed and the two 
oligonucleotides are joined together, resulting in a slower migrating product that can be separated 
by PAGE (Fig. 3.1).  
 
Figure 3.1. Overview of selections for amine-based cleavage of ester, anilide, and peptide 
substrates.  
 Each selection was performed using one of two incubation conditions defined as either 
(conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 
mM NaCl at 37 °C, or as (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl 
at 37 °C. Unfortunately, after 13 rounds of selection, no activity was observed and selections were 
discontinued. 
3.2.2 Deoxyribozymes that cleave acetylglycine, fluoroacetylglycine and difluoroacetyl 
glycine2  
 As a continuation to the hypothesis proposed in the previous section, if the electrophilicity 
of the carbonyl carbon is the primary factor in identification of deoxyribozymes for cleavage of 
that bond, then directly changing the electrophilicity of an amide bond should change whether 
                                                          
2 Prof. Silverman and I conceived of and planned the project. University of Illinois undergraduate student 
Yujeong Lee synthesized substrates and performed in vitro selections under my supervision. 
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deoxyribozymes are identified for its cleavage. If electrophilicity is sufficiently increased, then 
identification of deoxyribozymes for its cleavage should be certain. In order to directly increase 
the electrophilicity of an amide bond, electron-withdrawing substituents can be incorporated 
nearby. Selections were designed to identify deoxyribozymes for cleavage of acetyl or 
perfluoroacetylglycine. 
 The selection strategy was designed so that if the acetyl or its fluorinated derivative were 
cleaved, the revealed glycine amino group could be captured using a CO2H-modified 
oligonucleotide in a splinted capture. This captured product is sufficiently large to enable PAGE 
separation from inactive sequences. Strategies to cleave the acetyl group included both hydrolysis 
and aminolysis, in which an amino -modified oligo complementary to the right binding arm. In the 
case of aminolysis, cleavage that is strictly dependent on the NH2-oligo was not required for 
sequences to survive selection, because acetyl hydrolysis would still lead to products that are 
captured. 
 Acetylglycine, N-(fluoroacetyl)glycine, N-(difluoroacetyl)glycine, and N-
(trifluoroacetyl)glycine were conjugated to DNA-C3-NH2 using the glycine carboxylic acid. 
Stability assays were performed to measure the rate of uncatalyzed hydrolysis of the substrate 
during selection incubation, and N-(trifluoroacetyl)glycine underwent >50% degradation in an 
overnight incubation in selection conditions A. Therefore, selections with the trifluoroaceytl 
substrate were not performed. A much smaller amount of background cleavage was observed for 
N-(fluoroacetyl)glycine and N-(difluoroacetyl)glycine, respetively ~2-3% and ~5-6% cleavage in 
14 h. No background hydrolysis of acetylglycine was observed in 14 h, nor was any acetyl 
transamidation observed in a splinted reaction with an amino-modified oligo. 
 85 
 
 14 rounds of in vitro selection were performed, and despite the small amount of background 
activity described above in selections with fluoroacetylglycine and difluoroacetylglycine, no 
activity was observed and selections were discontinued.  
3.2.3 Use of Hydrazide and Thiol Nucleophiles for Amide Cleavage3  
 The use of stronger nucleophiles as cofactors for DNA-catalyzed amide cleavage was also 
explored. Hydrazide is an amine nucleophile that is substantially more nucleophilic than a simple 
amine (Fig. 3.2) due to the -effect.2,3 Thiols are also extremely strong nucleophiles, and are 
involved in natural peptide bond cleavage in the form of cysteine proteases. In the selection 
experiments, both the hydrazide and thiol were attached to the 5′-terminus of an oligonucleotide.  
The thiol nucleophile was the amino acid cysteine (Fig. 3.2), which was chosen because after 
reaction with the peptide bond to form a thioester, it would immediately undergo intramolecular 
S→N acyl transfer to trap the product as an amide bond. 
 
Figure 3.2. Overview of selection strategy seeking thiol-based or hydrazide-based peptide 
cleavage. 
  
                                                          
3 Prof. Silverman and I conceived of and planned this project. University of Illinois undergraduate student 
Yujeong Lee synthesized materials and performed in vitro selections under my supervision. 
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 A direct selection, analogous to the selection strategy illustrated in Figure 3.1, was with 
both the thiol and hydrazide and the 3′-succinyl-AFA substrate described above. Selections were 
performed in both conditions A and conditions B. After 13 rounds of selections with no activity 
(<0.5%) observed, selections were discontinued. 
3.2.4 Use of Internal Peptide Nucleophiles for Peptide Self-Cleavage4  
 DNA-catalyzed peptide self-cleavage was inspired by the very different rates of RNA 
transesterification and DNA hydrolysis. The uncatalyzed t1/2 of RNA transesterification is ~10 
years,4 while the uncatalyzed t1/2 of DNA hydrolysis is ~30 million years.
5 The rate of RNA 
transesterification is so much faster because the 2′-OH is well positioned to attack the adjacent 
phosphodiester bond. DNA-hydrolysis, however, requires water from solution to attack the 
phosphodiester in the proper orientation and, despite the high concentration of water in solution, 
this occurs much slower than in RNA when the nucleophile is preorganized. Extending this logic, 
perhaps DNA catalysts for peptide bond cleavage could be more rapidly identified if given the 
option of using a tethered nucleophile, such as a peptide side chain, to enable the cleavage reaction.  
 Additional experimental evidence supports this hypothesis that DNA may be able to 
catalyze peptide bond cleavage using a tethered nucleophile. When deoxyribozymes that catalyze 
DNA hydrolysis were identified when attempting to cleave peptide bonds, one of the enzymes, 
10MD9, catalyzed phosphodiester hydrolysis between the 4-hydroxybutyric acid linker connecting 
the peptide to the left DNA binding arm, and subsequently catalyzed lactonization of the 4-
hydroxybutyric acid linker to cleave an amide bond (Fig. 3.3).6 
 
                                                          
4 Prof. Silverman and I conceived and planned the project. University of Illinois undergraduate students 
Marissa Castner and Paul Klauser synthesized substrates under my supervision. Paul Klauser performed in 
vitro selections under my supervision. 
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Figure 3.3. 10MD9-catalyzed DNA cleavage6 and 4-hydroxybutyric acid linker. After DNA-
catalyzed phosphodiester hydrolysis, the linker connecting the tripeptide substrate to the left DNA 
binding arm undergoes catalyzed lactonization form the GHB lactone and revealed peptide N-
terminus. 
 Attack of the amino acid side chain on the peptide backbone is also the first step in protein 
splicing (Fig. 3.4).7 The amino acids serine and cysteine are most commonly involved, and attack 
of the peptide backbone causes an N→O or N→S acyl transfer to form the ester or thioester 
intermediate. This intermediate is then attacked by another nucleophilic side chain and 
intramolecular rearrangement completes removal of the intein to generate the mature protein. The 
first step in this process, attack of the peptide backbone by a nucleophilic side chain, generates a 
base-labile intermediate. In a selection experiment, if DNA were to catalyze only this first step, 
the final peptide bond cleavage could be completed using an additional base hydrolysis step.  
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Figure 3.4. Overview of protein splicing. Attack of the cysteine or serine side chain on the peptide 
backbone forms the thioester or ester intermediate. In protein splicing, this intermediate is attacked 
by another nucleophilic side chain, which after intramolecular rearrangement removes the intein. 
Figure reprinted with permission from Ref. 7. 
 Using the above examples as precedent for peptide self-cleavage, several substrates 
containing internal peptide nucleophiles were selected to use for in vitro selections. Serine and 
cysteine each have nucleophilic side chains on their -carbon which could enable self-cleavage. 
Attack by the side chain nucleophile on the peptide bond N-terminal to the side chain proceeds 
through a five membered ring results an N→O or N→S acyl transfer to form an ester of thioester 
intermediate (Fig. 3.5). Subsequent hydrolysis of this intermediate cleaves the peptide backbone 
and yields the products of hydrolysis. Additionally, side chain attack C-terminal to the amino acid 
proceeds through a seven membered ring and forms a lactone or thiolactone product and 
subsequent hydrolysis yields net peptide hydrolysis products.  
 Additionally, the unnatural amino acid homoserine has a hydroxyl nucleophile on the g-
carbon. This can attack the C-terminal peptide bond, proceeding through a five membered ring, or 
the N-terminal peptide bond, proceeding through a six membered ring (Fig. 3.6). In each case, 
N→O acyl transfer yields an ester intermediate. Importantly, attack of the homoserine hydroxyl 
on the C-terminal peptide bond is the same lactonization reaction observed in the 10MD9 reaction.  
 In vitro selections for self-cleavage with serine and cysteine cleavage were designed so 
that the carboxylic acid resulting from cleavage was captured in a splinted reaction using an NH2-
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modified oligonucleotide. Selections for self-cleavage with homoserine were designed so that the 
revealed amine was captured in a splinted reaction using a CO2H-modified oligonucleotide. In all 
selections, the captured product was separated from the uncaptured and inactive sequences by 
PAGE. In vitro selections were carried through 13 rounds of selection. Selections were 
discontinued after no activity was observed. 
 
 
Figure 3.5. Structural schematic of serine and cysteine self-cleavage. Attack of the side chain 
nucleophile on the peptide bond N-terminal to that amino acid proceeds through a 5-membered 
ring intermediate. Attack on the next C-terminal amino acid would proceed through a 7-membred 
ring. Products formed from each of these reactions could be subsequently hydrolyzed and captured 
using an amino-modified oligo. Attack on the immediate C-terminal peptide bond would require 
a 4-membered ring intermediate, which is unlikely to occur. 
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Figure 3.6. Structural schematic of homoserine self-cleavage. Attack of the homoserine side chain 
on the amide bond N-terminal to the amino acid (green arrow) would proceed through a 6-
membered ring intermediate. Attack of the homoserine side chain on the peptide bond C-terminal 
to the amino acid (blue arrow) would proceed through a 5-membered ring intermediate to form 
homoserine lactone. The blue arrow depicts lactonization to form a five-membered ring, similar to 
the reaction described in Fig. 3.3. 
3.2.5 Use of Extremely Long Random Region Lengths for Amide Cleavage5   
 As described in chapter 2, early experiments seeking DNA-catalyzed cleavage of aromatic 
amide and aliphatic amide substrates used N20-N60 random region lengths. No activity for aliphatic 
amide cleavage was observed for any of these lengths. Random region length has been shown to 
be an important variable in identifying DNA catalysts for different chemical reactions,8 and 
ribozymes have been identified from random region lengths exceeding N200.
9 Additionally, others 
have hypothesized that extremely long random region lengths might actually be favored in seeking 
to identify rare sequence motifs, despite the sparse sequence coverage with long random region. 
This insight is largely based on the fact that nucleic acid structures often contain loops that extend 
                                                          
5Prof. Silverman and I conceived of and planned the project. University of Illinois undergraduate Yujeong 
Lee synthesized substrates and performed in vitro selections under my supervision. Yujeong Lee, 
University of Illinois undergraduates Paul Klauser and Xinyi Li, and I characterized deoxyribozymes. 
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into solution that can be of variable length. Because rare sequence motifs require specific sections 
of sequences to physically come together in space, a long random region length provides more 
opportunities these events to occur.  Experimentally, this hypothesis is supported by the 
observation that many nucleic acid enzymes contain sections that can be deleted without affecting 
catalytic activity.10 Excess sequence could also inhibit an active catalyst or be more prone to 
misfolding into an inactive structure, but either of these consequences are outweighed by the 
prospect that use of long random region lengths may lead to active catalysts.  
 In vitro selections were performed using aliphatic amide substrate shown in Fig. 3.7, which 
is formed between the carboxylic acid of a 3′-glycolic acid oligo and 5′-NH2 thymidine oligo. 
Selections using N80 and N100 random region lengths were carried out, and active sequences were 
captured using an NH2-modified capture oligo in a splinted capture reaction (similar to the capture 
step described in chapter 2). Selection experiments using the N100 random region length (called 
the PW1 selections) were cloned from round 8. Screening of clones and mass spectrometric 
analysis of the reaction products showed that deoxyribozymes were not catalyzing amide bond 
cleavage, but were instead catalyzing oxidative DNA cleavage near to the amide bond. This 
oxidative cleavage was yielding a 3′-glycolate product (from the left side of the substrate) and a 
5′-phosphorylated product (from the left side of the substrate). These are the same products formed 
from DNA cleavage catalyzed by the natural product bleomycin, which has been widely 
studied.11,12 Deoxyribozymes that catalyze this cleavage were able to survive selections because 
the left substrate terminated in a 3′-carboxylic acid, the same chemical identity as cleavage at the 
desired peptide bond. All deoxyribozymes identified were also active with an all DNA substrate 
that does not contain the peptide bond. They are currently being characterized to better understand 
their mechanism of cleavage. 
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Figure 3.7. In vitro selection strategy using N80 and N100 random region lengths. Shown at the top 
of the figure is the amide substrate used in selections. The amide substrate is ligated to the N80 or 
N100 pool, and if hydrolysis occurs during the key selection step, the resulting carboxylic acid is 
captured with an amino-modified oligo.  
 The in vitro selection strategy would need to be changed for future experiments in order to 
avoid identifying deoxyribozymes which catalyze bleomycin cleavage. One strategy is to alternate 
the loop from the left side to right side in consecutive selection rounds. The capture strategy would 
need be altered to capture the 3′-carboxylic acid in rounds with loop on the left, and to capture the 
5′-NH2 in rounds with loop on the right. This alternation strategy would eliminate the possibility 
of selecting for bleomycin-like cleavage.  
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3.2.6 Use of Chemically Modified Nucleotides for Amide Cleavage6   
 Nucleic acids catalysts are at a distinct disadvantage compared to protein catalysts when 
considering functional diversity. Nucleic acids have four different nucleobases, while proteins 
have 20 different amino acids. Nucleic acid nucleobases are all structurally similar, consisting of 
aromatic heterocycles, while amino acids have great structural and chemical diversity. Others have 
speculated that the lack of functional diversity limits the functional capacity of nucleic acid 
enzymes. One option to overcome this lack of functional diversity is to incorporate chemically 
modified nucleotides that bear functional groups similar to that of amino acid side chains. This 
approach would maintain DNA’s advantage over proteins in that selection experiments can be 
performed starting from random populations of sequences, but with the expanded chemical 
functionality of proteins.  
 Modified nucleotides containing hydroxyl, carboxylic acid, amino, and imidazole 
functional groups were selected (Figure 3.8). Each of these can be incorporated by Taq polymerase 
or another commercially available polymerase. In vitro selections were designed around the amide-
containing substrate and using the same capture reaction described above. These selections were 
carried out, and deoxyribozymes for amide cleavage were identified from selections with 
hydroxyl, carboxylic acid, and amino functional groups. These catalysts are currently being 
characterized biochemically. Additional selection experiments with modified nucleotides are 
being performed using peptide substrates, with the hopes of eventually identifying 
deoxyribozymes that catalyze cleavage of untethered peptide and protein substrates.  
 
                                                          
6 The bulk of this project was performed by Silverman lab graduate student Cong Zhou. I assisted with 
initial substrate synthesis.  
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Figure 3.8. Structures of chemically modified nucleotides including amine, carboxylic acid, 
imidazole, and hydroxyl. Each modification is intended to mimic an amino acid side chain, as 
shown. 
 In addition, sequences that catalyze the same bleomycin-like cleavage described above 
were identified. These sequences did not require the chemically modified nucleotides for catalytic 
activity, and they also were active with the all-DNA substrate. Therefore, deoxyribozymes with 
only 40 nucleotide catalytic regions can also catalyze this oxidative cleavage. Characterization of 
these deoxyribozyme is in progress. 
3.3 Summary 
 Several additional efforts to identify DNA catalysts for amide cleavage have been 
performed. Each effort used a different approach to identify new catalysts. Although most efforts 
were unsuccessful for amide cleavage, a new deoxyribozyme catalytic activity was identified in 
separately in two different efforts. In addition, in vitro selection with chemically modified 
nucleotides, resulted in deoxyribozymes for amide cleavage. Chemical modifications that enabled 
catalysis included amino, hydroxyl, and carboxylate. These results are being extended to identify 
deoxyribozymes that cleave peptides, with the ultimate goal of identifying deoxyribozymes for 
site-specific protein cleavage. 
 95 
 
3.4 Materials and Methods 
3.4.1 Preparation of Oligonucleotides 
DNA oligonucleotides were obtained from Integrated DNA Technologies (Coralville, IA) 
or prepared by solid-phase synthesis on an ABI 394 instrument using reagents from Glen Research. 
All oligonucleotides and conjugates were purified by 7 M urea denaturing 20% or 8% PAGE with 
running buffer 1 TBE (89 mM each Tris and boric acid and 2 mM EDTA, pH 8.3), extracted 
from the polyacrylamide with TEN buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 300 mM NaCl), 
and precipitated with ethanol. AFA peptide was prepared by solid-phase synthesis using Fmoc 
Rink amide MBHA resin as described,13 and coupling succinic anhydride to the N-terminus as 
previously described.14 
3.4.2 Preparation of Peptide and Nucleophile Substrates 
A 20 μL solution containing 2 nmol of NH2-modified-DNA, 30 mM carboxylic acid small 
molecule (ester, anilide, AFA peptide), 100 mM MOPS, pH 7.0, and 450 mM DMT-MM was 
incubated at room temperature for 24 h. Unreacted reagents were removed by Amicon spin 
column, and the DNA conjugate was purified by HPLC. 
Synthesis of 5-hydrazide-modified nucleophile oligo. 
The DNA portion was prepared by automated solid-phase synthesis with free 5-OH 
terminus. The DNA synthesis column was dried under vacuum and the 5-C10-NHS ester 
phosphoramidate was introduced to the column manually. One bottle of C10-NHS ester 
phosphoramidate (100 µmol; Glen Research) was dissolved in 1 mL of anhydrous acetonitrile. 200 
µL of this solution was combined with 500 µL of activator solution (3% tetrazole in acetonitrile) 
and introduced to the DNA column under argon. This reaction was allowed to proceed for 15 min 
with mixing by syringe every 3 min. The column was washed with acetonitrile (3  mL) and 
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dried under nitrogen. 700 uL of oxidizer solution (0.02M iodine in THF/pyridine/water) was then 
applied to the column for 15 min with mixing by syringe every 3 min, after which the column was 
washed with acetonitrile (3  mL) and dried under nitrogen. Cleavage from the solid support, 
oligonucleotide deprotection, and hydrazide formation was carried out using a solution of 25 µL 
hydrazine, 75 µL water and 100 µL of ethanol. The mixture was incubated at room temperature 
for 5 h, desalted using a Bio-Rad P6 spin column, and purified by PAGE. 
Synthesis of 5-CO2H capture oligo.   
The 5-C10-NHS ester phosphoramidate was coupled manually as described above. 
Cleavage of the oligonucleotide from the CPG and nucleobase deprotection were performed using 
500 µL of 400 mM NaOH in 4:1 MeOH:H2O for 24 h at room temperature. The sample was diluted 
to 2 mL with water and desalted using a PD10 column (GE Healthcare). The fractions containing 
desalted oligonucleotide were concentrated and purified by 20% PAGE and HPLC. 
Synthesis of 3-CO2H capture oligo.   
5′-DMT-thymidine-derivatized CPG solid support (40 µmol/g; 200 nmol) was deprotected 
with TCA/CH2Cl2 (3  1 mL) and washed with CH2Cl2 (3  5 mL). The support was rinsed with 
2% (v/v) NMM/CH2Cl2 and CH2Cl2 (3  5 mL) to improve the efficiency of the next coupling step 
and dried under a stream of nitrogen. 5′-DMTglycolic acid (41 mg, 100 µmol), HATU (38 mg, 
100 µmol), and HOBt (14 mg, 100 mol) were dissolved in 500 µL of dry DMF. NMM (26 µL, 
230 µmol) was added to this solution, which was introduced into the DNA synthesis column via 
two syringes. The coupling step was performed for 18 h with mixing every 5 min for the first 2 h 
and no mixing for the remaining 16 h. The column was washed with DMF (3  5 mL) and CH2Cl2 
(3  5 mL) and dried under a stream of nitrogen. The remainder of the oligonucleotide was 
synthesized on the ABI 394 instrument using standard procedures. Cleavage of the oligonucleotide 
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from the CPG and nucleobase deprotection were performed using 500 µL of 400 mM NaOH in 
4:1 MeOH:H2O for 24 h at room temperature. The sample was diluted to 2 mL with water and 
desalted using a PD10 column (GE Healthcare). The fractions containing desalted oligonucleotide 
were concentrated and purified by 20% PAGE. 
3.4.3 Steps of in vitro selection 
General steps for in vitro selection experiments 
Procedure for ligation step in round 1. A 25 µL sample containing 600 pmol of DNA pool, 
750 pmol of DNA splint, and 900 pmol of DNA-C3-NH2 was annealed in 5 mM Tris, pH 7.5, 15 
mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. To this 
solution was added 3 µL of 10 T4 DNA ligase buffer (Fermentas) and 2 µL of 5 U/µL T4 DNA 
ligase (Fermentas). 10 T4 DNA ligase buffer that lacks DTT (400 mM Tris, pH 7.8, 100 mM 
MgCl2, and 5 mM ATP) was used with disulfide-linked oligonucleotide-peptide conjugates. The 
sample was incubated at 37 °C for 12 h and purified by 8% PAGE. 
Procedure for ligation step in subsequent rounds. A 17 µL sample containing the PCR-
amplified DNA pool (~5–10 pmol), 30 pmol of DNA splint, and 50 pmol of DNA-C3-NH2 was 
annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min 
and cooling on ice for 5 min. To this solution was added 2 µL of 10 T4 DNA ligase buffer 
(Fermentas) and 1 µL of 1 U/µL T4 DNA ligase (Fermentas). 10 T4 DNA ligase buffer that lacks 
DTT (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) was used with disulfide-linked 
oligonucleotide-peptide conjugates. The sample was incubated at 37 °C for 12 h and purified by 
8% PAGE. 
Procedure for selection step in round 1. Each selection experiment was initiated with 200 
pmol of the ligated pool. A 20 µL sample containing 200 pmol of ligated pool and 300 pmol of 5-
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ester, anilide, or tripeptide was annealed in (conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, 
and 0.1 mM EDTA or (conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 mM EDTA by 
heating at 95 °C for 3 min and cooling on ice for 5 min. The selection reaction was initiated by 
bringing the sample to 40 µL total volume containing (conditions A) 70 mM HEPES, pH 7.5, 40 
mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM NaCl or (conditions B) 50 mM CHES, pH 
9.0, 40 mM MgCl2, and 150 mM NaCl. The Mn
2+ was added from a 10 stock solution containing 
200 mM MnCl2. The Zn
2+ was added from a 10 stock solution containing 10 mM ZnCl2, 20 mM 
HNO3, and 200 mM HEPES at pH 7.5; this stock solution was freshly prepared from a 100 stock 
of 100 mM ZnCl2 in 200 mM HNO3. The metal ion stocks were added last to the final sample. The 
sample was incubated at 37 °C for 14 h. 
Procedure for selection step in subsequent rounds. A 10 µL sample containing the ligated 
pool and 30 pmol of 5-ester, anilide, or tripeptide was annealed in (conditions A) 5 mM HEPES, 
pH 7.5, 15 mM NaCl, and 0.1 mM EDTA or (conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, 
and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The selection 
reaction was initiated by bringing the sample to 20 µL total volume containing (conditions A) 70 
mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM NaCl or 
(conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl. The sample was 
incubated at 37 °C for 14 h. 
Procedure for PCR. In each selection round, two PCR reactions were performed, 10-cycle 
PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared containing the PAGE-
purified selection product, 200 pmol of forward primer, 50 pmol of reverse primer, 20 nmol of 
each dNTP, and 10 µL of 10 Taq polymerase buffer [1 = 20 mM Tris-HCl, pH 8.8, 10 mM 
(NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100]. This sample was cycled 10 times 
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according to the following PCR program: 94 °C for 2 min, 10 (94 °C for 30 s, 47 °C for 30 s, 72 
°C for 30 s), 72 °C for 5 min. Taq polymerase was removed by phenol/chloroform extraction. 
Second, a 50 µL sample was prepared containing 1 µL of the 10-cycle PCR product, 100 pmol of 
forward primer, 25 pmol of reverse primer, 10 nmol of each dNTP, 20 µCi of -32P-dCTP (800 
Ci/mmol), and 5 µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to 
the following PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 
72 °C for 5 min. Samples were separated by 8% PAGE. 
Capture step for 3-NH2 (acetylglycine cleavage) 
Procedure for capture step in round 1. A 90 L sample containing the selection product, 
300 pmol of DNA splint, and 400 pmol of 5-C10-CO2H capture oligonucleotide was annealed in 
100 mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on ice for 5 min. 
The capture reaction was initiated by bringing the sample to 100 µL total volume containing 100 
mM MOPS, pH 7.0, 1 M NaCl, and 50 mM EDC and 50 mM HOBt. DMF was used to dissolve 
the HOBt stock solution, and the total amount of DMF in the final capture reaction was 10 µL. 
The sample was incubated at 37 °C for 12 h. 
Procedure for capture step in subsequent rounds. A 20 L sample containing the selection 
product, 50 pmol of DNA splint, and 100 pmol of 5-C10-CO2H capture oligonucleotide was 
annealed in 100 mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on 
ice for 5 min. The capture reaction was initiated by bringing the sample to 25 µL total volume 
containing 100 mM MOPS, pH 7.0, 1 M NaCl, and 50 mM EDC and 50 mM HOBt. DMF was 
used to dissolve the HOBt stock solution, and the total amount of DMF in the final capture reaction 
was 10 µL. The sample was incubated at 37 °C for 12 h. 
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Capture step for 3-CO2H (serine/cysteine self-cleavage; AHA amide cleavage with N80, N100 
random regions and with chemically modified nucleotides) 
Procedure for capture step in round 1. A 90 L sample containing the selection product, 
300 pmol of DNA splint, and 400 pmol of 5-amino capture oligonucleotide was annealed in 100 
mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on ice for 5 min. 
The capture reaction was initiated by bringing the sample to 100 µL total volume containing 100 
mM MOPS, pH 7.0, 1 M NaCl, and 50 mM EDC and 50 mM HOBt. DMF was used to dissolve 
the HOBt stock solution, and the total amount of DMF in the final capture reaction was 10 µL. 
The sample was incubated at 37 °C for 12 h. 
 Procedure for capture step in subsequent rounds. A 20 L sample containing the selection 
product, 50 pmol of DNA splint, and 100 pmol of 5-amino capture oligonucleotide was annealed 
in 100 mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on ice for 5 
min. The capture reaction was initiated by bringing the sample to 25 µL total volume containing 
100 mM MOPS, pH 7.0, 1 M NaCl, and 50 mM EDC and 50 mM HOBt. DMF was used to dissolve 
the HOBt stock solution, and the total amount of DMF in the final capture reaction was 10 µL. 
The sample was incubated at 37 °C for 12 h.  
Capture step for 5-NH2 (homoserine self-cleavage) 
Procedure for capture step in round 1. A 90 L sample containing the selection product, 
300 pmol of DNA splint, and 400 pmol of 3-AHA-CO2H capture oligonucleotide was annealed 
in 100 mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on ice for 5 
min. The capture reaction was initiated by bringing the sample to 100 µL total volume containing 
100 mM MOPS, pH 7.0, 1 M NaCl, and 50 mM EDC and 50 mM HOBt. DMF was used to dissolve 
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the HOBt stock solution, and the total amount of DMF in the final capture reaction was 10 µL. 
The sample was incubated at 37 °C for 12 h. 
Procedure for capture step in subsequent rounds. A 20 L sample containing the selection 
product, 50 pmol of DNA splint, and 100 pmol of 3-AHA-CO2H capture oligonucleotide was 
annealed in 100 mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on 
ice for 5 min. The capture reaction was initiated by bringing the sample to 25 µL total volume 
containing 100 mM MOPS, pH 7.0, 1 M NaCl, and 50 mM EDC and 50 mM HOBt. DMF was 
used to dissolve the HOBt stock solution, and the total amount of DMF in the final capture reaction 
was 10 µL. The sample was incubated at 37 °C for 12 h. 
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Chapter 4: DNA-Catalyzed Lysine Side Chain Modification1 
4.1 Introduction 
4.1.1 DNA-Catalyzed Nucleopeptide Formation 
 Deoxyribozymes have primarily been used to catalyze reactions involving nucleic acid 
substrates, and this is reasonable considering how DNA can interact with both DNA and RNA 
substrates via Watson-Crick base pairing. Previous selections seeking DNA catalysts for formation 
of branched RNA revealed a DNA enzyme that forms a three-helix-junction (3HJ) architecture, in 
which additional base pairing juxtaposes the 2-OH nucleophile and 5-triphosphorylated RNA 
electrophile close together (Figure 4.1). This 3HJ architecture was used to identify the first 
deoxyribozymes that catalyze reaction of the tyrosine side chain with a triphophosphorylated 
RNA.1 In subsequent efforts, the 3HJ was used to identify deoxyribozymes for reaction of the 
serine side chain as part of an Ala-Ser-Ala tripeptide.2 The 3HJ architecture is inherently limited, 
however, when seeking to identify deoxyribozymes that catalyze reaction of untethered peptide 
substrates. In subsequent efforts, an open architecture was used during selection to successfully 
identify deoxyribozymes that catalyze formation of nucleopeptide linkages with tyrosine-
containing peptide substrates.3,4 
                                                          
1This work has been published:  
 
Brandsen, B. M.; Velez, T. E.; Sachdeva, A.; Ibrahim, N. A.; Silverman, S. K. DNA-Catalyzed Lysine Side 
Chain Modification. Angew. Chem. Int. Ed. 2014, 53, 9045-9050. 
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Figure 4.1. Illustration of three-helix-junction (3HJ) architecture. Initially discovered for the 
identification of RNA-branching deoxyribozymes, it was subsequently used to identify 
deoxyribozymes for reaction of amino acid side chains.  
 Despite successfully identifying deoxyribozymes for nucleopeptide formation with 
tyrosine and serine nucleophiles, the identification of deoxyribozymes that catalyze reaction of the 
lysine side chain have been elusive. This difficulty is especially surprising considering lysine’s 
strong nucleophilicity. In one effort seeking DNA catalysts for lysine side-chain reactivity, 
deoxyribozymes were identified that utilized a phosphoramidate linkage between the lysine-
containing tripeptide and the DNA binding arm to form a pyrophosphoramidate linkage.5 It is not 
clear why DNA catalysts are identified that use a much weaker nucleophile when a much stronger 
nucleophile is available.  
 The reaction of lysine with an activated phosphoryl electrophile to form a phosphoramidate 
product has biological precedent. The enzyme T4 DNA ligase proceeds through a nucleopeptide 
intermediate in which the -NH2 of the lysine side chain attacks the -phosphate of ATP.6 This 
phosphoramidate intermediate reacts with its 5-phosphorylated DNA substrate to form an 
adenylylated intermediate, after which the enzyme catalyzes phosphodiester formation to form to 
the ligated products.  
 Because DNA-catalyzed lysine reactivity has been difficult to achieve using 
triphosphorylated RNA as the electrophilic reaction partner, perhaps the use of a more reactive 
could allow for successful identification of deoxyribozymes for lysine reactivity. 
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Phosphorimidazolides are imidazole-activated phosphate species that are more approximately 
100-fold reactive than triphosphate electrophiles (Fig 4.2).7 Phosphorimidazolides have been 
previously used in chemical primer extensions for reaction with hydroxyl and amino 
nucleophiles.8-10 Additionally, phosphorimidazolides can be prepared easily on 5 or 3-
phosphorylated DNA or RNA. 
 
Figure 4.2. Triphosphate and phosphorimidazolide electrophiles. Figure adapted with permission 
from Ref. 11.  
4.1.2 In Vitro Selection Design 
 Previous efforts for DNA-catalyzed lysine modification exclusively used a three helix 
junction architecture in which the lysine nucleophile was held in close proximity to the 
triphosphate electrophile (Figure 4.3 A). Considering the success identifying deoxyribozymes for 
tyrosine and serine in an open architecture in which the reaction partners are not held closely 
together (Figure 4.3 B), the open architecture was chosen for the selections with 
phosphorimidazolide electrophiles. Looking forward, the eventual goal is to identify 
deoxyribozymes for modification of lysine in larger peptide and protein substrates, and the open 
architecture is much more conducive to this goal than is the three helix junction, for which the use 
of protein substrates is virtually impossible.  
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Figure 4.3. Architectures for DNA-catalyzed nucleophilic reactivity of amino acid side chains. (a) 
3HJ architecture for juxtaposing nucleophile and electrophile, illustrated with Tyr as nucleophile 
and 5-triphosphate (5-ppp) as electrophile. Base pairing creates the third helix and preorganizes 
the nucleophile and electrophile. (b) Open architecture, with amine as nucleophile and 5-
phosphorimidazolide (5-Imp) as electrophile. Note the lack of preorganization of nucleophile and 
electrophile in the open architecture relative to the 3HJ architecture. Figure adapted with 
permission from Ref. 11. 
 Two amine nucleophiles were chosen: DNA-C3-NH2 and DNA-HEG-CKA (Fig. 4.4). In 
the DNA-C3-NH2 substrate, the amine nucleophile is closely tethered to the DNA anchor 
oligonucleotide. With this closely tethered substrate, a DNA enzyme is only required to catalyze 
the reaction of the substrate, and not to recognize and bind the substrate from solution. In contrast, 
the DNA-HEG-CKA substrate is loosely tethered on the end of a hexaethylene glycol linker, and 
a DNA enzyme is required to first bind the peptide from solution (at the end of a long tether) before 
catalyzing its reaction.  
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Figure 4.4. Structures of the DNA-C3-NH2 and DNA-HEG-CKA nucleophiles. Figure adapted 
with permission from Ref. 11. 
 
 Reaction between the amine nucleophile and phosphorimidazolide electrophile results in 
formation of a phosphoramidate linkage. This bond formation links the two DNA susbtrates 
together, which results in sufficient addition of mass to enable separation by PAGE (Fig. 4.5), and 
no additional capture step was necessary. Immediately after incubation in the selection conditions, 
samples were separated by PAGE, and sequences migrating at the position of the desired product 
were excised and amplified by PCR. Selection experiments were performed under two conditions, 
named conditions A and conditions B. Conditions A consisted of 70 mM HEPES, pH 7.5 with 40 
mM Mg2+, 20 mM Mn2+, 1 mM Zn2+, and 150 mM Na+ incubated at 37 °C for 14 h. Conditions B 
consisted of 50 mM CHES, pH 9.0 with 40 mM Mg2+ and 150 mM Na+ at incubated at 37 °C for 
14 h.  
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Figure 4.5. Key in vitro selection step. N40 denotes a 40-nucleotide random region. The dashed 
loop enables separation of catalytically active DNA sequences from the random N40 population 
by PAGE shift but is dispensable for catalysis and was absent in all single-turnover kinetic assays. 
Reaction between the amine nucleophile and 5-ImpDNA formed new phosphoramidate bond, 
which was directly separated by PAGE and amplified by PCR to enter the next selection round. 
4.2 Results and Discussion 
4.2.1 DNA Catalysts for DNA-C3-NH2 
 In both selection experiments using the DNA-C3-NH2 substrate, DNA-catalyzed activity 
was observed.11 After 8 rounds of selection (conditions A, final incubation reduced to 2 h) or 7 
rounds of selection (conditions B), 20% or 13% ligation activity was observed (Fig. 4.6). 
Individual deoxyribozymes were cloned and shown to catalyze amine reactivity with 5-ImpDNA 
(Fig. 4.7).  
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Figure 4.6. Progressions of the in vitro selection experiments. Arrows mark the cloned rounds. 
The DW1 and DX1 selections were for reaction of the DNA-C3-NH2 substrate under conditions A 
and B, respectively, using an N40 random region. Conditions A were 50 mM HEPES, pH 7.5 with 
40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+, and 150 mM Na+ at 37 °C for 14 h or 2 h as indicated. 
Conditions B were 50 mM CHES, pH 9.0 with 40 mM Mg2+ and 150 mM Na+ at 37 °C for 14 h, 
2 h, or 10 min as indicated. All metal ions were provided as chloride salts.  
 
 
 
Figure 4.7. Sequences of the seven 8DW1 deoxyribozymes and six 7DX1 deoxribozymes. Only 
the initially random (N40) sequences are shown. All deoxyribozymes were used as 5ʹ-
CGAAGCGCTAGAACAT-N40-ATAGTGAGTCGTATTA-3ʹ. In each alignment, a dot denotes 
conservation, i.e., the same nucleotide as in the uppermost sequence; a dash denotes a gap. On the 
far right is shown the sequence length and (in parentheses) the number of times that the particular 
sequence was found during cloning. 
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 Seven unique deoxyribozymes were identified from conditions A (called the 8DW1 
deoxyribozymes), with single-turnover kobs values of 0.2–1.2 h–1 and up to 85% yield (Fig. 4.8). 
Three different metal dependences were observed among these seven deoxyribozymes. 8DW115 
and four other deoxyribozymes each require Mn2+, with no activity observed with only Mg2+ or 
Zn2+. 8DW120 was optimally active with Mn2+, but also showed reduced activity with Mg2+ and 
Zn2+. 8DW120 showed no activity with Mg2+ alone or Zn2+ alone. Finally, 8DW113 requires both 
Mn2+ and Zn2+ for catalysis, and Mg2+ is dispensable. Each 8DW1 deoxyribozyme was assayed at 
pH 7.2, 7.5, or 7.8; all catalysts except 8DW120 had optimal yield at pH 7.5 (but still generally 
substantial yield at pH 7.2 and 7.8). 8DW120 had slightly higher yield at pH 7.8 (Fig. 4.9). 
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Figure 4.8. Kinetic plots with various metal ions for all seven 8DW1 deoxyribozymes. Incubation 
conditions: conditions A with the indicated combinations of 40 mM MgCl2, 20 mM MnCl2, and 1 
mM ZnCl2 at 37 °C. These data sets are representative; each illustrated data set was acquired at 
least two times independently. kobs values (h
–1): 8DW103 Mg/Mn/Zn 0.24, Mn 0.23, Mg/Zn 
0.0022; 8DW112 Mg/Mn/Zn 0.37, Mn 0.32; 8DW113 Mg/Mn/Zn 0.28, Mn/Zn 0.27; 8DW115 
Mg/Mn/Zn 1.02, Mn 1.20, Mg/Zn 0.0010; 8DW118 Mg/Mn/Zn 0.23, Mn 0.18; 8DW120 
Mg/Mn/Zn 0.26, Mn 0.22, Mg/Zn 0.12; 8DW134 Mg/Mn/Zn 0.23, Mn 0.21; Mg/Zn 0.0009. 
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Figure 4.9. Kinetic plots at various pH values for all seven 8DW deoxyribozymes. Incubation 
conditions: 70 mM HEPES, pH 7.2 or 7.5 or 7.8, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 
150 mM NaCl at 37 °C. For each deoxyribozyme except 8DW120, optimal activity was observed 
at pH 7.5, and the deoxyribozymes maintained activity at pH 7.2 and 7.8. For 8DW120, optimal 
activity was at pH 7.8.  
 
 Separately, seven unique deoxyribozymes were identified from conditions B (called the 
7DX1 deoxyribozymes), each with kobs of ~0.03 h
–1 and 30-40% yield in 48 h. The optimal Mg2+ 
concentration for each deoxyribozyme was determined to be ~30 mM (Fig. 4.10). Each 
113 
 
deoxyribozyme was also assayed at pH values of 8.0 through 10.0, and in each instance, optimal 
activity was observed at either pH 8.5 or pH 9.0 (Fig. 4.11). 
 
Figure 4.10. Mg2+ concentration dependence of the 7DX1 deoxyribozymes. Incubation 
conditions: 50 mM CHES, pH 9.0, 0–300 mM MgCl2, and 150 mM NaCl at 37 °C. kobs values 
were determined from initial-rate kinetics (linear fits to plots of yield versus time from 0 to 12 h). 
The two symbols represent data sets collected at different times. 
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Figure 4.11. Kinetic plots at various pH values for all seven 7DX1 deoxyribozymes. Incubation 
conditions: 50 mM buffer, pH 8.0–10.0 with 40 mM MgCl2 and 150 mM NaCl at 37 °C. 
 
4.2.2 DNA Catalysts for DNA-HEG-CKA 
 Each in vitro selection experiment that used the DNA-HEG-CKA substrate also led to 
DNA-catalyzed activity. After 9 rounds (conditions A) or 14 rounds (conditions B), 19% or 14% 
ligation activity was observed (Fig. 4.12). Two unique sequences were identified from selection 
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in conditions A, and six unique sequences were identified from selection in conditions B (Fig. 
4.13). 
 
Figure 4.12. Progressions of the in vitro selection experiments. Arrows mark the cloned rounds. 
The DW1 and DX1 selections were for reaction of the DNA-C3-NH2 substrate under conditions A 
and B, respectively, using an N40 random region. Conditions A were 50 mM HEPES, pH 7.5 with 
40 mM Mg2+, 20 mM Mn2+, 1 mM Zn2+, and 150 mM Na+ at 37 °C for 14 h 2 h, or as 10 min as 
indicated. Conditions B were 50 mM CHES, pH 9.0 with 40 mM Mg2+ and 150 mM Na+ at 37 °C 
for 14 h, 2 h, or 10 min as indicated. All metal ions were provided as chloride salts.  
 
 
Figure 4.13. Sequences of the two 9DT1 deoxyribozymes and six 14DV1 deoxyribozymes. Only 
the initially random (N40) sequences are shown. All deoxyribozymes were used as 5ʹ-
CGAAGCGCTAGAACAT-N40-ATAGTGAGTCGTATTA-3ʹ. In each alignment, a dot denotes 
conservation, i.e., the same nucleotide as in the uppermost sequence. On the far right is shown the 
sequence length and (in parentheses) the number of times that the particular sequence was found 
during cloning. 
 
One of these DNA sequences from selection in conditions A, 9DT105, catalyzed the 
expected reaction between DNA-HEG-CKA and 5-ImpDNA with kobs of 0.10 h–1 and 50% yield 
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in 48 h. It strictly requires both Zn2+ and Mn2+ for catalytic activity, and Mg2+ is dispensable. No 
activity is observed with either Zn2+ or Mn2+ alone (Fig. 4.14). 9DT105 was assayed at pH 7.2, 
7.5, and 7.8, and reaction yield was substantially reduced in conditions below pH 7.5 (Fig. 4.15). 
The other sequence, 9DT114, catalyzed a reaction with kobs of 0.17 h
–1, but did not require the 
CKA peptide for activity and was active with the DNA anchor alone. Detailed investigation of this 
9DT114 activity is discussed later in this chapter. 
 
Figure 4.14. Metal dependence of the 9DT105 deoxyribozyme.  
 
 
Figure 4.15. pH dependence of the 9DT105 deoxyribozyme.  
 
 Deoxyribozymes from conditions B, called the 14DV1 deoxyribozymes, had single-
turnover kobs of ~0.05 h
–1, yields up to 50% in 48 h, and optimal Mg2+ concentration of >50 mM 
(Fig. 4.16). For all six deoxyribozymes, yield increased with pH between 8.0 and 10.0 (Fig. 4.17).  
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Figure 4.16. Mg2+ concentration dependence of the 14DV1 deoxyribozymes in conditions B. kobs 
values were determined from initial-rate kinetics (linear fits to plots of yield versus time from 0 to 
6 h). The two symbols represent data sets collected at different times. Each illustrated curve fit is 
to the standard titration equation kobs = kmax•([Mg2+]/(Kd+[Mg2+]), assuming a Hill coefficient of 
1. Each combined data set is fit well with apparent Kd of 30 to 41 mM. However, because the data 
do not turn over at high [Mg2+] (up to 300 mM), we more conservatively estimate that each 
apparent Kd is >50 mM. Curve fit values of apparent Kd (mM): 14DV103 31 ± 7; 14DV104 37 ± 
8; 14DV108 31 ± 8; 14DV111 30 ± 7; 14DV117 41 ± 10; 14DV131 37 ± 10. 
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Figure 4.17. Kinetic plots at various pH values for all six 14DV1 deoxyribozymes. Incubation 
conditions: 50 mM buffer, pH 8.0–10.0 with 40 mM MgCl2 and 150 mM NaCl at 37 °C. 
 
4.2.3 Dependence of Substrate Structure on Catalysis 
 All 21 deoxyribozymes collectively identified from the four selection experiments 
(excluding 9DT114) were each assayed for activity with four substrates, as shown in Figures 4.18-
4.21. The two selection substrates, DNA-C3-NH2 and DNA-HEG-CKA, as well as DNA-HEG-
NH2 and DNA-C3-CKA. In summary, substrates with both long and short tethered amines and 
long and short tethered tripeptides were assayed. For simplicity, the DNA prefix will be omitted 
and substrates will simply be referred to as C3-NH2, HEG-NH2, C3-CKA, and HEG-CKA. The 
purpose of these assays was to evaluate comprehensively the nucleophile and tether dependence 
of each deoxyribozyme. The results reveal two distinct substrate preferences, each of which is 
sensible considering the selection origins of each deoxyribozyme. The DW1 and DX1 
deoxyribozymes, identified using the C3-NH2 substrate from either conditions A or conditions B, 
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all have substrate preference in order of C3-NH2 > HEG-NH2 > C3-CKA and HEG-CKA. 
Deoxyribozymes identified from selection with the HEG-CKA substrate under conditions A 
(9DT1) or conditions B (14DV1), all have higher activity with the CKA substrates in the order of 
HEG-CKA > HEG-NH2 and C3-CKA > C3-NH2. 9DT105 prefers the short-tethered C3-CKA 
substrate, whereas the 14DV1 deoxyribozymes all have higher activity with the long-tethered 
HEG-CKA substrate. From these data, a key finding is that performing selection using the HEG-
tethered substrate is necessary to achieve substantial DNA-catalyzed reactivity with that substrate. 
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Figure 4.18. Comprehensive assays of the 8DW1 deoxyribozymes with substrates that have 
different tether lengths and amine contexts under conditions A. A small amount (ca. 2%) of a 
dimeric species is observed when using the C3-CKA or HEG-CKA substrate, in which the peptide 
is conjugated to its DNA anchor via a disulfide linkage. This dimer is attributed to a small amount 
of disulfide reduction followed by thiol-disulfide interchange. For the HEG-CKA substrate, the 
dimer band migrates slower than the product band on PAGE, and product quantification is not 
impacted; no correction is needed. For the C3-CKA substrate, the dimer band exactly comigrates 
with the product band. As a correction, the average product yield of the 30 s timepoint (ca. 2%) 
was subtracted from the product yield at each timepoint. 
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Figure 4.19. Comprehensive assays of the 7DX1 deoxyribozymes with substrates that have 
different tether lengths and amine contexts under conditions B. The background correction for 
dimer formation in the C3-CKA assay described in the Figure 4.18 caption is applied here. 
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Figure 4.20. Comprehensive assays of the 9DT105 deoxyribozymes with substrates that have 
different tether lengths and amine contexts under conditions A. The background correction for 
dimer formation in the C3-CKA assay described in the Figure 4.18 caption is applied here. 
 
 
Figure 4.21. Comprehensive assays of the 14DV1 deoxyribozymes with substrates that have 
different tether lengths and amine contexts under conditions B. The background correction for 
dimer formation in the C3-CKA assay described in the Figure 4.18 caption is applied here. 
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4.2.4 MALDI Mass Spectrometry to Confirm Products of DNA-Catalyzed Reactions 
 MALDI mass spectrometry was used to confirm the products of representative 
deoxyribozyme-catalyzed reactions (Fig. 4.22. In all cases, observed product masses were 
consistent with the expected mass. For 9DT114, DNA-catalyzed reaction was performed with the 
DNA anchor oligonucleotide and 5ʹ-ImpDNA, and the observed mass is consistent with reaction 
between these substrates. For each of 9DT105, 14DV104, and 14DV117, the product was 
additionally treated with 50 mM DTT (pH 7.5, 37 °C, 2 h), precipitated with ethanol, and again 
analyzed by MALDI mass spectrometry. In all three cases (not shown), the two peaks expected 
upon disulfide cleavage between the HEG and CKA components of the product were observed. 
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Figure 4.22. MALDI mass spectrometry to establish identities of products from representative 
deoxyribozymes. All m/z values are [M+H]+. Although 9DT114 was identified by selection with 
the DNA-HEG-CKA substrate, it functions well with the unmodified DNA substrate (3ʹ-OH), 
which was therefore used for the mass spectrometry experiment.  
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4.2.5 Evaluation of Phosphoramidate product 
 To confirm that the intended amine nucleophile was indeed reacting in the DNA-catalyzed 
reaction, the product of each deoxyribozyme was tested for sensitivity to acid (Fig. 4.23). 
Phosphoramidate linkages involving an aliphatic amine are sensitive to 80% aqueous acetic 
acid.2,5,12,13 Each product showed the expected cleavage after acid treatment, confirming the 
existence of the phosphoramidate.  
 
Figure 4.23. Treatment with 80% aqueous acetic acid to verify the identities of the newly formed 
phosphoramidate (P–N) linkages. A phosphoramidate linkage involving an aliphatic amine is 
sensitive to such treatment. Products from the 21 deoxyribozymes collectively obtained from the 
four different selection experiments (excluding 9DT114) were each assayed. One representative 
data image is shown for the deoxyribozymes from each selection experiment (DW1, DX1, and 
DV1). The 5ʹ-32P-radiolabeled product from each deoxyribozyme was incubated in 80% aqueous 
acetic acid at 37 °C for 5 h. 
Negative control assays were performed for each deoxyribozyme to further support the 
reaction of the amine nucleophile. Deoxyribozymes that use the DNA-C3-NH2 substrate (DW1, 
DX1 deoxyribozymes) were also assayed with the analogous DNA-C3-OH substrate, in which the 
amine is replaced with a hydroxyl (Fig. 4.24A). Trace reactivity was still observed with the DNA-
C3-OH substrate, which is not surprising considering that hydroxyl can still act as a nucleophile. 
For all deoxyribozymes, much better activity is observed with DNA-C3-NH2, which strongly 
supports reaction of the intended amine nucleophile. 
DNA catalysts that use the DNA-HEG-CKA substrate (DT1, DV1 deoxyribozymes) were 
also assayed with DNA-HEG-CAA, in which Lys is replaced with Ala (Fig 4.24A). For each 
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deoxyribozyme, trace activity is observed, resulting from a small amount of disulfide reduction. 
This disulfide reduction forms DNA-HEG-SH, which is structurally analogous to the DNA-HEG-
NH2 assayed above and for which minor activity with each enzyme is observed. The greatly 
reduced activity with DNA-HEG-CAA strongly supports reaction of the lysine side chain. 
Each deoxyribozyme was additionally tested with the 5ʹ-phosphorylated DNA the 
precursor to the 5ʹ-ImpDNA substrate (Fig. 4.24B). No deoxyribozyme showed activity with 
unactivated 5ʹ-phosphorylated DNA, showing that activation to the 5ʹ-phosphorimidazolide is 
required. 
 
Figure 4.24 Negative control experiments to assess requirement of the nucleophilic amine group 
or electrophilic 5ʹ-Imp group. The 21 deoxyribozymes collectively obtained from the four different 
selection experiments (excluding 9DT114) were each assayed. One representative data image is 
shown for each selection experiment. (a) Negative control experiments for nucleophilic amine 
group. Each deoxyribozyme was assayed with both the DNA-C3-NH2 substrate and its DNA-C3-
OH counterpart (DW1, DX1 deoxyribozymes) or both the DNA-HEG-CKA substrate and its 
DNA-HEG-CAA counterpart (9DT105 and 14DV1 deoxyribozymes). For the 8DW1 and 7DX1 
deoxyribozymes, trace activity is observed with C3-OH rather than C3-NH2 (e.g., 1.3% in 24 h for 
8DW115; 1.3% in 48 h for 7DX112). This is unsurprising because the hydroxyl group is still a 
nucleophile. For 9DT105 and the 14DV1 deoxyribozymes, trace activity is observed with HEG-
CAA rather than HEG-CKA (e.g., 2.8% in 48 h for 9DT105; 0.5% in 48 h for 14DV103). The 
trace product is attributed to a small amount of disulfide reduction of the HEG-CAA substrate, 
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Fig. 4.24. (cont.) which forms a nucleophilic HEG-thiol that is directly analogous to HEG-NH2. 
(b) Negative control experiments for 5ʹ-Imp group. Each deoxyribozyme was assayed with both 
the 5ʹ-ImpDNA substrate and its unactivated 5ʹ-phosphorylated DNA precursor. No product was 
observed when the unactivated 5ʹ-phosphorylated DNA precursor was used.  
 
4.2.6 Evaluation of Splinted Background Reaction 
Rate enhancements for the various deoxyribozymes were estimated by comparing their kobs 
values to the observed rate constants for appropriate background reactions (kbkgd; Fig. 4.25). 
Background reactivity for both conditions A and conditions B were evaluated. Using the random 
N40 pool in place of a catalytically active deoxyribozyme in the background assay, kbkgd values 
were ~10–4 h–1 (for A) and ~2–3-fold higher (for B). For conditions A, the DNA-catalyzed rate 
enhancement was up to 104 with the DNA-C3-NH2 substrate and up to 10
3 with the DNA-HEG-
CKA substrate. For conditions B, the rate enhancements were as high as 102 for both substrates, 
with these more modest values largely reflecting that the deoxyribozymes from conditions B have 
lower kobs than do their counterparts from conditions A. 
As shown in Fig. 4.25, observed rate constants, kbkgd, for various background (uncatalyzed) 
reactions were determined for 5ʹ-ImpDNA reacting with either DNA-C3-NH2 or DNA-HEG-CKA 
under either conditions A (pH 7.5, Mg2+/Mn2+/Zn2+) or B (pH 9.0, Mg2+). The Imp functional group 
is relatively unstable under conditions A, and the background reaction yields increased very little 
after 24 h of incubation. Imp is more stable under conditions B, and yields continued to increase 
through 96 h. 
For both substrates under conditions A, the deoxyribozyme was replaced with either an exactly 
complementary DNA splint (equivalent to the deoxyribozyme but with deletion of the entire 40-
nucleotide catalytic region; “n = 0”), a complementary DNA splint that includes a single unpaired 
T nucleotide in place of the 40-nucleotide catalytic region (“n = 1”), or the random N40 pool 
(“n = 40”). The n = 0 and n = 1 assays provide an overestimate of kbkgd for computing the rate 
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enhancement (kobs/kbkgd), because the deoxyribozyme is structurally more complex than a simple 
n = 0 or 1 splint. In contrast, the n = 40 assays provide a fairer assessment of the catalytic roles of 
the particular 40-nucleotide regions. 
For both substrates under conditions B, a more expansive set of experiments was performed. 
The deoxyribozyme was replaced with n = 0, 1, 2, 3, and 4 splints (with 0 to 4 unpaired T 
nucleotides in place of the 40-nucleotide catalytic region), the n = 40 random pool as splint, a 
“hairpin” splint in which the 40-nucleotide catalytic region was replaced with a well-defined 6 bp 
stem-loop structure, or a “scrambled hairpin” splint in which the stem-loop sequence was 
scrambled and therefore lacked any secondary structure. The hairpin splint has the effect of merely 
holding the two substrate-containing duplexes close together, which would be achievable by a 40-
nucleotide catalytic region that is selected for simple hairpin formation rather than formation of a 
more sophisticated catalytic structure. The scrambled hairpin splint is functionally equivalent to a 
random pool splint that has n = 16 nucleotides. 
For the DNA-C3-NH2 and DNA-HEG-CKA substrates under conditions A, the n = 40 yields at 
24 h were 0.22% and 0.20%, respectively. From these values, we estimate kbkgd  10–4 h–1 in both 
cases. Noting kobs as high as 1.2 h
–1 for DNA-C3-NH2 and 0.08 h
–1 for DNA-HEG-CKA, the 
corresponding rate enhancements (kobs/kbkgd) are ~10
4 and ~103. 
For the DNA-C3-NH2 substrate under conditions B, the yields at 96 h for the n = 40 and 
scrambled hairpin splint were 2.2% and 2.5%, respectively, corresponding to kbkgd of ~2  10–4 h–
1. With kobs of ~0.03 h
–1 for the 7DX1 deoxyribozymes, the rate enhancements (kobs/kbkgd) are 150 
(~102). For the DNA-HEG-CKA substrate under conditions B, the yields at 96 h for the n = 40 and 
scrambled hairpin splint were 1.9% and 1.6%, respectively, corresponding to kbkgd of ~2  10–4 h–
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1. With kobs of ~0.05 h
–1 for the 14DV1 deoxyribozymes, the rate enhancements (kobs/kbkgd) are 250 
(~102). 
Note that for the DNA-C3-NH2 background assay under conditions B, the hairpin splint gave 
much lower yield than did the n = 0 splint (7% versus 60% at 96 h). This finding emphasizes the 
very high degree of preorganization provided by the n = 0 splint and supports the use of the n = 40 
splint to compute kbkgd. In this assay, also note the steady drop in yield from n = 0 to n = 4, the 
equivalent yields for n = 4 and the hairpin splint, and the equivalent yields for n = 40 and the 
scrambled hairpin splint. 
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Figure 4.25. Determining observed rate constants, kbkgd, for various background (uncatalyzed) 
reactions. (a) Depiction of the background assays. (b) Kinetic plots. 
4.2.7 Evaluation of Branch-Forming Deoxyribozymes 
The 9DT114 deoxyribozyme forms a reaction product with kobs 0.17 h
–1, requiring both 
Mn2+ and Zn2+ for optimum yield. A DNA substrate with 3ʹ-OH was used, because the 3ʹ-HEG-
CKA segment was found to be dispensable for catalysis. The DNA substrate was 5ʹ-
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GGATAATACGACTCACTAT-3ʹ, where the 3ʹ-terminal T is designated as T(–1), the adjacent A is 
A(–2), and so on. The T nucleotide in the deoxyribozyme 3ʹ-binding arm located across from A(–
5) in the substrate was found to be deleted; restoring this T into the binding arm led to complete 
loss of catalytic activity (data not shown). 
Experiments were performed to determine the connectivity of the product formed by 
9DT114 (Fig. 4.26). Three 5ʹ-32P-radiolabeled DNA substrates with 3ʹ-OH were prepared, each 
with a single ribonucleotide substitution at one of C(–4), A(–5), or C(–6). All three ribo-substituted 
substrates were accepted by 9DT114. The product from each substrate was isolated by PAGE and 
cleaved under alkaline conditions (100 mM NaOH, 75 °C, 2 h), which removes several nucleotides 
from the 3ʹ-end of the product and leaves behind a 2ʹ,3ʹ-cyclic phosphate. The 20% PAGE 
migration rates of the three products clearly reveal that C(–4) is the site of nucleophilic reactivity 
on the DNA substrate. The rC(–4) product, after alkaline cleavage, migrates considerably more 
slowly than does the analogous rC(–4) substrate after alkaline cleavage (green arrow in the figure). 
In contrast, the rA(–5) and rC(–6) products both migrate at the same position as their analogous 
ribo-modified substrates after alkaline cleavage. 
The only reasonable nucleophile on nucleotide C(–4) is its C4-NH2 group, which would 
form a phosphoramidate (P–N) bond upon reaction with 5ʹ-ImpDNA. To support the assignment 
of the C4-NH2 functional group of nucleotide C(–4) as the 9DT114 modification site, a functional 
group deletion experiment was performed (Fig. S9c). Two new 5ʹ-32P-radiolabeled DNA substrates 
with 3ʹ-OH were prepared, using Glen Research phosphoramidites for solid-phase synthesis. Each 
substrate was substituted at C(–4) with either 5-methyl-2ʹ-deoxyzebularine (where zebularine is 
the cytidine analogue that lacks the C4-NH2 group) or 5-methyl-2ʹ-deoxycytidine as a control, 
noting that for zebularine, only the 5-methyl-2ʹ-deoxy phosphoramidite is commercially available. 
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After 48 h incubation, the parent substrate with cytidine provided 51% yield; the substrate with 5-
methyl-2ʹ-deoxycytidine provided 7.2% yield; and the substrate with 5-methyl-2ʹ-deoxyzebularine 
provided 0.5% yield. Therefore, the 5-methyl modification by itself is deleterious but still allows 
activity, whereas removal of the C4-NH2 group almost completely abolishes activity. This finding 
is consistent with the conclusion that 9DT114 uses the C4-NH2 group of nucleotide C(–4) of the 
DNA substrate as the nucleophile. The identity of the trace amount of product observed with the 
5-methyl-2ʹ-deoxyzebularine substrate is unknown; this product likely arises from secondary 
usage by 9DT114 of an alternate nucleophile in the substrate. 
 
 
Figure 4.26. 9DT114 deoxyribozyme and determination of its reaction product connectivity. (a) 
Kinetic assay and metal dependence of 9DT114, using the DNA-3ʹ-OH substrate. Metal 
dependence was assayed using conditions A as described, but withholding one or more metals   
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Fig. 4.26. (cont.) depending on the indicated combination. PAGE image time points = 30 s, 6 h, 
24 h, 48 h. (b) Using ribo-substituted DNA substrates to ascertain that 9DT114 modifies the DNA 
substrate at nucleotide C(–4). (c) Functional group deletion experiments to support the assignment 
of the C4-NH2 of nucleotide C(–4) as the nucleophile (performed using 20 mM Mn2+ and 1 mM 
Zn2+). 
4.3 Summary 
 Deoxyribozymes for covalent modification of DNA-C3-NH2 and the lysine side chain were 
identified using phosphorimidazolide-modified DNA as the electrophilic reaction partner. Mass 
spectrometry was used to confirm products of the correct mass were formed, and negative controls 
confirmed that both the intended amine nucleophile and phosphorimidazolide electrophile were 
reacting.  
 Deoxyribozymes for DNA-C3-NH2 modification were identified from both conditions A 
and conditions B. Catalysts from conditions A exhibited higher kobs and reaction yields, the best of 
which had kobs of 1.2 h
–1 and 85% yield.  
 Deoxyribozymes for HEG-CKA modification were also identified from conditions A and 
conditions B. A single deoxyribozyme, 9DT105, came from conditions A. It catalyzed lysine 
modification with single-turnover kobs of 0.10 h
–1 and 50% yield in 48 h. It required Mn2+ and Zn2+ 
for catalytic activity, and functioned best with peptide substrates, suggesting a bias for the substrate 
present in selection. Six deoxyribozymes were identified from conditions B. These had kobs of 
~0.05 h–1 and 50% yield in 48 h. These deoxyribozymes functioned best with increasing 
concentration of Mg2+, up to ~100 mM. None of the deoxyribozymes identified for HEG-CKA 
modification were active with the untethered peptide substrate.  
In all cases splinted background reaction rates and yields were significantly lower than the 
DNA-catalyzed reaction. This suggests that, despite the rather low catalytic rates for 
134 
 
deoxyribozymes from conditions B, the DNA is indeed acting as a catalyst and not just holding 
the reaction partners in close proximity.  
 In vitro selection experiments for lysine modification carried out in conditions A also led 
to identification of deoxyribozyme that catalyzes formation of a branched oligonucleotide product. 
A nucleotide deletion in the left binding arm was required for catalytic activity, which causes a 
bubbled out nucleotide in the substrate oligo. Biochemical and mutagenesis experiments 
confirmed that the C4-NH2 of a substrate cytidine nucleotide was acting as the nucleophile adjacent 
to the bubbled nucleotide. Despite successfully identifying deoxyribozymes for lysine 
modification, identification of deoxyribozymes for a much poorer nucleophile reflect the previous 
challenges to identify deoxyribozymes using amine nucleophiles. This further supports the idea 
that the relationship between different nucleophiles and electrophiles with respect to their use in 
DNA-catalyzed reactions is complicated.  
 After successfully identifying DNA catalysts for lysine modification, the next efforts will 
focus on identification of deoxyribozymes that catalyze a post-translational modification of lysine: 
acylation. The important lesson learned in this study, that identification of deoxyribozymes for 
lysine modification requires the use of a sufficiently reactive electrophile, will inform our choice 
of electrophilic reaction partners.  
4.4 Materials and Methods 
4.4.1 Preparation of Oligonucleotides 
DNA oligonucleotides were obtained from Integrated DNA Technologies (Coralville, IA) 
or prepared by solid-phase synthesis on an ABI 394 instrument using reagents from Glen Research. 
All oligonucleotides and conjugates were purified by 7 M urea denaturing 20% or 8% PAGE with 
running buffer 1 TBE (89 mM each Tris and boric acid and 2 mM EDTA, pH 8.3), extracted 
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from the polyacrylamide with TEN buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 300 mM NaCl), 
and precipitated with ethanol. Peptides were prepared by solid-phase synthesis using Fmoc Rink 
amide MBHA resin as described.14 Each peptide was coupled to the DNA anchor oligonucleotide 
via a disulfide bond with the N-terminal cysteine side chain as described.14 
4.4.2 In vitro selection procedure 
4.4.2.1 In vitro selection procedure steps 
Procedure for preparation of 5-ImpDNA. -
phosphorylated DNA, 100 mM 1-ethyl 3-(3-dimethylaminopropyl) carbodiimide (EDC), and 100 
mM imidazole (pH 6.0 with HCl) was incubated at room temperature for 2 h. A Micro Bio-Spin 
P-6 desalting column (Bio-Rad) was prepared by centrifuging at 1000 g for 1 min and rinsing 4 
by adding 500 µL of water followed by centrifuging at 1000 g for 1 min. The 60 µL sample was 
applied to the column and eluted by centrifuging at 1000 g for 4 min. The resulting sample was 
quantified by UV absorbance (A260). 
Procedure for ligation step in round 1. A 25 µL sample containing 600 pmol of DNA pool, 
750 pmol of DNA splint, and 900 pmol of DNA-C3-NH2 or DNA-HEG-CKA substrate was 
annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min 
and cooling on ice for 5 min. To this solution was added 3 µL of 10 T4 DNA ligase buffer 
(Fermentas) and 2 µL of 5 U/µL T4 DNA ligase (Fermentas). 10 T4 DNA ligase buffer that lacks 
DTT (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) was used with disulfide-linked 
oligonucleotide-peptide conjugates. The sample was incubated at 37 °C for 12 h and purified by 
8% PAGE. 
Procedure for ligation step in subsequent rounds. A 17 µL sample containing the PCR-
amplified DNA pool (~5–10 pmol), 30 pmol of DNA splint, and 50 pmol of DNA-C3-NH2 or 
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DNA-HEG-CKA substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA 
by heating at 95 °C for 3 min and cooling on ice for 5 min. To this solution was added 2 µL of 10 
T4 DNA ligase buffer (Fermentas) and 1 µL of 1 U/µL T4 DNA ligase (Fermentas). 10 T4 DNA 
ligase buffer that lacks DTT (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) was used 
with disulfide-linked oligonucleotide-peptide conjugates. The sample was incubated at 37 °C for 
12 h and purified by 8% PAGE. 
Procedure for selection step in round 1. Each selection experiment was initiated with 200 
pmol of the ligated pool. A 20 µL sample containing 200 pmol of ligated pool and 300 pmol of 5-
ImpDNA was annealed in (conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA 
or (conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 
3 min and cooling on ice for 5 min. The selection reaction was initiated by bringing the sample to 
40 µL total volume containing (conditions A) 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM 
MnCl2, 1 mM ZnCl2, and 150 mM NaCl or (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, 
and 150 mM NaCl. The Mn2+ was added from a 10 stock solution containing 200 mM MnCl2. 
The Zn2+ was added from a 10 stock solution containing 10 mM ZnCl2, 20 mM HNO3, and 200 
mM HEPES at pH 7.5; this stock solution was freshly prepared from a 100 stock of 100 mM 
ZnCl2 in 200 mM HNO3. The metal ion stocks were added last to the final sample. The sample 
was incubated at 37 °C for 14 h. 
Procedure for selection step in subsequent rounds. A 10 µL sample containing the ligated 
pool and 30 pmol of 5-ImpDNA was annealed in (conditions A) 5 mM HEPES, pH 7.5, 15 mM 
NaCl, and 0.1 mM EDTA or (conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The selection reaction was 
initiated by bringing the sample to 20 µL total volume containing (conditions A) 70 mM HEPES, 
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pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM NaCl or (conditions B) 50 mM 
CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl. The sample was incubated at 37 °C for 14 h. 
Procedure for PCR. In each selection round, two PCR reactions were performed, 10-cycle 
PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared containing the PAGE-
purified selection product, 200 pmol of forward primer, 50 pmol of reverse primer, 20 nmol of 
each dNTP, and 10 µL of 10 Taq polymerase buffer [1 = 20 mM Tris-HCl, pH 8.8, 10 mM 
(NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100]. This sample was cycled 10 times 
according to the following PCR program: 94 °C for 2 min, 10 (94 °C for 30 s, 47 °C for 30 s, 72 
°C for 30 s), 72 °C for 5 min. Taq polymerase was removed by phenol/chloroform extraction. 
Second, a 50 µL sample was prepared containing 1 µL of the 10-cycle PCR product, 100 pmol of 
forward primer, 25 pmol of reverse primer, 10 nmol of each dNTP, 20 µCi of -32P-dCTP (800 
Ci/mmol), and 5 µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to 
the following PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 
72 °C for 5 min. Samples were separated by 8% PAGE. 
4.4.2.2 Identification of Individual Deoxyribozymes 
Cloning and screening of individual deoxyribozymes. The PCR primers used for cloning 
were 5-CGAAGCGCTAGAACAT-3 (forward primer; same as in selection) and 
5-TAATTAATTAATTACCCATCAGGATCAGCT-3 (reverse primer). The 10-cycle PCR 
product from the appropriate selection round was diluted 103-fold. A 50 µL sample was prepared 
containing 1 µL of the diluted 10-cycle PCR product from the appropriate selection round, 100 
pmol of forward cloning primer, 25 pmol of reverse cloning primer, 10 nmol of each dNTP, and 5 
µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to the following 
PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 
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min. The sample was separated by 1% agarose gel and extracted using a GeneJET Gel Extraction 
Kit (Fermentas). The extracted product was quantified by absorbance (A260) and diluted to 4–8 
ng/µL. A 1 µL portion of the diluted PCR product was inserted into the pCR2.1-TOPO vector 
using a TOPO TA cloning kit (Life Technologies). Individual E. coli colonies harboring plasmids 
with inserts were identified by blue-white screening and grown in LB/amp media. Miniprep DNA 
was prepared using a GeneJET Plasmid Miniprep Kit (Fermentas) and screened for properly sized 
inserts by EcoRI digestion and agarose gel analysis. Before sequencing, assays of individual 
deoxyribozyme clones were performed with PAGE-purified DNA strands prepared by PCR from 
the miniprep DNA, using the single-turnover assay procedure described below. 
4.4.3 Assaying Deoxyribozymes 
4.4.3.1 Single-turnover deoxyribozyme assay 
Single-turnover assay. The DNA-anchored amine substrate was 5-32P-radiolabeled using 
-32P-ATP and T4 polynucleotide kinase (Fermentas), using 10 kinase buffer that lacks DTT (500 
mM Tris, pH 7.6, 100 mM MgCl2, and 1 mM spermidine) for disulfide-linked oligonucleotide-
peptide conjugates. A 10 µL sample containing 0.2 pmol of 5-32P radiolabeled substrate, 10 pmol 
of deoxyribozyme, and 30 pmol of 5-Imp substrate were annealed in (for conditions A) 5 mM 
HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA or (for conditions B) 5 mM CHES, pH 9.0, 15 
mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice 5 min. The DNA-
catalyzed reaction was initiated by bringing the sample to 20 µL total volume containing 
(conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2 and 150 mM 
NaCl or (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl. The sample was 
incubated at 37 °C. At appropriate time points, 2 µL aliquots were quenched with 5 µL of stop 
solution (80% formamide, 1 TBE [89 mM each Tris and boric acid and 2 mM EDTA, pH 8.3], 
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50 mM EDTA, 0.025% bromophenol blue, 0.025% xylene cyanol). Samples were separated by 
20% PAGE and quantified using a Phosphorimager. Values of kobs were obtained by fitting the 
yield versus time data directly to first-order kinetics; i.e., yield = Y•(1 – e–kt), where k = kobs and Y 
is the final yield. Each kobs value is reported with error calculated as the standard deviation from 
the indicated number of independent determinations. When kobs was sufficiently low such that an 
exponential fit was not meaningful, the initial points were fit to a straight line, and kobs was taken 
as the slope of the line. 
4.4.3.2 Mass spectrometry  
The products of representative individual deoxyribozymes were analyzed by MALDI mass 
spectrometry (Fig. S12). Each product was prepared from a 50 µL sample containing 200 pmol of 
DNA-C3-NH2 or DNA-HEG-CKA substrate, 300 pmol of deoxyribozyme, and 400 pmol of 5-
ImpDNA. The sample was annealed in (for conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, 
and 0.1 mM EDTA or (for conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 M EDTA 
by heating at 95 °C for 3 min and cooling on ice for 5 min. The DNA-catalyzed reaction was 
initiated by bringing the sample to 100 µL total volume containing (conditions A) 70 mM HEPES, 
pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, and 150 mM NaCl or (conditions B) 70 mM 
CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl. The sample was incubated at 37 °C for 24 h, 
precipitated with ethanol, purified by 20% PAGE, and analyzed by MALDI mass spectrometry. 
Data were acquired on a Bruker UltrafleXtreme MALDI-TOF mass spectrometer with matrix 3-
hydroxypicolinic acid in positive ion mode at the UIUC School of Chemical Sciences Mass 
Spectrometry Laboratory. 
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Chapter 5: Efforts towards DNA Catalysts for Lysine Side Chain Acylation 
5.1 Introduction 
5.1.1 Lysine Acylation 
 Lysine acylation is a critically important post-translational modification involved in gene 
expression, cellular metabolism, and protein signaling. Lysine acetylation has been linked to 
important genetic targets such as histones,1 tubulin,2 tumor suppressor protein P53,3 and Tat-HIV 
transcription regulator.4 
 More recently, 388 new lysine acetylation sites were identified using a combination of 
antibody-enabled acetylation enrichment and high-resolution mass spectrometry.5 Cellular 
processes connected to newly-discovered proteins with acetylated lysine residues include 
chromatin remodeling and cell-cycle regulation. Additionally, acetylation directly affected protein 
phosphorylation processes, showing that these two post-translational modifications interact in 
complex cellular regulation.  
 Other forms are lysine acylation are also biologically important. Lysine crotonylation was 
recently discovered in a study mapping histone modification.6 Interestingly, crotonyl lysine served 
as a marker for different genes than did lysine acetylation, strongly suggesting the two 
modifications have distinct function. Each of lysine malonylation and succinylation have also been 
reported,7,8 and although their direct biological importance is unknown, enzymes that catalyze their 
removal are involved in metabolism.9  
 Despite the broad biological scope of lysine acylation, robust methods to prepare peptides 
and proteins with specific acylation profiles is limited. In general, chemical methods for amine 
acylation do not provide the site specificity needed for selective protein modification. Synthesis of 
site-specifically acetylated histone proteins has been reported using native chemical ligation to 
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join N-terminal peptide fragments prepared by solid-phase synthesis to recombinantly expressed 
globular histone domains.10 Enzymatic methods employing lysine acetyltransferases have been 
reconstituted and used in vitro for incorporating the natural acetyl modification,11 as well as for 
incorporating unnatural acyl modifications useful for protein labeling.12,13 Genetic methods have 
also been developed14,15 that incorporate an unnatural amino acid (usually containing 
selenocysteine) which is subsequently converted to dehydrolalanine, forming an electrophile 
within the protein. This dehydroalanine is then reacted with derivatized thiols, including acetyl 
amines, to yield site-specifically modified proteins that mimic the naturally modified protein. In 
general, however, a robust method to prepare protein samples with selectively-acylated lysine 
residues would be of practical utility. This chapter describes initial efforts to identify using in vitro 
selection deoxyribozymes that catalyze lysine acylation, specifically lysine glutarylation.  
5.1.2 DNA-Catalyzed Amine Reactivity 
 As discussed in Chapter 4, DNA catalysts that utilize nucleophilic amine substrates can be 
identified, provided a sufficiently reactive electrophile is also used. Chapter 3 discussed 
unsuccessful efforts to use amine nucleophiles in DNA-catalyzed acylation reactions using esters, 
aromatic amides, and peptides as acyl donors. Although these efforts were focused on using a 
strong nucleophile to enable cleavage of the carbonyl substrates, the failure to identify 
deoxyribozymes for its cleavage was also indicative of the challenge to identify amine acylation. 
This study focuses on the use of more reactive thioester substrates, which are used as substrates 
for a number of natural acylation reactions.  
5.1.3 In Vitro Selection Design 
 These selections were designed around two thioester substrates: 5-glutaryl-DNA thioester 
and glutaryl-coenzyme A (Fig. 5.1). The DNA-anchored thioester substrate is closely tethered to 
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the DNA catalyst by Watson-Crick base pairing, and thus the DNA catalyst is only required to use 
the substrate in a reaction. In contrast, glutaryl-Coenzyme A is present at 1 mM in solution, and 
the DNA enzyme is required to bind to the glutaryl-Coenzyme A in solution and then use it in 
reaction.  
 
Figure 5.1. Glutaryl thioester substrates used for in vitro selection. Glutaryl-CoA was provided in 
solution during the key selection step at 1 mM concentration. 
 Additionally, two amine substrates were chosen: 5-DNA-C3-NH2 and 5-DNA-HEG-
AAAKAA. In the limiting case, if DNA under these conditions can catalyze acylation reactions, 
it should be able to utilize 5-DNA-C3-NH2, which is closely tethered and does not require the 
DNA to bind a peptide that is more loosely tethered. 5-DNA-HEG-AAAKAA has the hexapeptide 
substrate loosely tethered, which requires DNA to bind it in solution and then catalyze the acylation 
reaction. 
 Because it is not known which random region length is optimal for DNA-catalyzed 
acylation, two random region lengths were selected: N40 and N80. N40 has worked well for 
identifying deoxyribozymes for a large number of chemical reactions, while N80 should be able to 
adopt more complex catalytic structures than N40 (discussed in Chapter 3), although it’s not known 
if this is necessary for acylation. 
All selections were performed under only conditions A, because the thioester substrates 
should be more stable at lower pH, and in general conditions A that include transition metal 
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cofactors give better reactivity and frequently enable reactivity (i.e., deoxyribozymes are only 
identified from conditions A) compared to conditions B. An overview of each selection experiment 
is shown in Figure 5.2. 
 
Figure 5.2. Overview of selections performed for amine acylation. Selection variables of amine 
nucleophile, thioester acyl donor, and random region length are illustrated.  
 The selection process was designed so that if the acylation reaction occurs, glutaric acid is 
transferred from the thioester acyl donor to the amine nucleophile (Fig. 5.3). The transfer of 
glutaric acid does not provide sufficient mass to enable a direct gel shift selection. Instead, the 
additional carboxylic acid on glutaric acid was used for a subsequent capture reaction with a DNA 
splint and 5-amino DNA capture oligo. This additional capture reaction adds sufficient mass to 
enable selection by gel shift.  
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Figure 5.3. In vitro selection summary. DNA-catalyzed acylation using the glutaryl-DNA 
thioester (as shown) or untethered glutaryl-CoA results in transfer of glutaric acid to the amine 
nucleophile. The acylated product is captured in a DNA splinted chemical reaction using an amino-
modified DNA, EDC and HOBt. Captured products are separated by PAGE and amplified by PCR. 
5.2 Results and Discussion 
 In vitro selections have been performed for 11 rounds (Fig. 5.4). In each round, a standard 
capture reaction that consisted of capturing the either the DNA-C3-NH2 or DNA-HEG-AAAKAA 
that was chemically glutarylated was performed. Capture of glutarylated DNA-C3-NH2 was 40-
60%, and capture of glutarylated DNA-HEG-AAAKAA was between 25-50%.  
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After 11 rounds of selection, selections using the glutaryl acid thioester donor were 
showing 5-10% activity (Fig. 5.4). Each selection was assayed in trans, without ligating the DNA-
acnchored amine substrate to the PCR product. In these assays, no capture reaction was performed, 
and instead the direct addition of glutaric acid to the amino oligo was assayed using a 20% gel and 
radiolabeled DNA-anchored amine. In each instance, no addition of glutaric acid was detected.  
 
 
Figure 5.4. Selection progression data. Blue bars show selection activity, and gray bars show the 
standard capture yield in each round of selection. 
 This finding could mean that the deoxyribozymes are only active in cis, when the DNA-
anchored amine is ligated. Perhaps any deoxyribozyme sequence requires the DNA loop that is 
present during selection for activity, and it loses activity when the loop is not present, such as when 
the deoxyribozyme is assayed in trans. To investigate this, an experiment is planned to incorporate 
a ribonuceotide linkage in the loop region. This allows for the selection step to be performed in 
cis, as it is during in vitro selection. After selection, the ribonucleotide linkage will be cleaved by 
RNase, making the DNA-anchored amine product small enough to detect addition of glutaric acid.  
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5.3 Summary 
 Lysine acylation is involved in many cellular processes including gene expression, cellular 
metabolism, and direct control of protein function. The identification of deoxyribozymes that 
catalyze acylation would provide a valuable approach to studying different acylation states. 
Acylation selections do not show catalytic activity. This is surprising because thioesters are good 
electrophiles are known to react readily with amine nucleophiles.16 In addition, a small amount of 
background activity was detected during selections, suggesting that this reaction does not require 
a catalyst. Despite this, no activity in trans was observed. If the enzymes are shown to work only 
in cis, selections could be performed with the loop region base paired by a complementary oligo, 
which would greatly reduce the possibility of the loop being involved in catalysis. If activity in cis 
is not occurring, and selection activity is a result of something else occurring, the next selection 
experiments would incorporate chemically modified nucleotides to enhance the catalytic ability of 
DNA, a strategy that has been successful to identify amide-cleaving DNA catalysts (Chapter 3). 
5.4 Materials and Methods 
5.4.1 Preparation of Oligonucleotides 
DNA oligonucleotides and oligonucleotide conjugates were obtained from Integrated DNA 
Technologies (Coralville, IA) or prepared by solid-phase synthesis on an ABI 394 instrument using 
reagents from Glen Research. All oligonucleotides and conjugates were purified by 7 M urea 
denaturing PAGE with running buffer 1 TBE (89 mM each Tris and boric acid and 2 mM EDTA, 
pH 8.3), extracted from the polyacrylamide with TEN buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 
300 mM NaCl), and precipitated with ethanol as described previously.17,18 Hexapeptide 
AAAK(tfa)AA was prepared by solid-phase synthesis using Fmoc Rink amide MBHA resin as 
 149 
 
described. The trifluoroacetyl protecting group was removed after conjugation to the DNA anchor 
oligonucleotide. 
Conjugation of AAAK(tfa)AA to DNA anchor oligonucleotide 
The DNA anchor oligonucleotide was 5-GGATAATACGACTCACTAT-HEG-rA-3, 
where the 3-terminal ribonucleotide was oxidized by NaIO4 and used for conjugation to the 
peptide N-terminus. A 100 µL sample containing 1.0 nmol of DNA anchor oligonucleotide in 100 
mM HEPES, pH 7.5, and 10 mM NaIO4 was incubated at room temperature for 1 h. The oxidized 
product was precipitated to remove excess NaIO4 by addition of 10 µL of 3 M NaCl and 330 µL 
of ethanol. The precipitated product was dissolved in 65 µL of water and used directly in the next 
step. A 100 µL sample containing the NaIO4- oxidized DNA anchor oligonucleotide and 100 nmol 
(100 equiv) of hexapeptide in 100 mM NaOAc, pH 5.2, 50 mM NiCl2, and 10 mM NaCNBH3 was 
incubated at 37 °C for 14 h. The DNA-anchored hexapeptide was precipitated by addition of 10 
µL of 3 M NaCl and 330 µL of ethanol. The trifluoroacetyl protecting group was removed by 
incubation in 100 uL of 30% NH4OH for 1 h at room temperature. NH4OH was removed in a 
speedvac and the conjugation product was purified by 20% PAGE. 
Synthesis of DNA-Glutaryl Thioester  
The DNA anchor oligonucleotide was 5-GGATAATACGACTCACTAT-C3-SSC3-OH-
3, where the 5-disulfide linker was introduced via standard solid-phase DNA synthesis and 
unmasked to a 5-thiol by DTT treatment. A 50 µL sample containing 2 nmol of DNA anchor 
oligonucleotide in 50 mM HEPES, pH 7.5, and 50 mM DTT was incubated at 37 °C for 2 h. The 
reduced product was precipitated to remove excess DTT by addition of 50 µL of water, 10 µL of 
3 M NaCl, and 330 µL of ethanol. The precipitated product (5-HS-C6-DNA) was dissolved in 35 
µL of water and used directly in the next reaction. A 50 µL reaction containing 100 mM sodium 
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phosphate buffer pH 7.4 and 60 mM glutaric anhydride was incubated at room temperature for 2 
h. Excess salts were removed using a 3kD Amicon column, and the DNA thioester product was 
purified by reverse-phase HPLC. Collected HPLC peaks were pooled, dried in a SpeedVac, 
redissolved in water, and quantified by UV absorbance (A260). 
5.4.2 In Vitro Selection Procedure 
In Vitro Selection Procedure Steps 
Procedure for ligation step in round 1. A 25 µL sample containing 600 pmol of DNA pool, 
750 pmol of DNA splint, and 900 pmol of DNA-C3-NH2 or DNA-HEG-AAAKAA substrate was 
annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min 
and cooling on ice for 5 min. To this solution was added 3 µL of 10 T4 DNA ligase buffer 
(Fermentas) and 2 µL of 5 U/µL T4 DNA ligase (Fermentas). 10 T4 DNA ligase buffer that lacks 
DTT (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) was used with disulfide-linked 
oligonucleotide-peptide conjugates. The sample was incubated at 37 °C for 12 h and purified by 
8% PAGE. 
Procedure for ligation step in subsequent rounds. A 17 µL sample containing the PCR-
amplified DNA pool (~5–10 pmol), 30 pmol of DNA splint, and 50 pmol of DNA-C3-NH2 or 
DNA-HEG-AAAKAA substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. To this solution was added 2 
µL of 10 T4 DNA ligase buffer (Fermentas) and 1 µL of 1 U/µL T4 DNA ligase (Fermentas). 
10 T4 DNA ligase buffer that lacks DTT (400 mM Tris, pH 7.8, 100 mM MgCl2, and 5 mM ATP) 
was used with disulfide-linked oligonucleotide-peptide conjugates. The sample was incubated at 
37 °C for 12 h and purified by 8% PAGE. 
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Procedure for selection step in round 1. Each selection experiment was initiated with 200 
pmol of the ligated pool. A 20 µL sample containing 200 pmol of ligated pool and 300 pmol of 5-
glutaryl thioester DNA was annealed in (conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, and 
0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. The selection reaction 
was initiated by bringing the sample to 40 µL total volume containing (conditions A) 70 mM 
HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM NaCl The Mn
2+ was 
added from a 10 stock solution containing 200 mM MnCl2. The Zn2+ was added from a 10 stock 
solution containing 10 mM ZnCl2, 20 mM HNO3, and 200 mM HEPES at pH 7.5; this stock 
solution was freshly prepared from a 100 stock of 100 mM ZnCl2 in 200 mM HNO3. The metal 
ion stocks were added last to the final sample. The sample was incubated at 37 °C for 14 h. 
Procedure for selection step in subsequent rounds. A 10 µL sample containing the ligated 
pool and 30 pmol of 5-glutaryl thioester DNA was annealed in (conditions A) 5 mM HEPES, pH 
7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 min. 
The selection reaction was initiated by bringing the sample to 20 µL total volume containing 
(conditions A) 70 mM HEPES, pH 7.5, 40 mM MgCl2, 20 mM MnCl2, 1 mM ZnCl2, and 150 mM. 
The sample was incubated at 37 °C for 14 h. 
Procedure for capture step in round 1. A 90 L sample containing the selection product, 
300 pmol of DNA splint, and 400 pmol of 5-amino capture oligonucleotide was annealed in 100 
mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on ice for 5 min. 
The capture reaction was initiated by bringing the sample to 100 µL total volume containing 100 
mM MOPS, pH 7.0, 1 M NaCl, and 50 mM EDC and 50 mM HOBt. DMF was used to dissolve 
the HOBt stock solution, and the total amount of DMF in the final capture reaction was 10 µL. 
The sample was incubated at 37 °C for 12 h. 
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Procedure for capture step in subsequent rounds. A 20 L sample containing the selection 
product, 50 pmol of DNA splint, and 100 pmol of 5-amino capture oligonucleotide was annealed 
in 100 mM MOPS, pH 7.0, and 1 M NaCl by heating at 95 °C for 3 min and cooling on ice for 5 
min. The capture reaction was initiated by bringing the sample to 25 µL total volume containing 
100 mM MOPS, pH 7.0, 1 M NaCl, and 50 mM EDC and 50 mM HOBt. DMF was used to dissolve 
the HOBt stock solution, and the total amount of DMF in the final capture reaction was 10 µL. 
The sample was incubated at 37 °C for 12 h. 
Procedure for PCR. In each selection round, two PCR reactions were performed, 10-cycle 
PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared containing the PAGE-
purified selection product, 200 pmol of forward primer, 50 pmol of reverse primer, 20 nmol of 
each dNTP, and 10 µL of 10 Taq polymerase buffer [1 = 20 mM Tris-HCl, pH 8.8, 10 mM 
(NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100]. This sample was cycled 10 times 
according to the following PCR program: 94 °C for 2 min, 10 (94 °C for 30 s, 47 °C for 30 s, 72 
°C for 30 s), 72 °C for 5 min. Taq polymerase was removed by phenol/chloroform extraction. 
Second, a 50 µL sample was prepared containing 1 µL of the 10-cycle PCR product, 100 pmol of 
forward primer, 25 pmol of reverse primer, 10 nmol of each dNTP, 20 µCi of -32P-dCTP (800 
Ci/mmol), and 5 µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to 
the following PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 
72 °C for 5 min. Samples were separated by 8% PAGE. 
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Chapter 6: DNA-Catalyzed Glycosyltransferase Activity1 
6.1 Introduction 
6.1.1 Glycosylation 
Protein glycosylation affects more than 50% of human proteins and is involved in protein 
recognition, cellular communication.1  Methods to prepare peptides, proteins, and small molecules 
in vitro with specific glycan profiles are of widespread interest. Several different methods have 
been developed towards this goal. Natural glycosyltransferase enzymes have bene used to create 
libraries of glycosylated species, and directed evolution has been used to expand the promiscuity 
of glycosyltransferases to catalyze reactions with an expanded scope of glycosyl donors and 
glycosyl acceptors.2-5 Additional synthetic efforts have been reported,6 but this approach comes 
with significant challenges. 
 In vivo methods to produce specific glycosylation profiles have also been reported. 
Metabolic engineering of biosynthesis pathways can yields proteins with desired glycan profiles 
different from those produced from the natural pathway.7 Genetic methods that incorporate an 
unnatural amino acid which can be further derivatized (e.g., a selenium-containing amino acid that 
is converted to dehydroalanine and reacted with a glycosylated thiol species) to yield a glycosyl 
mimic have been widely used.8 In general, each in vitro or in vivo technique has one or more major 
challenges associated with its widespread use. Alternatively, the development of deoxyribozymes 
which catalyze reaction between unique glycosyl donors and acceptors would provide a robust, in 
vitro method to prepare glycosylated proteins and small molecules. 
 
                                                          
1 A manuscript describing this work is in preparation. University of Illinois undergraduate Anthony 
Hesser performed some of the work in this chapter under my supervision. 
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6.1.2 Previous Efforts for DNA-Catalyzed Glycosylation 
Toward the longer-term goal of peptide glycosylation deoxyribozymes, we previously 
sought9 DNA-catalyzed glycosylation using the sugar nucleotide UDP-GlcNAc as the glycosyl 
donor during the key in vitro selection step of each round, followed by capture via NaIO4 oxidation 
of the GlcNAc moiety and reductive amination with amino-modified DNA. However, that 
approach was subverted by a UDP-GlcNAc-independent DNA-catalyzed DNA deglycosylation 
reaction.  
6.1.3 In Vitro Selection Design 
 To avoid side reactions resulting from capture step difficulties, the glycosyl donor was 
tethered to an oligonucleotide substrate. The in vitro selection strategy would then be similar to 
others described in prior chapters. Reaction between the nucleophile and the glycosyl donor would 
form a new glycosidic linkage. Because each of these is tethered to an oligonucleotide, reaction 
would add enough mass to the product to enable direct PAGE shift selection. 
6.2 Results and Discussion 
Nucleoside Diphosphate Glycosyl donors 
Initial attempts to conjugate nucleoside diphosphate sugars used the enzyme galactose 
oxidase to oxidize C6 of UDP-galactose to an aldehyde, followed by conjugation to an amino-
modified or hydrazide-modified oligo. Unfortunately, this strategy never afforded high-yielding 
conjugation. Commercially-available UDP-glucuronic acid has the C6 of glucose oxidized to a 
carboxylic acid. This was conjugated to an amino-modified oligo using DMT-MM, affording the 
DNA-Glc-UDP conjugate.  
On the basis of previous reports nucleotide sugar instability in the presence of divalent 
metal ions, the stability of the DNA-Glc-UDP conjugate was evaluated. The conjugate degraded 
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extremely rapidly in the presence of either 1 mM Zn2+ or 20 mM Mn2+ at pH 7.5, showing ~50% 
degradation after 30 sec. The nucleotide sugar was more stable in 1 mM Zn2+ and 20 mM Mn2+ at 
pH 6.0, showing ~50% degradation after 2 h at 37 C. The DNA-Glc-UDP conjugate was less 
sensitive to 40 Mg2+, showing ~25% degradation at pH 7.5 after 2 h and ~25% degradation at pH 
9.0 after 2 h. Eventually, three selection conditions were identified in which the nucleotide sugar 
was adequately stable for a 2h incubation: MES pH 6.0 with 1 mM Zn2+, 20 mM Mn2+, 40 mM 
Mg2+, and 150 mM NaCl; HEPES pH 7.5 with 40 mM Mg2+ at 150 mM NaCl; and CHES pH 9.0 
with 5 mM Mg2+ at 150 mM NaCl.  
Three glycosyl acceptors were included in selection: DNA-HEG-CYA, DNA-HEG-CKA, 
and DNA-5-OH. DNA-catalyzed peptide and protein glycosylation is the long-term goal, while 
the DNA-5-OH substrate was chosen as the most basic glycosyl acceptor. 12 rounds of in vitro 
selections were as illustrated in Fig. Selection, but no activity was observed and selections were 
discontinued. It is somewhat surprising no deoxyribozymes were identified considering the strong 
reactivity of the nucleotide sugar glycosyl donors. One hypothesis is that the selection conditions 
chosen were not capable of supporting active DNA catalysts, and thus glycosyl donors that are 
stable in selections must be identified.  
O-Aryl Glycoside Glycosyl donors 
 O-aryl glycosides are can also act as glycosyl donors. A recent report showed that, with 
electron-withdrawing substituents on the aryl ring, O-aryl glycosides can be even more reactive 
than nucleotide sugars in enzyme-catalyzed reactions.3 In addition, because they don’t contain a 
diphosphate moiety which is known to bind to divalent metal ions, O-aryl glycosides would likely 
be less sensitive to divalent metal ion cofactors than nucleotide sugars.  
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 The 2-Cl-4-NO2 derivative was reported to be one of the most activated derivatives of O-
aryl β-D-glucose. The glucuronic acid version was prepared in two steps starting from peracylated 
β-D-glucopyranoside bromide. This was reacted 2-chloro-4-nitrophenol using Ag2O as a Lewis 
acid catalyst to form peracylated 2-chloro-4-nitrophenyl β-D-glucopyranoside. Cleavage of the O-
acetyl and methyl ester protecting groups yielded the desired product. After conjugation to an 
amino-modified DNA oligo, the stability of the conjugate was evaluated. No degradation in the 
selection conditions was observed with 2-Cl-4-NO2-β-D-glucose conjugate was observed.  
Initial selections used DNA-HEG-CAASAA, DNA-HEG-CAAYAA, and DNA- 3-OH as 
nucleophiles. Ideally, deoxyribozymes will be identified for serine and tyrosine glycosylation, 
because that is of broader biological interest. The 3-OH substrate was chosen as a substrate similar 
to serine, because both substrates have aliphatic hydroxyl nucleophiles. In the 3-OH substrate, the 
hydroxyl is held more tightly to the NDA anchor, which but the hydroxyl on the oligonucleotide 
is held more tightly to the DNA anchor to reduce the requirement for the DNA enzyme to bind the 
loosely tethered substrate from solution (as with DNA-HEG-CAASAA). Four selection conditions 
were identified: (conditions A) 70 mM HEPES, pH 7.5, 1 mM Zn2+, 20 mM Mn2+, 40 mM Mg2+, 
and 150 mM NaCl; (conditions B) 50 mM CHES, pH 9.0, 40 mM Mg2+, and 150 mM NaCl; 
(conditions C) 70 mM HEPES, pH 7.5, 1 mM Zn2+, 10 μM Ce3+, 10 μM Eu3+, 10 μM Yb3+, and 
150 mM NaCl; or (conditions D) 70 mM HEPES, pH 7.5, 10 μM Ce3+, 10 μM Eu3+, 10 μM Yb3+, 
and 150 mM NaCl. Selections with lanthanide cofactors were included because they have been 
useful cofactors for DNA-catalyzed reactions previously.10,11  
After 11 selection rounds, the pool activity for tyrosine reactivity under selection 
conditions A (named the GQ1 selection) was ~30% (Fig. 6.1). Evaluation of these sequences 
showed that full activity was observed when only the DNA anchor was present, suggesting peptide 
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glycosylation was not occurring. Despite the observation that peptide glycosylation was not 
occurring, the selection were cloned from round 11 and sequencing revealed three unique 
sequences (Fig. 6.2). The two highest yielding sequences, 11GQ114 and 11GQ117, were prepared 
by solid-phase synthesis. Preliminary results show that each sequence is catalyzing glycosylation 
of the DNA enzyme region. Additional experiments to determine the site of branching are 
underway. 
Selection for DNA-3-OH glycosylation in conditions A showed approximately was cloned 
from round 11 with ~15% pool (Fig. 6.1). Two unique sequences were identified after sequencing 
(Fig. 6.2), and their biochemical activity is being investigated. 
11GV112 was chosen for reselection. It was partially randomized to the extent of 25% per 
nucleotide and reselected with the parent 2-chloro-4-nitrophenyl-β-D-glucose substrate. The 
selection was cloned from 24% pool activity after eight rounds of selection (Fig. Prog1). Several 
related sequences were identified (Fig. 6.3), and their catalytic activity is being investigated. 
 
Figure 6.1. Selection progression for GQ1, GV1, and LZ1 selection experiments. Both GQ1 and 
GV1 were cloned from round 11. LZ1 was cloned from round 8.  
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Figure 6.2. Sequence alignment of the deoxyribozyme sequences identified from the GQ1 and 
GV1 selections. Alignment shows only the initially random region. A dot denotes conservation, 
i.e., the same nucleotide as in the uppermost sequence.  
 
 
Figure 6.3. Sequence alignment of the deoxyribozyme sequences identified from the LZ1 
selection relative to the parent enzyme sequence 11GV112. Alignment shows only the initially 
random region. A dot denotes conservation, i.e., the same nucleotide as in the uppermost sequence.  
 Because no deoxyribozymes for peptide glycosylation were identified from selections 
using the -anomer, selections using the -anomer were explored. 4-NO2--D-glucose is 
commercially available, and methods to synthesize the -anomer of O-aryl glycosides are more 
limited than those for the -anomer. Synthesis of 2-Cl-4-NO2--D-glucose was not attempted, and 
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instead 4-NO2--D-glucose was oxidized to 4-NO2--D-glucuronic acid in a single step. Stability 
assays showed no degradation in the selection conditions A. 
 The 4-NO2--D-glucuronic acid conjugate was used in selections seeking tyrosine 
reactivity and 3-OH reactivity. Selection for tyrosine showed no activity after 17 rounds and was 
discontinued. Selection for 3-OH reactivity was cloned from 15% activity at round 16 (Fig. 6.4). 
Two unique 16MJ1 sequences were identified after sequencing (Fig. 6.5). These were prepared by 
solid-phase synthesis and are being assayed for biochemical properties (e.g., metal dependence, 
pH dependence, substrate specificity) 
 
Figure 6.4. Selection progression for MJ1 selection experiment. MJ1 was cloned from round 16. 
 
Figure 6.5. Sequence alignment of the deoxyribozyme sequences identified from the MJ1 
selections. Alignment shows only the initially random region. A dot denotes conservation, i.e., the 
same nucleotide as in the uppermost sequence.  
The sequence of 16MJ101 was chosen for reselection with the parent substrate. The 
sequence was randomized to the extent of 25% per nucleotide and subjected to reselection. 
Reselections are currently in round 7.  
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6.3 Summary 
 Glycosylation is a critically important post-translational modification that affects a number 
of diverse cellular processes including molecular recognition, signaling, and cellular interactions. 
Because of their complex structure, the chemical synthesis of polysaccharides is extremely 
challenging, and this synthetic difficulty significantly limits complete understanding of their 
biological purpose. Therefore, the continued development of methods to prepare glycosylated 
peptides and proteins will affect glycobiology.  
 The first efforts seeking DNA-catalyzed glycosylation were subverted by a DNA-catalyzed 
reaction in the capture step conditions. Any such side reactions were avoided by the tethering of 
the glycosyl acceptor to DNA, so that direct PAGE selection could be performed. This strategy 
was first used with nucleotide sugars, but no deoxyribozymes were identified, perhaps due to the 
limited selection conditions required by nucleotide sugar instability.  
 Subsequent efforts used both the  and  anomer of O-aryl glycosides. These substrates 
were significantly less sensitive to degradation in the presence of divalent metal ions. Separately, 
deoxyribozymes for glycosylation of DNA 3-OH that use either the  or  another of O-aryl D-
glucose have been identified. Additionally, deoxyribozymes that catalyze self-glycosylation of the 
DNA enzyme region, most likely at a nucleobase, have been identified. These branching 
deoxyribozymes were identified from a selection seeking peptide glycosylation, although it is 
surprising that this branched product was preferred to reactivity at tyrosine, considering tyrosine’s 
strong nucleophilic character. A revised selection design to prevent identification of branch-
forming deoxyribozymes has been implemented, and selections seeking peptide glycosylation are 
underway.  
6.4 Materials and Methods 
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6.4.1 Preparation of Oligonucleotide Substrates 
DNA oligonucleotides and oligonucleotide conjugates were obtained from Integrated DNA 
Technologies (Coralville, IA) or prepared by solid-phase synthesis on an ABI 394 instrument using 
reagents from Glen Research. All oligonucleotides and conjugates were purified by 7 M urea 
denaturing PAGE with running buffer 1 TBE (89 mM each Tris and boric acid and 2 mM EDTA, 
pH 8.3), extracted from the polyacrylamide with TEN buffer (10 mM Tris, pH 8.0, 1 mM EDTA, 
300 mM NaCl), and precipitated with ethanol as described previously.12,13 
Preparation of DNA-anchored Peptide and Glysoside substrates 
Procedure for synthesis of DNA-anchored peptide conjugates. A 50 μL sample containing 
5 nmol of 5-DNA-HEG-p-C3-SS-C3-OH-3 or 5-DNA-C3-SS-C3-OH-3 oligonucleotide in 100 
mH HEPES, pH 7.5, and 50 mM DTT was incubated at 37 °C for 2 h. The reduced product was 
precipitated by adding 50 μL of water, 10 μL of 3 M NaCl, and 330 μL of ethanol. The precipitated 
product (DNA-HEG-p-C3-SH or DNA-C3-SH) was dissolved in 35 μL of water and 10 μL of 100 
mM triethylammonium acetate, pH 7.0. Activation as the pyridyl disulfide was achieved by adding 
5 μL of 100 mM 2,2-dipyridyl disulfide in DMF and incubating at 37 °C for 2 h. The product 
(DNA-HEG-p-C3-SSPy or DNA-C3-SSPy) was precipitated by adding 50 μL water, 10 μL of 3 M 
NaCl, and 330 μL of ethanol and dissolved in 35 µL of water. The oligonucleotide was conjugated 
to the peptide by adding 10 μL of 100 mM triethylammonium acetate, pH 7.0, and 5 μL of 20 mM 
peptide (100 nmol, 20 equivalents). The reaction was incubated at 37 °C for 12 h and purified by 
20% PAGE. 
 Procedure for synthesis of DNA-glycoside conjugates. A 20 μL solution containing 2 nmol 
of 5-NH2-DNA-3, 45 mM of activated glucuronide, 50 mM MOPS, pH 7.0, and 450 mM DMT-
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MM was incubated at room temperature for 24 h. Unreacted reagents were removed by Amicon 
spin column, and the DNA conjugate was purified by HPLC. 
6.4.2 In Vitro Selection 
In Vitro Selection Procedure Steps 
Procedure for ligation step in round 1. A 25 µL sample containing 1.2 nmol of DNA pool, 
900 pmol of DNA splint, and 600 pmol of carbonyl-based substrate was annealed in 5 mM Tris, 
pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice for 5 
min. To this solution was added 3 µL of 10 T4 DNA ligase buffer (Fermentas) and 2 µL of 5 
U/µL T4 DNA ligase (Fermentas). The sample was incubated at 37 °C for 12 h and purified by 
8% PAGE. 
Procedure for ligation step in subsequent rounds. A 17 µL sample containing the PCR-
amplified DNA pool (~5–10 pmol), 30 pmol of DNA splint, and 50 pmol of carbonyl-based 
substrate was annealed in 5 mM Tris, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 
°C for 3 min and cooling on ice for 5 min. To this solution was added 2 µL of 10 T4 DNA ligase 
buffer (Fermentas) and 1 µL of 1 U/µL T4 DNA ligase (Fermentas). The sample was incubated at 
37 °C for 12 h and purified by 8% PAGE. 
Procedure for selection step in round 1. Each selection experiment was initiated with 200 
pmol of the ligated pool. A 20 µL sample containing 200 pmol of ligated pool was annealed in 
(conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA or (conditions B) 5 mM 
CHES, pH 9.0, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and cooling on ice 
for 5 min. The selection reaction was initiated by bringing the sample to 40 µL total volume 
containing (conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, 
and 150 mM NaCl or (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 150 mM NaCl. 
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The Mn2+ was added from a 10 stock solution containing 200 mM MnCl2. The Zn2+ was added 
from a 10 stock solution containing 10 mM ZnCl2, 20 mM HNO3, and 200 mM HEPES at pH 
7.5; this stock solution was freshly prepared from a 100 stock of 100 mM ZnCl2 in 200 mM 
HNO3. The metal ion stocks were added last to the final sample. The sample was incubated at 37 
°C for 14 h and precipitated with ethanol. 
Procedure for selection step in subsequent rounds. A 10 µL sample containing the ligated 
pool was annealed in (conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA or 
(conditions B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 
min and cooling on ice for 5 min. The selection reaction was initiated by bringing the sample to 
20 µL total volume containing (conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 
40 mM MgCl2, and 150 mM NaCl or (conditions B) 50 mM CHES, pH 9.0, 40 mM MgCl2, and 
150 mM NaCl. The sample was incubated at 37 °C for 14 h and precipitated with ethanol. 
Procedure for PCR in subsequent rounds. In each selection round, two PCR reactions were 
performed, 10-cycle PCR followed by 30-cycle PCR. First, a 100 µL sample was prepared 
containing the PAGE-purified selection product, 200 pmol of forward primer, 50 pmol of reverse 
primer, 20 nmol of each dNTP, and 10 µL of 10 Taq polymerase buffer (1 = 20 mM Tris-HCl, 
pH 8.8, 10 mM (NH4)2SO4, 10 mM KCl, 2 mM MgSO4, and 0.1% Triton X-100). This sample was 
cycled 10 times according to the following PCR program: 94 °C for 2 min, 10 (94 °C for 30 s, 
47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 min. Taq polymerase was removed by PCI extraction. 
Second, a 50 µL sample was prepared containing 1 µL of the 10-cycle PCR product, 100 pmol of 
forward primer, 25 pmol of reverse primer, 10 nmol of each dNTP, 20 µCi of -32P-dCTP (800 
Ci/mmol), and 5 µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to 
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the following PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 
72 °C for 5 min. Samples were separated by 8% PAGE. 
6.4.3 Characterization of Deoxyribozymes 
Identification of individual deoxyribozyme sequences 
Cloning and screening of individual deoxyribozymes. The PCR primers used for cloning 
were 5-CGAAGCGCTAGAACAT-3 (forward primer; same as in selection) and 
5-TAATTAATTAATTACCCATCAGGATCAGCT-3 (reverse primer). The 10-cycle PCR 
product from the appropriate selection round was diluted 103-fold. A 50 µL sample was prepared 
containing 1 µL of the diluted 10-cycle PCR product from the appropriate selection round, 100 
pmol of forward cloning primer, 25 pmol of reverse cloning primer, 10 nmol of each dNTP, and 5 
µL of 10 Taq polymerase buffer. This sample was cycled 30 times according to the following 
PCR program: 94 °C for 2 min, 30 (94 °C for 30 s, 47 °C for 30 s, 72 °C for 30 s), 72 °C for 5 
min. The sample was separated by 1% agarose gel and extracted using a GeneJET Gel Extraction 
Kit (Fermentas). The extracted product was quantified by absorbance (A260) and diluted to 4–8 
ng/µL. A 1 µL portion of the diluted PCR product was inserted into the pCR2.1-TOPO vector 
using a TOPO TA cloning kit (Life Technologies). Individual E. coli colonies harboring plasmids 
with inserts were identified by blue-white screening and grown in LB/amp media. Miniprep DNA 
was prepared using a GeneJET Plasmid Miniprep Kit (Fermentas) and screened for properly sized 
inserts by EcoRI digestion and agarose gel analysis. Before sequencing, assays of individual 
deoxyribozyme clones were performed with PAGE-purified DNA strands prepared by PCR from 
the miniprep DNA, using the single-turnover assay procedure described in the main text. 
Single-turnover deoxyribozyme assay 
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Single-turnover deoxyribozyme assay. The ester or anilide substrate was 5-32P-
radiolabeled using -32P-ATP and polynucleotide kinase (Fermentas). A 10 µL sample containing 
0.2 pmol of 5-32P-radiolabeled ester or anilide substrate and 20 pmol of deoxyribozyme was 
annealed in (conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM EDTA or (conditions 
B) 5 mM CHES, pH 9.0, 15 mM NaCl, and 0.1 mM EDTA by heating at 95 °C for 3 min and 
cooling on ice for 5 min. The DNA-catalyzed hydrolysis reaction was initiated by bringing the 
sample to 20 µL total volume containing (conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 
mM MnCl2, 40 mM MgCl2, and 150 mM NaCl or (conditions B) 50 mM CHES, pH 9.0, 40 mM 
MgCl2, and 150 mM NaCl. The sample was incubated at 37 °C. At appropriate time points, 2 µL 
aliquots were quenched with 5 µL stop solution (80% formamide, 1 TBE [89 mM each Tris and 
boric acid and 2 mM EDTA, pH 8.3], 50 mM EDTA, 0.025% bromophenol blue, 0.025% xylene 
cyanol). Samples were separated by 20% PAGE and quantified with a PhosphorImager. Values of 
kobs were obtained by fitting the yield versus time data directly to first-order kinetics; i.e., 
yield = Y•(1 – e–kt), where k = kobs and Y is the final yield. Each kobs value is reported with error 
calculated as the standard deviation from the indicated number of independent determinations. 
When kobs was sufficiently low such that an exponential fit was not meaningful, the initial points 
were fit to a straight line, and kobs was taken as the slope of the line. 
RNase Digestion Procedure 
 The monoribonucleotide-substituted deoxyribozyme was 5’-32P-radiolabeled using γ-32P-
ATP and polynucleotide kinase (Fermentas). 2 pmol of the radiolabeled deoxyribozyme, 30 pmol 
of DNA-glycoside conjugate, and 50 pmol of 5’-DNA-OH-3’ L substrate were annealed in a 10 
μL solution of (for selection conditions A) 5 mM HEPES, pH 7.5, 15 mM NaCl, and 0.1 mM 
EDTA. The selection reaction was initiated by bringing the sample to 20 μL total volume 
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containing (conditions A) 70 mM HEPES, pH 7.5, 1 mM ZnCl2, 20 mM MnCl2, 40 mM MgCl2, 
and 150 mM NaCl. The reaction was incubated at 37 °C for 14 h, and the product was purified by 
15% PAGE. 
1 μL of 10 RNase T1 buffer (100 mM Tris-HCl, pH 7.0, 1 M KCl, 100 mM MgCl2) or 1 
μL of 10 RNase 1 buffer (195 mM Tris-HCl, pH 8.0, 1 mM EDTA, 0.1% Triton X-100, 1 M 
NaCl) and 0.5 μL of 20 U/μL RNase T1 (Ambion) or 0.5 μL of 20 U/μL RNase 1 (Ambion) were 
added to a 8.5 μL solution containing 0.2 pmol of 5’-32P-radiolabeled enzyme-glycoside branched 
product. The 10 μL reaction was incubated at 37 °C for 1 h and quenched with 10 μL stop solution 
(80% formamide, 1 TBE [89 mM each Tris and boric acid and 2 mM EDTA, pH 8.3], 50 mM 
EDTA, 0.025% bromophenol blue, 0.025% xylene cyanol). Samples were separated by 20% 
PAGE and quantified with a PhosphorImager. 
6.4.4 Chemical Synthesis of Glycoside Donors 
Reagents were commercial grade and used without purification unless otherwise indicated. 
Dry solvents were obtained from Aldrich Sure/Seal or Acros Acroseal bottles. All reactions were 
performed under argon unless otherwise noted. Thin-layer chromatography (TLC) was performed 
on silica gel plates pre-coated with fluorescent indicator with visualization by UV light (254 nm). 
Flash column chromatography was performed with silica gel (230-400 mesh). 1H and 13C spectra 
were recorded on a Varian Unity 500 or Varian Unity 500 VXR instrument. The chemical shifts 
in parts per million (δ) are reported downfield from TMS (0 ppm) and referenced to the residual 
proton signal of the deuterated solvent, as follows: CDCl3 (7.26 ppm), CD3OD (3.31 ppm) for 
1H 
NMR spectra; CDCl3 (77.2 ppm), CD3OD (49.2 ppm) for 
13C NMR spectra. Multiplicities of 1H 
NMR spin couplings are reported as s (singlet), d (doublet), t (triplet), q (quartet), dd (doublet of 
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doublets), or m (multiplet and overlapping spin systems). Values for apparent coupling constants 
(J, Hz) are reported. 
Peracylated 2-chloro-4-nitrophenyl β-D-glucopyranoside 
To a flame-dried, 25-mL round-bottom flask under argon, peracylated β-D-glucopyranoside 
bromide (105 mg, 0.264 mmol, 1.0 equiv; Carbosynth) was added and dissolved with 2.8 mL of 
anhydrous CH3CN. 2-Chloro-4-nitrophenol (49 mg, 0.282 mmol, 1.1 equiv) and Ag2O (151 mg, 
0.652 mmol, 2.5 equiv) were added, the flask was covered with aluminum foil, and the mixture 
was stirred at room temperature for 24 h, after which the reaction was deemed complete by TLC 
(Rf = 0.69, 1:1 hexanes:ethyl acetate). The mixture was twice passed through a plug of Celite 545. 
The yellow filtrate was concentrated on a rotary evaporator and the resulting light brown oil was 
dissolved in 30 mL ethyl acetate, washed with 3 portions of 25 mL saturated NaHCO3, 3 portions 
of 25 mL brine, and dried over MgSO4. The filtrate from vacuum filtration was concentrated on a 
rotary evaporator, yielding a light brown solid. The solid was dissolved in 0.5 mL of 2:1 
hexanes:ethyl acetate and 2 mL CH2Cl2 and purified by silica gel flash column chromatography 
(15 g of silica, gradient elution with hexanes:ethyl acetate). Fractions containing the desired 
compound were concentrated on a rotary evaporator and dried under high vacuum, yielding a white 
solid (113 mg, 0.231 mmol, 87% yield). 
1H NMR (500 MHz, CDCl3): δ 8.26 (d, J = 2.7 Hz, 1H), 8.12 (dd, J = 2.7 Hz, 9.1 Hz, 1H), 7.28 
(d, J = 9.1 Hz, 1H), 5.40-5.34 (m, 3H), 5.29-5.27 (m, 1H), 4.29 (d, J = 8.6 Hz, 1H), 3.71 (s, 3H), 
2.08 (s, 3H), 2.05 (s, 6H) ppm. 
13C NMR (125 MHz, CDCl3): δ 170.1, 169.5, 166.8, 157.3, 143.5, 126.3, 125.1, 123.9, 116.8, 99.0, 
72.9, 71.1, 70.4, 68.8, 53.3, 20.8, 20.7 ppm. 
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2-chloro-4-nitrophenyl-β-D-glucuronide 
Peracylated β-D-glucopyranoside-O-(2-chloro-4-nitro)phenol (100 mg, 0.204 mmol) was 
dissolved in 10 mL methanol. To this solution, 10 mL of 200 mM NaOH were added, and the 
yellow mixture was stirred at room temperature for 3 h. The solution was neutralized with 
Amberlite IR-120 H+ form resin, filtered, and concentrated on a rotary evaporator. The residue 
was dissolved in 3 mL of methanol and passed through a small plug of silica with 20% methanol 
in CH2Cl2. The fractions containing the compound were concentrated on a rotary evaporator. The 
resulting residue was dissolved in a minimal amount of ethanol, cooled on ice, and crystallized 
upon addition of cold hexanes. The free-floating solid was collected by vacuum filtration through 
a glass frit. The glass frit was washed with methanol to elute the sample, and the filtrate was 
concentrated on a rotary evaporator (9 mg, 0.026 mmol, 13% yield). 
1H NMR (500 MHz, CD3OD): δ 8.29 (d, J = 2.7 Hz, 1H), 8.17 (dd, J = 2.7 Hz, 9.2 Hz, 1H), 7.46 
(d, J = 9.2 Hz, 1H), 5.20 (d, J = 7.6 Hz, 1H), 3.87-3.84 (m, 1H), 3.65-3.53 (m, 3H) ppm. 
4-nitrophenyl-α-D-glucuronide 
4-Nitrophenyl-α-D-glucose (106 mg, 0.350 mmol, 1 equiv; Chem-Impex) was added to 5.33 mL 
of NaHCO3/Na2CO3 buffer (100 mM, pH 10.7) in a 25 mL round-bottomed flask and the mixture 
was stirred until most of the solid dissolved. NaBr (8 mg, 0.078 mmol, 0.22 equiv) and TEMPO 
(0.9 mg, 0.006 mmol, 0.02 equiv) were added, and the solution was cooled to 0 °C. 1.22 mL of 
5% NaOCl solution in water was added, and the mixture was allowed to return to room temperature 
while stirring continued. After 3 h, another 1.22 mL of 5% NaClO was added on ice, 0.02 equiv 
of TEMPO were added, and the solution was stirred at room temperature for 3 d. The reaction was 
quenched by addition of 4.5 mL MeOH and was stirred for 1 h at room temperature. The solution 
was concentrated on a rotary evaporator to approximately 2 mL. The resulting yellow solution was 
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purified by eluting through a Waters Sep-Pak Plus C18 Cartridge (0.5 mL loading volume, eluted 
with 1 mL/min flow rate). The appropriate fractions were concentrated on a SpeedVac, and the 
resulting light yellow solid was triturated 3 times with EtOH and dried on a SpeedVac, leaving a 
light yellow powder (141 mg, crude) that was used without further purification. 
1H NMR (500 MHz, D2O): δ 8.08 (d, J = 9.4 Hz, 2H), 7.13 (d, J = 9.4 Hz, 2H), 5.68 (d, J = 3.7 
Hz, 1H), 3.84-3.80 (m, 2H), 3.68 (dd, J = 3.7 Hz, 9.9 Hz, 1H), 3.44 (dd, J = 9.3 Hz, 9.9 Hz, 1H) 
ppm. 
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